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ABSTRACT 
The aim of this investigation was to define the in vitro conditions 
necessary to support cytochrome P450-mediated metabolism in rat 
cultured hepatocytes, such that this system could then be used as an 
in vitro model in the study of cytochrome P450-mediated cytotoxicity. 
Maintenance of P450-dependent enzyme activities in culture was not 
affected by supplementation of culture medium with haem, but was 
markedly influenced by the age and sex of the hepatocyte donor 
animal. 
Induction in primary culture by phenobarbitone and 
beta-naphthoflavone was investigated, and found to be quantitatively 
and qualitatively different to the induction observed in vivo, 
hepatocytes in culture being particularly refractive to induction by 
phenobarbitone. The maintenance in primary culture of a range of 
enzyme activities was determined following treatment of rats in vivo 
with isoniazid and dexamethasone, in addition to phenobarbitone and 
beta-naphthoflavone, and in general, there was good maintenance of 
the induced activities. The activities were chosen as possible 
selective substrates for the different induced isozymes, with a view 
to using the activity profiles to characterise different classes of 
inducer; however, although selective induction was observed with 
isoniazid, beta-naphthoflavone and dexamethasone, all the chosen 
activities were induced by phenobarbitone. 
The final part of this work involved determining cytotoxicity in 
vitro, following induction of P450 in vivo with phenobarbitone and 
iii 
beta-naphthoflavone. Seven known hepatotoxins were investigated, 
and the results obtained agreed well with available in vitro and in 
vivo literature data. 
In summary, a range of constitutive and induced enzyme activities 
were maintained at high levels in hepatocytes cultured for 
twenty-four hours from adult male rats, and an induction in i/ 
vivo/hepatocyte culture protocol shown to be a viable in vitro model 
for the study of metabolism-mediated toxicity, as an alternative to 
induction and detection of toxicity in vitro. 
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ABBREVIATIONS 
All abbreviations are defined the first time that they appear in the 
text, with the exception of the following, deemed acceptable by the 
Biochemical Journal (257: 1-21,1989) which are used without 
definition: 
AMP adenosine monophospate 
ATP adenosine triphosphate 
CoA coenzyme A 
DNA deoxyribonucleic acid 
EDTA ethylenediaminetetraacetic acid 
EGTA ethyleneglycol-bis (B-aminoethyl ether) 
N-^  Nj N' N'-tetraacetic acid 
FAD flavin adenine dinucleotide 
FMN flavin mononucleotide 
HEPES N-(2-hydroxyethyl) piperazine-N'-
(2-ethanesulphonic acid) 
NAD(H) nicotinamide adenine dinucleotide 
NADP(H) nicotinamide adenine dinucleotide phosphate 
mRNA messenger ribonucleic acid 
Tris tris(hydroxymethyl) aminomethane 
UDP uridine diphosphate 
CHAPTER 1 
INTRODUCTION 
2 
CHAPTER 1 
CONTENTS PAGE 
General Introduction 4 
1.1 CYTOCHROME P450 5 
1.1.1 Background and history 5 
1.1.2 Chemistry and enzymology of MFO reactions 7 
1.1.3 Isozymic forms of P450 10 
1.2 REGULATION OF P450 EXPRESSION 15 
1.2.1 Constitutive P450 expression 15 
1.2.2 Induction of P450 21 
1.2.3 Molecular mechanisms of regulation 24 
1.2.4 Inhibition of P450 25 
1.3 P450 AND XENBIOTIC METABOLISM 26 
1.3.1 Factors affecting drug metabolism 29 
1.4 METHODS OF STUDYING HEPATIC DRUG METABOLISM 
AND TOXICITY 33 
1.4.1 In vivo and perfused organ studies 33 
1.4.2 In vitro techniques 34 
1.4.3 Intact cell systems 37 
1.4.4 Hepatocytes in primary culture 39 
1.4.5 Maintenance of P450 in primary culture 42 
1.4.6 Induction of P450 in culture 47 
1.4.7 Metabolism/toxicity studies in cultured rat 
hepatocytes 50 
1.4.8 Human hepatocytes in primary culture 51 
3 
1-4.9 Use of hepatoma cell lines 51 
1-4.10 Species differences in metabolism 53 
1.5 RATIONALE AND AIMS OF THIS STUDY 56 
TABLES AND FIGURES 
4 
CHAPTER 1 
GENERAL INTRODUCTION 
The cytochrome P450 mixed-function oxygenases are involved in the 
metabolism of a variety of endogenous substrates. However, a 
considerable number of these enzymes also have the capacity to 
metabolise a wide range of structurally diverse xenobiotics 
including dietary constituents, environmental pollutants, 
insecticides and therapeutically administered drugs. Some of these 
xenobiotics are noxious to man per se, but many others are 
biotransformed to reactive highly toxic intermediates, predominantly 
by the action of cytochrome P450 enzymes. This can lead to 
cellular dysfunction, carcinogenesis and death. The function of 
these enzymes is probably to activate compounds such that they can 
be detoxified by the action of conjugative enzymes, however, the 
balance of these reactions can be disrupted by many factors. The 
potential for P450 to generate toxic metabolites has important 
ramifications in many areas of study e.g. occupational or accidental 
exposure to industrial chemicals or environmental pollutants, and 
drug development and therapy. 
The cytochrome P450s have been found in most of the organisms in 
which they have been sought. They are also found in most mammalian 
tissues, hence the literature available on these enzymes is 
enormous, and this review cannot adequately cover every aspect of 
P450 metabolism. The work presented here is concerned with hepatic 
P450 metabolism and toxicity, and therefore most of this 
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introduction is confined to the role of cytochrome P450 in hepatic 
biotransformation, and the development of toxicity in this organ. 
Where possible, reference is made to drug metabolism in Man; 
however, much of our understanding of P450 metabolism has been 
obtained from rodent studies, particularly the rabbit, rat and 
mouse. This introduction is divided into four main sections; the 
latter parts deal with regulation of P450 expression and with 
methods of studying hepatic drug metabolism; the first part of this 
review deals with the integrated role of P450 in metabolism, 
particularly in the liver. 
1.1 CYTOCHROME P450 
1.1.1 Background and history 
Cytochromes are electron carrier proteins that contain 
iron-porphyrin prosthetic groups. Electron transfer is effected by 
reversible valence changes of the iron during the catalytic cycle. 
The iron is complexed to the porphyrin ring by co-ordinate bonds 
(the number of which determine the spin-state of the cytochrome). 
Most cytochromes, including the mitochondrial respiratory 
cytochromes and cytochrome P450 contain a haem (iron protoporphyrin 
IX) prosthetic group (Lehninger, 1975). 
In 1958 a membrane-bound cytochrome was described that had an 
unusual absorption maximum at 450nm on binding carbon monoxide in 
liver microsomes reduced with dithionite (Garfinkle, 1958; 
Klingenberg, 1958); this cytochrome was later characterized as a 
haemoprotein and designated cytochrome P450 (Omura and Sato, 1962). 
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P450 was later shown to be reduced by both NADH and NADPH, and was 
rapidly re-oxidised in the presence of oxygen (Omura and Sato, 
1964). It is now known that there are multiple isozymic forms of 
P450; to date, over 50 mammalian gene products have been identified 
(Nebert et al_., 1989). P450s have been found in bacteria, plants 
and most animal phyla; mammalian P450s are located in the 
endoplasmic reticulum (ER) of most tissues (Fevold, 1983; Nebert and 
Gonzalez, 1987), and are also present in the adrenal mitochondria 
(Nebert and Gonzalez, 1987). Recent work on the topology of P450s 
suggests that the amino-terminal amino acids, which are 
predominantly hydrophobic residues, anchor the cytochrome in the ER 
membrane, the bulk of the molecule sitting on the cytoplasmic side 
possibly with other regions of the molecule traversing the membrane, 
and the haem group parallel to, or at a slight angle to the membrane 
surface (Nelson and Strobel, 1988; Vergeres et al., 1989). 
P450 is the terminal oxidase component of the microsomal electron 
transport system (Cooper et al., 1965) which catalyses mixed 
function oxidation (MFO) of an extensive variety of structurally 
diverse endogenous and xenobiotic compounds (Table 1.1). These MFO 
reactions serve to make lipophilic compounds more hydrophilic by the 
addition of a polar functional group. This is essential in the 
detoxification process, since the resulting water-soluble 
derivatives can then be metabolised by conjugative enzymes to 
readily excretable compounds. Metabolism of xenobiotics falls into 
two main categories: Phase I, (oxidative or reductive) which adds a 
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functional group, and Phase II which are generally the true 
detoxification reactions. 
1.1.2 Chemistry and enzymology of MFO reactions 
There are three essential components of the MFO system: P450, 
NADPH-cytochrome P450 reductase and lipid (Lu and Coon, 1968; Lu £t 
al., 1969). NADPH-cytochrome P450 reductase (P450 reductase) is a 
flavoprotein containing both FAD and FMN prosthetic groups. P450 
reductase is also ER-membrane-bound and passes reducing equivalents 
from NADPH to P450. P450 reductase appears to be a 'transducer' 
protein, in that the reductase is a two electron acceptor whereas 
P450 is a one electron acceptor. Electrons are passed sequentially 
from NADPH + H"^  to FAD to FMN to P450. A heat-stable lipid 
component is also required for MFO activity and appears to be 
phosphatidylcholine. Reconstitution studies indicate that the fatty 
acid composition is also vital for activity, suggesting that the 
composition of the lipid environment of P450 is a determining factor 
for MFO activity (Rietjens et al., 1989). 
The role of P450 in MFO is to bind both molecular oxygen (Op) and 
the substrate, cyclic oxidation/reduction of P450 and P450 reductase 
resulting in the catalytic conversion of the substrate. Substrate 
binding to the ferric form of P450 changes the absorbance spectrum 
of the cytochrome. This is due to alterations in the spin 
equilibrium. 
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The spin state is determined by ligand co-ordination. In addition 
to the four equatorial iron-pyrrole nitrogen bonds there are 1 
(penta-co-ordinate) or 2 (hexa-co-ordinate) axial bonds to amino 
acid side chains. Most P450s exist with the spin equilibrium 
predominantly in the low-spin state (hexa-co-ordinate), and 
substrate binding, usually to the protein part of the molecule, 
alters the conformation of the protein and therefore its ligand 
interactions with the haem group. This causes a spin-state shift 
to predominantly high-spin configurations (producing a Type I 
binding spectrum). Substrate binding to a high-spin form is thought 
to be via the haem iron itself producing a hexa-co-ordinated 
low-spin haemoprotein and a Type II binding spectrum (Gibson and 
Skett, 1986). Substrates were originally classified as to their 
ability to elicit Type I or II binding spectra (Schenkman et al., 
1967), before the existence of multiple isozymes was fully realised. 
The overall stoichiometry of MFO reactions is: 
NADPH + H"^  + O2 + SH ^^—> NADP"^ + H2O + SOH 
where SH is the substrate. A simplified version of the catalytic 
cycle is shown in Figure 1.1. Briefly; 
(i) Substrate binds to P450 causing a shift in spin-state and a 
change in redox potential which facilitates electron acceptance. 
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(ii) Two electrons are transferred from NADPH+H'*' to P450 reductase, 
and one electron transferred from P450 reductase to P450. 
(iii) Binding of 0-^  to the reduced P450 to produce a highly unstable 
oxy-ferrous-substrate complex. 
(iv) Second electron reduction by P450 reductase or cytochrome b5, 
oxygen insertion (via a peroxy-intermediate?) and product release. 
These latter steps are not well characterized, along with the role 
of cytochrome b5 in the catalytic cycle. Cytochrome b5 can form a 
covalent complex with P450 that seems to enhance binding of selected 
substrates, and also the shift in spin-state equilibrium, for 
certain isozymes (Jansson et al., 1985). 
Also, the second electron may be donated either by the reductase or 
by b5, which can also be reduced by cytochrome b5 reductase, with 
NADH as the electron donor. These electrons are transferred to 
stearyl CoA desaturase, but it now seems that they can also be 
passed from b5 to P450, explaining the observed NADH synergism on 
NADPH-supported metabolism (Schenkman et al., 1976). 
It has also been suggested that b5 increases the 'coupling' of the 
cycle. During the catalytic cycle, there is an increase in hydrogen 
10 
peroxide (HpOo) formation, since P450 also has an oxidase activity 
concomitant with monooxygenation of substrates: 
NADPH + H"^  + O2 > NADP"^  + H2O2 
This activity has been viewed as an 'uncoupling' of electron 
transfer from substrate oxidation. The binding of b5 to P450 may 
result in tighter coupling due to more efficient/faster electron 
transfer. It should be noted that P450 isozymes that exist as 
predominantly high —spin forms i.e. P450nEl, have high endogenous 
oxidase activity (Gorsky et al_., 1984; Ingelman-Sundberg and 
Johansson, 1984). 
1.1.3 Isozymic forms of P450 
P450 exists as a superfamily of isozymic forms, which accounts for 
the observed broad and overlapping substrate specificity. The 
isozymes have been organised into thirteen families based on the 
divergent evolution of the P450 genes derived from protein primary 
sequence alignment data (Nebert et al., 1988; 1989). Families I-IV 
contain most of the mammalian hepatic catabolic P450s; families 
XVII, XIX, XXI and XXII comprise the mammalian extrahepatic P450s 
involved in steroid biosynthesis while family XI contains the 
mitochondrial P450s that use adrenodoxin for electron transfer. In 
addition there are the yeast (LI and LII) bacterial (CI and CII) and 
insect (VI) families (Gonzalez, 1989). 
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The isozymes have been classified into families and subfamilies 
based on the percentage similarity of their primary sequences. In 
general, there is less than 40% similarity between isozymes of 
different families. Sequences within a family are taken to be 
greater than 40% similar, and greater than 59% similar for mammalian 
subfamilies. Also, sequences that are more than 97% similar are 
assumed to be allelic variants, unless demonstrated to be different 
gene products. This classification has enabled a standard 
nomenclature for P450s to be devised. Table 1.2 gives the standard 
nomenclature for the main hepatic P450s from families I - III. 
This nomenclature for P450 proteins (e.g. P450IA1) and genes 
(CYPlAl) will be used here throughout, where possible. 
Although the sequence similarity between isozymes from bacteria and 
mammals is less than 25%, there is sufficient localised sequence 
identity to classify these isozymes as members of one superfamily 
e.g. there is a highly conserved 21-residue cysteinyl fragment 
associated with the haem-binding pocket that is present in all 
eukaryotic P450s and the prokaryotic P450 CI (Nebert and Gonzalez, 
1987). 
There is much speculation as to why there are so many P450 isozymes. 
Diversification of P450 forms probably occurred as species adapted 
to new environments. It has been suggested that changes in dietary 
flora necessitated the development of enzyme systems that could 
detoxify and/or utilise many of the plant products. In order to be 
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an evolutionary success, an organism must be able to protect itself 
from environmental poisons and survive on new energy sources 
(Gonzalez, 1989). 
The P450I family 
There are two proteins in this family: P450IA1 is found in most 
phyla from insects upwards to the mammals, whereas IA2 appears to be 
expressed only in the liver (Gonzalez, 1989). However, despite the 
ubiquitous nature of lAl, no endogenous substrate has been 
identified for this P450. lAl metabolises planar, aromatic 
compounds e.g. benzo-[a]-pyrene and 7-ethoxyresorufin; IA2 
metabolises predominantly arylamines. Both genes are inducible by 
polycyclic aromatic hydrocarbons e.g. tetrachlorodibenzo-(p)-dioxin 
(TCDD), 3-methylcholanthrene (3-MC) and beta-naphthoflavone (BNF; 
Haugen et al., 1976; Thomas et al., 1983). 
The P450II family 
The P450II family has five main subfamilies A to E. There are at 
least three rat genes in the IIA subfamily: CYP2A1 and CYP2A2 are 
expressed in the liver, and although they exhibit 93% nucleotide 
sequence similarity, they are differentially and developmentally 
regulated. IIAl is a testosterone-7ok -hydroxylase, and IIA2 a l5o( 
-hydroxylase. A third gene is expressed in rat lung, although its 
orthologue in the mouse is expressed in the liver and kidney 
(Matsunaga etal., 1988; Gonzalez, 1989). 
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There are at least ten genes in the IIB subfamily, the rat 
phenobarbitone (PB)-inducible genes being CYP2B1 and 2, the 
proteins having similar substrate specificities e.g. for 
benzphetamine and testosterone (Ryan et al., 1979). These genes 
seem to have diverged from each other recently in the rat, as most 
rodents do not have orthologues for both these genes (Adesnik and 
Atchison, 1986). 
The lie subfamily contains mostly constitutive P450s, many of which 
are developmentally/sex regulated, although some are inducible by 
PB. The rat has at least five genes and one pseudogene. These 
include the male-specific IICll and 13 and the female-specific IIC7 
and 12 isozymes involved in steroid hydroxylations (Waxman et al., 
1983; Adesnik and Atchison, 1986). This subfamily also contains 
three genes (CYP2C8-10) responsible for mephenytoin metabolism 
(Nebert and Gonzalez, 1988; Gonzalez, 1989). 
The IID subfamily is highly polymorphic in the rat and the human, 
being involved in debrisoquine metabolism. This subfamily appears 
to have a unique lineage, being less similar to the other 
subfamilies (Gonzalez et al., 1988; Gonzalez, 1989). 
The HE subfamily contains two genes, although, to date only rabbits 
have been shown to possess both genes, however there is differential 
tissue expression (Porter et a1., 1989). P450IIE1 is inducible by 
ethanol (Ryan etal., 1986), diabetes and fasting (Ma etal., 1989) 
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and acetone (Johansson et al_., 1988), and substrates include 
acetone, acetoacetate, halothane and pyridine. This P450 may play 
a role in gluconeogenesis during fasting (Gonzalez, 1989). 
The P450III family. 
There are to date six genes in this family: 2 rat, 3 human and 1 
rabbit. Of the rat genes, CYP3A1 is inducible by pregnenolone-16«. 
-carbonitrile and dexamethasone (Dex; Heuman et al., 1982), whereas 
CYP3A2 is constitutive in male rats. Macrolide antibiotics also 
induce P450IIIA proteins (Wrighton et al., 1978). However, it has 
been difficult to reconcile interlaboratory data with respect to the 
multiple isozymes in this family, and thus correspondence of 
different isozymes from different groups. It may be therefore, 
that there are several, very closely related isozymes in this 
family, all of which have not yet been resolved (Halpert, 1988). 
Both gene products appear to possess testosterone-6p -hydroxylase 
activity (Nebert and Gonzalez, 1988; Gonzalez, 1989). 
The P450IV family. 
These constitutive P450s catalyse the -v-hydroxylation of 1 auric 
acid and arachidonic acid and are inducible by hypolipidaemic drugs 
that are also rodent peroxisome proliferators e.g. clofibric acid 
(Tamburini etal., 1984; Hardwick etal., 1987). 
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1.2 REGULATION OF P450 EXPRESSION 
P450 expression is regulated at two levels. Physiological and 
environmental factors alter the isozyme complement of an organ by 
influencing the molecular mechanisms responsible for gene 
expression, while regulation at the molecular level can be via 
control of gene transcription, mRNA and/or apoprotein stability and 
haem biosynthesis/degradation. These will be discussed below 
(1.2.3). Many factors have been shown to affect P450 expression: 
there are compounds that induce their own biotransformation and/or 
the metabolism of other substances, in addition to physiological 
conditions that affect primarily constitutive P450s. In both 
cases, alterations in isozyme complement can have profound effects 
on metabolism/toxicity of P450 substrates, both endogenous and 
xenobiotic. Induction and control of constitutive expression are 
discussed in the following sections, and although dealt with 
separately, are not completely discrete processes. 
1.2.1 Constitutive P450 expression 
There are many factors that are known to influence constitutive 
expression of P450, including genotype, hormones and liver disease, 
as well as infection, starvation and stress (Vesell, 1988). 
Genotype Species and strain differences in P450 metabolism in 
experimental animals have been recognised for a long time (Kato, 
1979), but it is now known that there are several examples of genetic 
polymorphisms for drug metabolism in Man, some with racial 
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differences in distribution frequency. One of the best 
characterized is the polymorphic metabolism of the anti-hypertensive 
drug, debrisoquine (DB). The 4-hydroxylation of DB shows a bimodal 
distribution between the extensive metabolisers and the poor 
metabolisers (who excrete no 4-hydroxydebrisoquine), with a low 
incidence of poor metabolisers. The deficient hydroxylation of DB is 
an autosomal recessive trait, and is associated with deficient 
metabolism of several other drugs e.g. sparteine, phenytoin and 
phenacetin, and is due to the absence of a single P450 isozyme: 
P450IID1 (Maghoub et al_., 1977; Gonzalez et al_., 1988). 
Mephenytoin metabolism is also polymorphic in humans, as well as the 
non-P450-mediated N-acetylation of many drugs e.g. isoniazid (Levi 
et a1., 1968; Gonzalez, 1989). 
Tissue-specific regulation Many P450s exhibit tissue-specific 
regulation, although the molecular mechanisms responsible are 
unknown. P450IIB1 is constitutively expressed in the lung and 
testis, but not in the liver of untreated rats, whereas IIB2 is only 
detectable in the liver of untreated animals. P450IA2 also appears 
to be liver-specific as are IIAl, IIA2 and IICll (Nebert and 
Gonzalez, 1988; Gonzalez, 1989). Recently, an olfactory-specific 
P450 was identified which appears to be a member of the II gene 
family (Nef et a1., 1989); the P450IV family, in contrast, may be 
more ubiquitous, having been found in liver, lung, kidney, placenta, 
intestine and leukocytes (Gonzalez, 1989). 
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Hormonal regulation Hormonal influences on P450 expression cover a 
wide range of conditions including pregnancy and lactation, diabetes 
and fasting, and is also the basis of age and sex differences in 
drug metabolism, e.g. 7-propoxycoumarin 0-dealkylation (Kamataki et^ 
al., 1980), hexachlorobenzene metabolism (Rizzardini and Smith, 
1982), phenytoin metabolism (Billings, 1983). Age and sex 
differences in drug metabolism are related to P450-mediated steroid 
metabolism which is regulated by growth hormone; the secretion and 
effects of growth hormone are discussed in detail in Chapter Four 
and will only be outlined here. Briefly, most P450s are not 
expressed prenatally: birth, weaning and puberty each influence the 
P450 profile (Waxman et al., 1985) in particular, neonatal, gonadal 
androgen production imprints the adult pattern of pituitary growth 
hormone secretion, which is different in males and females and which 
then influences hepatic P450 expression, primarily via suppression 
of P450 synthesis (extensively reviewed by Skett, 1987; 1988). 
Thyroid hormones affect P450 expression, although their exact mode 
of action is unclear. Thyroxine appears to markedly affect the 
levels of P450 reductase (Kato, 1977; Waxman et al_., 1989), and 
thyroidectomy has been shown to have substrate and sex-specific 
effects on P450 metabolism, which can be reversed or enhanced by 
subsequent administration of thyroxine (Skett, 1987). The 
confusing picture of thyroid effects on P450 metabolism may be a 
result of the failure in early studies to discriminate the actions 
of thyroxine and tri-iodothyronine and/or the compounding influence 
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of age, since thyroid suppression of P450 appears to be particularly 
marked for neonatally expressed P450s (Yamazoe et al., 1989). 
There is a general decrease in drug metabolism in the pregnant rat, 
thought to be associated with increased progestagen levels (Gibson 
and Skett, 1986), Decreases in aniline hydroxylation and 
ethylmorphine N-demethylation were paralleled by changes in P450 
content (Kato, 1977). These changes also correlate with the reported 
decreases in total microsomal phospholipid content and the 
phosphatidylcholine: phosphotidylethanolamine ratio in pregnancy, 
along with the decreased proportion of P450 in the high- spin state 
(Turcan et al., 1981; Symons et al., 1982). The lipid composition 
of reconstituted systems is known to markedly affect P450 activity 
(Yamazoe et al_., 1988). It has been suggested that 
sex-differentiated activities as well as the pregnancy-associated 
inhibition of drug metabolism are due to specific lipid requirements 
of different isozymes (Skett, 1987). 
Diabetes, although a disease state, is a hormonally-based disorder, 
and its effects on P450 will thus be discussed here. 
Chemically-induced or spontaneous diabetes mellitus dramatically 
alters drug metabolism in the male rat, effects in the female being 
less marked (Kato and Gillette, 1965a; Skett, 1987). In acute 
chemically-induced diabetes, there is suppression of male-specific 
and increases in female-specific activities in the male rat, which 
can be reversed by insulin replacement treatment (Kato and Gillette, 
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1965a). This is also seen in genetically diabetic rats, where it 
was also shown that diabetic males had lower serum testosterone 
levels than the control males (Warren et al., 1983). Castration and 
diabetes appear to have similar effects on male rats, in that 
androgens, like insulin, can partially reverse the effects of 
diabetes. However, the time-courses of changes in drug metabolism 
and serum testosterone levels do not correlate with each other 
(Skett, 1987). Despite this, it has been proposed that insulin and 
androgens may act through a common mediator i.e. growth hormone, 
this being a feminising factor, and insulin a masculinising factor 
with respect to P450 metabolism (Skett, 1987). 
In addition to effects on sex-differentiated metabolism, diabetes 
induces a specific P450 isozyme, P450IIE1 (Bellward ft al^., 1988). 
This isozyme is also induced by ethanol and isoniazid and is 
associated with aniline hydroxylase activity (Ryan et al_., 1986). 
Fasting and obesity also induce IIEl (Hong et al., 1987; Salazar et^  
al,, 1988). Fasting appears to exaggerate sex differences in P450 
metabolism, with male-type metabolism being depressed, as in 
diabetes (Kato and Gillette, 1965b; Ma et al,, 1989). Fasting and 
diabetes, however, do not have identical effects on P450 isozyme 
expression; although IICll and IIAl were decreased by both 
conditions, fasting decreased and diabetes increased the PCN-E 
isozyme (a male-specific steroid 6/3 -hydroxylase); fasting also 
increased total P450 whereas diabetes had no effect on the total 
microsomal P450 content (Ma et al,, 1989), The induction of IIEl 
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in diabetes and fasting is associated with ketosis (Honn et al., 
1977; Bellward et al., 1988); IIEl is also inducible by acetone and 
acetoacetate and it has been suggested that IIEl is involved in the 
gluconeogenic response to glucose deficiency (Gonzalez, 1989). 
However, there are molecular differences in IIEl induction by 
acetone and fasting - these will be discussed in section 1.2.3. 
Disease Many liver disorders can adversely affect drug metabolism; 
cirrhosis and chronic viral hepatitis can reduce the number of 
functional hepatocytes and any disease that affects blood flow 
through the liver can affect extraction and clearance (Kato, 1977). 
In general, the impairment of drug metabolism in chronic liver 
disease correlates with the severity of dysfunction. 
Relatively little is known about the effects of the porphyrias on 
drug metabolism, although clearly deficiencies in haem biosynthesis 
or increased degradation will reduce the amount of P450-holoenzyme. 
Regulation of haem biosynthesis and degradation in relation to P450 
activity is discussed in Chapter Three. However, it is known that 
TCDD, oestrogens and hexachlorobenzene can induce hepatic porphyrias 
in Man and experimental animals (Rizzardini and Smith, 1982), and 
that acute intermittent porphyria selectively impairs drug 
metabolism (Anderson et al., 1976). 
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1.2.2 Induction of P450 
Conney et al. (1956) first reported the induction of aminoazo dye 
metabolism by 3-methylcholanthrene (3-MC). The enzyme induced was 
benzpyrene hydroxylase or aryl hydrocarbon hydroxylase (AHH), now 
known to be associated with P450IA1. P450IA1, and to a lesser 
extent, IA2 have been shown to be inducible by the polycyclic 
aromatic hydrocarbons (PAH), e.g. 3-MC, BNF and TCDD, isosafrole 
being more selective for P450IA2 induction (Conney et al., 1967; 
Thomas et al., 1983). The early work on PAH-induction of P450 was 
facilitated by the discovery of a polymorphism in mice with respect 
to responsiveness to PAH-induction of AHH. PB and PCN were shown 
to induce different proteins to BNF and TCDD in responsive mice 
strains; in non-responsive strains there was no induction of AHH by 
BNF or TCDD (Haugen et al., 1976). TCDD was shown to be a potent 
ligand for a receptor whose binding affinity segregated with 
AHH-responsiveness in mice, and subsequently cytosolic 
receptor-bound TCDD was shown to be the factor responsible for AHH 
induction; this receptor is encoded by the £h locus (Poland et al., 
1976; Gonzalez, 1989). The TCDD-receptor complex appears to 
translocate into the nucleus where it acts as a positive 
transcriptional activation element, possibly binding to regulatory 
elements that have been identified upstream of the CYPlAl gene 
(Gonzalez, 1989). 
Autoregulation of the ^  locus by an endogenous repressor has been 
postulated from work using cell lines with normal receptor levels but 
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no AHH induction. In these cell lines however there is high 
constitutive expression of lAl mRNA, i.e. in the absence of inducer. 
These mRNAs coded for defective proteins, and it was suggested that 
the lAl enzyme metabolises an endogenous compound to a repressor of 
the All locus (Hankinson et al., 1985). 
Several other enzymes are associated with the jftli locus including a 
glutathione transferase, NAD(P)H:menadione oxidoreductase, a 
UDP-glucuronyl transferase and P450IA2 (Nebert and Gonzalez, 1988; 
Gonzalez, 1989), suggesting that there is co-ordinate regulation of 
certain components of Phase I and II metabolism. 
In contrast to PAH-induction of P450, very little is known about the 
mechanism of PB induction, other than that PB stimulates de novo 
synthesis of P450, and there is no evidence for the involvement of a 
receptor (Adesnik et al., 1981). PB induces proliferation of the 
ER, and in addition to induction of total P450 and P450s IIBl and 
IIB2, levels of P450 reductase, epoxide hydrolase and a 
UDP-glucuronyl transferase are also increased (Hardwick et al., 
1983a). The P450IIIA1/2 proteins and also some members of the IIC 
subfamily are also inducible by PB (Gonzalez, 1989). Induction of 
IIBl and 2 is co-ordinate, but the transcription rate is different 
to that of the reductase and epoxide hydrolase (Hardwick et al., 
1983a). Other inducers of IIBl/2 include SKF-525A, isoniazid, 
chlordane and Arochlor 1254 (Gonzalez, 1989). 
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Isoniazid, acetone and ethanol all induce P450IIE1, which is also 
inducible by fasting and diabetes (see section 1.2.1. above). The 
mechanism of induction appears to be primarily post-transcriptional 
and is discussed below. 
P450s in the IIIA family are inducible by synthetic glucocorticoids 
(e.g. DEX) and synthetic steroids (e.g. PCN and betamethasone) as 
well as hydrocortisone and corticosterone, Progesterones, 
oestrogens, androgens and mineralocorticolds do not induce these 
P450s (Schuetz et al_., 1984). DEX and PCN both induce the same 
P450, IIIAl, DEX being the better inducer (Heuman et &]_., 1982; 
Hardwick et al., 1983b). DEX/PCN induce the same protein in 
cultured hepatocytes as in vivo (Schuetz et al., 1984). Induction 
of P450 does not appear to be mediated by the glucocorticoid 
receptor: concentrations, time-courses and rank order of potency of 
the steroids are different for induction of P450 and tyrosine 
aminotransferase (Schuetz and Guzelian, 1984). PB and 
organochlorine pesticides also induce one of the IIIA proteins 
(Heuman et al., 1982; Schuetz et al., 1986). 
Clofibrate and other hypolipidaemic agents induce peroxisomal and 
microsomal proteins involved in fatty acid /3-oxidation, including 
P450IVA1; this P450 has no immunocrossreactivity with the PAH-, PCN-
or PB-inducible P450s (Tamburini et al., 1984; Hardwick et al_., 
1987). 
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1.2.3 Molecular mechanisms of regulation 
Transcriptional activation This is the major regulatory mechanism 
during developmental induction of P450 activities, and most 
xenobiotic inducers increase gene transcription to a greater or 
lesser extent. Induction of P450IA1 by PAHs and IIBl/2 by PB is 
almost exclusively transcriptional (Adesnik and Atchison, 1986; 
Gonzalez, 1989). PCN and DEX both transcriptionally activate the 
CYP3A genes (Hardwick et al., 1983b; Simmons et al., 1987). 
Post-transcriptional regulation This can involve stabilisation of 
mRNA or of protein. Transcription of P450IA2 in vivo is activated 
two-fold by 3-MC but there is a 30-fold accumulation of protein; 
similar results were obtained in hepatocyte cultures, suggesting a 
considerable post-transcriptional component in IA2 regulation (Pasco 
et al_., 1988; Silver and Krauter, 1988). DEX, in addition to 
transcriptional activation of the CYP3A genes, induces P450s IIBl/2 
and P450 reductase via mRNA stabilisation (Simmons et al,, 1987). 
Macrolide antibiotics e.g. triacetyl oleandomycin (TAO) have been 
shown to induce a protein in vitro, indistinguishable from a 
PCN-inducible protein, in the absence of an increase in mRNA. It 
was proposed that TAO bound to the P450 inhibiting its degradation, 
thus stabilising (and inactivating) the P450 (Watkins et al., 1986). 
IIEl expression is also induced in the absence of any 
transcriptional activation. In untreated rats IIEl degradation 
appears to be biphasic, whereas degradation is monophasic in 
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pyrazole-treated rats. Dimethyl sulphoxide and ethanol increased 
IIEl protein 2- to 7-fold, although there was no increase in mRNA 
levels (Eliasson et al., 1988); in contrast, fasting increased both 
protein and mRNA levels (Honn et al,, 1987). It has been suggested 
that ligand binding by small organic molecules stabilises IIEl 
protein by inhibiting degradation whereas fasting and diabetes 
inhibit RNA catabolism (Eliasson et al., 1988; Gonzalez, 1989). 
1.2.4. Inhibition of P450 Induction and inactivation of 
steroid-inducible P450s by TAO was mentioned above. Other 
compounds, particularly inhibitors of P450 metabolism, interact with 
the protein to inactivate it. Inhibitors such as SKF-525A, safrole 
and piperonyl butoxide form stable, inactive complexes with P450: 
the inactivation is usually reversible, and these compounds do not 
destroy the haemoprotein. This type of inactivation requires 
metabolism of the inhibitor by P450 (Netter, 1980), Safrole and 
alpha-naphthoflavone selectively inhibit the PAH-inducible P450s 
(Delaforge et al., 1985), SKF-525A and metyrapone preferentially 
inactivate PB-inducible P450s (Netter, 1980; Parkinson et al^,, 
1982). Metyrapone is a pyridine derivative, and binds at (or near) 
the haem iron centre, like carbon monoxide, so that the haemoprotein 
cannot bind oxygen (Netter, 1980). There are also suicide 
substrates of P450 that are metabolised to intermediates that 
irreversibly alkylate the P450 haem group, resulting in haem 
degradation and accumulation of porphyrins e.g. many olefins and 
acetylenes like allylisopropylacetamide and ethinyloestradiol. 
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Nitrosamines can also alkylate haem groups (Ortiz de Montellano and 
Correia, 1983). Metal ions also inhibit P450: 
cobalt-protoporphyrins decrease total P450 and total haem and also 
induce haem oxygenase (Galbraith and Jellinck, 1989); zinc, in the 
form of a zinc-protoporphyrin, inhibits P450 metabolism and 
decreases P450 content (Matsuura et al., 1988) and may decrease the 
ability of P450 to interact with substrate and/or reductase 
(Jeffery, 1982). 
Recently it has been shown that P450 is a substrate for 
cyclic-AMP-dependent kinase (Pyerin et al., 1984) and that 
phosphorylation inhibits P450 activity: IIBl/2 are markedly 
phosphorylated, leading to inactivation (Koch and Waxman, 1989). 
Phosphorylation is also associated with an increase in P420 
(Taniguchi et al., 1985). Phosphorylation also inhibited the 
b5-induced spin-state transition and b5 interaction with P450 
(Epstein et al., 1989). 
1.3 P450 AND XENOBIOTIC METABOLISM 
The P450/MF0 is the major contributory component to Phase I 
xenobiotic metabolism, however, there are other oxidative enzyme 
systems including the alcohol and aldehyde dehydrogenases, xanthine 
oxidase and monoamine oxidase. In addition, the reductases, P450 
reductase and menadione:NAD(P)H oxidoreductase can contribute to 
Phase I metabolism (Gibson and Skett, 1986; Ziegler, 1988). There 
is also a flavin monooxygenase. This flavoprotein is an integral 
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microsomal membrane protein with a broad substrate specificity, 
active towards sulphur, phosphorus and nitrogen centres e.g. 
thioureas, hydrazines (Ziegler, 1988), 
Phase I metabolism produces intermediates which are not necessarily 
less toxic than the parent compound, and have several possible 
fates. They can interact with cellular components which may cause 
toxicity, or they may be further metabolised by the Phase II 
conjugation enzymes. This usually results in a hydrophilic, 
readily excretable metabolite. These reactions involve conjugation 
of reactive intermediates with a variety of molecules e.g. sugars, 
sulphate and amino acids, these cofactors usually requiring 
activation prior to reaction (Gibson and Skett, 1986). As with 
Phase I activities, many endogenous compounds are substrates for 
Phase II metabolism (Table 1.3). 
The major conjugation reaction for detoxification of a range of 
xenobiotic compounds is glucuronidation. UDP-D-glucuronic acid can 
be transferred to a variety of functional groups by the 
UDP-glucuronyltransferases (UDPGTs) to form a glucuronic acid 
conjugate. These molecules are very polar and easily excretable. 
The UDPGTs have recently been reviewed (Burchell and Coughtrie, 
1989). The liver is the most important site of glucuronidation for 
many compounds e.g. clofibrate and valproic acid (Howell et al., 
1986) and paracetamol (Prescott et al,, 1981). The UDPGTs exist as a 
family of microsomal isozymes, like the P450s, and there is 
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differential induction of the isozymes, in Man and rats, by the 
common MFO inducers including PB, 3-MC and clofibrate (Thompson ejt 
al., 1982). Often there is simultaneous induction of MFO and 
conjugation enzymes (Hardwick et al., 1983a). 
The sulphotransferases are soluble enzymes that also exist in 
multiple forms, but in general, sulphation is less important than 
glucuronidation in Man and rats, due to the limited availability of 
activated sulphate (phosphoadenosine-5'-phosphosulphate; Gibson and 
Skett, 1986). Paracetamol and 2 -acetylaminofluorene are two of the 
many drugs where sulphation is involved in the metabolism (Prescott 
et al., 1981; Meerman et al., 1987). 
The glutathione transferases are another family of soluble isozymes, 
that are also inducible by MFO inducers. They catalyse 
glutathione-conjugation e.g. of paracetamol, but 
glutathione (GSH)can also spontaneously bind to drugs e,g, 
tetracycline (Gibson and Skett, 1988). GSH-conjugates can be 
further metabolised by the intestinal flora and the kidney 
C-S-lyases, to mercapturic acids (Jakoby, 1988). Glycine 
conjugation, methylation and hydrolysis are other Phase II 
reactions, but these are relatively minor pathways of metabolism 
(Jakoby, 1988). 
Although Phase I metabolism is often referred to as the activation 
phase, and Phase II metabolism as detoxification, it is more a case 
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of Phase I and II metabolism together resulting in detoxification. 
The interactions between the two, especially under conditions of 
enzyme induction or limited cofactor availability, will determine 
the eventual fate and intracellular effects of a potential toxin, 
1.3.1 Factors affecting drug metabolism 
The main biochemical factors that influence P450 activity are oxygen 
supply and substrate availability. Oxygen is essential for MFO 
activity, and under normal circumstances is readily available. 
However in the centre of an organ like the liver, and under certain 
pathological conditions oxygen supply may be limiting resulting in a 
predominance of reductive metabolism, which may markedly alter the 
metabolic profile of a drug, e.g. halothane can be metabolised by 
oxidative and reductive P450 pathways, which yield different 
metabolites with different toxic potentials (Timbrel 1, 1983). 
Intra-tissue gradients in oxygen tension may also influence 
hepatocyte heterogeneity with respect to isozyme activity (see 
below). 
Substrate availability is also important in determining P450 
activity: the lipophilicity of a compound will affect its access to 
the membrane-bound P450s and plasma binding will affect its 
availability to the hepatocytes. Biliary excretion and 
enterohepatic recirculation, e.g. of glucuronides, can also affect 
bioavailability (Gibson and Skett, 1986). 
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Cofactor supply can limit P450 reactions: NADPH is produced by the 
pentose phosphate pathway, but is also required for fatty acid 
biosynthesis and the reduction of oxidized glutathione (Thurman and 
Kauffman, 1980). Thus NADPH content is determined by prevailing 
metabolic conditions and may be limiting during oxidative stress. 
Cofactor supply also influences Phase II metabolism e.g. 
UDP-glucuronic acid formed from glucose-1-phosphate, which is 
derived from NAD -dependent glycogenic pathways, may be depleted 
during glucuronidation of xenobiotics e.g. paracetamol (Howell £t 
al., 1986; Hjelle et al_,, 1986). Maintenance of adequate GSH 
levels is also important in preventing oxidative stress. The factors 
that influence drug metabolism have all been extensively reviewed, 
especially with respect to the liver (Thurman and Kauffman, 1980; 
Gibson and Skett, 1986). 
The major determinant of the metabolic profile of a compound is the 
P450 isozyme complement of the organ/cell (and to a lesser extent, 
the distribution of Phase II enzymes). Differential P450 isozyme 
expression is probably one of the main explanations for 
organ-specific toxicity although extra-hepatic toxicity may also be 
strongly influenced by other factors e.g. solute concentration in 
the kidney and oxygen tension in the lung; tissue-specific 
differences in isozyme expression were discussed in 1.2.1. Although 
the liver is the main site of MFO metabolism and a primary target 
for MFO-generated toxins, there are well documented examples of 
non-hepatic MFO-activated toxins e.g. the pulmonary toxin. 
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4-ipomeanol (Boyd and Burka, 1978); renal toxicity of chloroform and 
benzene toxicity to bone marrow (Gram et al., 1986), 
With respect to the liver itself, it has been proposed that there is 
metabolic heterogeneity within the functional unit of the liver. The 
acinus as the functional unit of the liver was first described in 
1954(Rappaport et al,), and represents the cellular organisation 
around the hepatic blood vessels (Figure 1.2), Blood flow is 
unidirectional and sequential across the acinus from the hepatic 
portal venules to the hepatic venules, and the acinus is divided 
into three zones. Zone 1 is the periportal region and zone 3 the 
perivenous region. Functional differences between the two are 
thought to relate to composition of the perfusing blood; periportal 
hepatocytes are exposed to higher concentrations of solutes and 
oxygen (Gumucio, 1989), Many metabolic processes appear to be 
regulated by blood composition e.g. the zonal sites of maximal 
oxygen consumption and carbohydrate metabolism change as the 
direction of perfusion is changed. Although the oxygen tension of 
the sinusoidal blood might be expected to affect MFO activity, in 
fact activity seems to be unaffected by the direction of blood flow 
and instead appears to be associated with perivenous hepatocytes 
suggesting a heterogeneous distribution of P450 isozymes (Gumucio, 
1989). Many hepatotoxins e.g. paracetamol, carbon tetrachloride, 
cause predominantly zone 3 necrosis i.e. perivenous, which also 
suggests that P450s may not be evenly distributed within the acinus. 
Alternatively, zone 3 hepatocytes may be more susceptible to damage 
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from P450-generated metabolites e.g. low levels of glutathione 
peroxidase in perivenous hepatocytes have been reported (Kera et_ 
al., 1987), From the work that has been done to date, P450IIE1, 
IIBl/2 and lAl appear to be predominantly expressed in the 
centrilobular region or zone 3 (Gumucio and Chianale, 1988; 
Ingelman-Sundberg et al,, 1988). 
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1.4 METHODS OF STUDYING HEPATIC DRUG METABOLISM AND TOXICITY 
1.4.1 In vivo and perfused organ studies 
There are many different techniques available for studying 
P450-mediated metabolism and toxicity including whole animal 
studies, intact cells, use of subcellular fractions and purified 
isozymes. In vivo metabolism studies involve sampling of urine, 
serum or expired air after administration of a drug, followed by 
analysis of metabolites or biochemical indicators of tissue damage. 
Thus, the different metabolites of a radiolabelled dose of 
antipyrine can be recovered from samples, providing information on 
the extent of metabolism, the relative proportions of the various 
metabolites and their rate of production and clearance (Poulsen and 
Loft, 1988), whilst the presence of liver-specific enzymes such as 
aspartate and alanine aminotransferases in serum samples are 
sensitive indicators of the extent and severity of hepatic damage 
(depending on whether the enzyme is cytoplasmic or organellar; 
Animal Clinical Association, 1988). However, whole animal studies 
are slow and costly and unsuitable for mechanistic studies or 
investigations into drug effects at the cellular level. For these 
reasons investigators have turned to in vitro methods of studying 
metabolism. 
The perfused liver has been used as an alternative to in vivo 
studies of drug metabolism. The liver is perfused via the portal 
vein, but this must be initiated in situ to reduce the period of 
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potentially deleterious anoxia (Thurman and Kaufmann, 1980). The 
advantages of this system are that it is easy to sample the 
perfusate, the tissue can be freeze-clamped prior to future analysis 
and conditions can be carefully controlled, with high doses of drug 
being administered without the complication of toxicity in a whole 
animal. This approach has been used to investigate many aspects of 
drug metabolism including measurement of binding spectra and redox 
states of P450 (Sies and Brauser, 1970) and the biotransformation of 
drugs (e.g. valproic acid, Rettenmeier et al., 1985). However, the 
viability of these perfused organs is limited to a few hours, high 
flow rates must be used for haemoglobin-free perfusates (which is 
necessary since the presence of haemoglobin decreases MFO activity, 
interferes with fluorescence measurements and results in progressive 
haemolysis) and large volumes of perfusate are required in 
non-circulating systems (Thurman and Kauffman, 1980). 
1.4.2 In vitro techniques 
Since the P450 system is located in the ER, microsomal fractions 
have been used to study drug metabolism and toxicity at the 
subcellular level. The studies include measurement of spectral 
changes on binding of substrate to P450 (Schenkman ft al^., 1967) 
determination of P450-dependent enzyme kinetics (Boobis et al_., 
1981); the metabolic activation of hepatotoxic compounds (Boyd £t 
a]., 1978; Ravindranath and Boyd, 1985); the detection of reactive 
metabolites (Garle and Fry, 1989). However, although microsomal 
fractions can generate active metabolites, no information is 
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obtained about possible cytotoxicity of these metabolites. There 
have been attempts to combine rodent S-9 fractions (9000g 
supernatant: microsomes and cytosol) with cultured cells to detect 
cytotoxic metabolites e.g. the activation of bromobenzene by S-9 
fractions to metabolites cytotoxic to cultured Chinese hamster 
fibroblast cells (Horner et al., 1987); however, the use of this 
approach is not widespread in cytotoxicity studies, although 
microsomes/S-9 fractions are routinely used as the activation system 
in in vitro mutagenesis assays (Maron and Ames, 1983). 
It is now possible to isolate and purify individual P450 enzymes, 
from solubilised microsomes and examine their catalytic properties 
in reconstituted systems (Lu and West, 1980). P450s, like other 
proteins, can be purified by gel electrophoresis, although 
resolution of individual isozymes by differential mobility due to 
molecular weight is difficult, since the molecular weight of most 
P450s is in the 45,000-60,000 dalton weight range. Purification and 
characterization of isozymic forms has been facilitated by the use 
of antibodies, although crossreactivity with closely related 
isozymes is always possible, even with monoclonal antibodies 
(Gonzalez, 1989). 
However, the use of antibodies, in combination with microsomes and 
purified P450s in reconstituted systems has allowed both 
quantitation of different isozymes and estimations of isozymic 
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contributions to metabolism to be made e.g. an antibody to P450IIA1 
that inhibited more than 98% of microsomal testosterone - 7D( 
-hydroxylase activity was used to probe the effects of age, sex and 
xenobiotics on P450IIA1 expression (Arlotto and Parkinson, 1989); 
antibodies have been used in conjunction with microsomes and 
reconstituted systems to identify P450IIC6, IICll and IIBl as the 
isozymes that are primarily responsible for the activation of 
cyclophosphamide (Clarke and Waxman, 1989). There are disadvantages 
to the use of these systems: incorporation of different lipids in 
the reconsituted systems can affect the measured catalytic rate 
(Yamazoe et al., 1988); purified P450s may exhibit activities on 
reconstitution that cannot be inhibited by specific antibodies to 
the isozyme and vice versa (Waxman et al., 1985; Yamazoe et al., 
1988); there is also the problem of crossreactivity of antibody 
preparations with more than one isozyme. 
There are other difficulties associated with biochemical techniques 
for isolation and purification of P450 isozymes, in that intrinsic 
membrane proteins are difficult to purify, particularly the minor 
forms expressed at "jery low levels (e.g. extrahepatic P450s). There 
is also the problem of homogeneity, since wery similar P450s can 
have identical SDS-gel mobilities, amino-terminal primary sequences 
and reactions with antibodies. These problems can be largely 
overcome by the use of molecular biological techniques. It is 
possible to generate cDNA (complementary DNA) libraries from mRNAs 
isolated from untreated or induced animals. Clones of these cDNAs 
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can then be screened with cDNA probes synthesized from the mRNAs, 
This method can also be used for low abundance mRNAs, by screening 
with antibodies. The development of cDNA expression vectors has 
further aided the isolation of minor P450 isozymes (Gonzalez, 1989). 
Purified P450s are particularly useful for investigating substrate 
specificity and catalytic activity of individual isozymes (assuming 
that the preparation is homogeneous for a single isozyme). In 
addition, purified P450s and cDNAs can be used to analyse the 
primary amino acid and nucleotide sequences of the P450s. This has 
allowed the evolutionary and structural relationships between 
different isozymes to be explored (Nebert and Gonzalez, 1987). 
The major limitation to the use of subcellular -fractions and 
purified isozymes is in the effects of P450-metabolism on the intact 
cell, and the assessment of toxic potential. Intact cell systems 
possess the Phase II enzyme systems in addition to the MFO system, 
and since the balance between these two systems is crucial for 
determining the toxicity of many compounds the development of intact 
cell systems for metabolism studies has received much attention in 
the last twenty years. 
1.4.3 Intact cell systems 
The use of intact cells, i.e. isolated hepatocytes, cultured 
hepatocytes and cell lines, has several advantages over the 
sub-cellular preparations discussed above, including the presence of 
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intact intracellular organisation. Phase I and Phase II metabolism 
and physiological levels of co-factors (Fry, 1982). In addition, 
hepatocytes can be isolated from other liver cells and maintained in 
a defined environment free from nervous and hormonal influences. A 
preparation of phenotypically similar cells can be obtained, and 
many parameters of cellular function/metabolism can be examined 
concurrently. Isolated hepatocytes have been used to study many 
aspects of drug metabolism e.g. the metabolism of menadione (Thor ft 
al., 1982); the effect of tert-butyl hydroperoxide metabolism on the 
pentose phospate pathway (Rush and Alberts, 1985); the effect of 
ascorbic acid on conjugation of 4-hydroxybiphenyl (Paterson and Fry, 
1983); species differences in paracetamol toxicity (Tee ft al_., 
1987); the effect of induction on the covalent binding of valproic 
acid (Porubek et al., 1989b). Although the cells are intact, there 
is disruption of the spatial heterogeneity of the liver (Thurman and 
Kauffman, 1980); however, the major drawback to the use of isolated 
hepatocytes is their limited life-span in suspension (several 
hours). In order to prolong the useful life span of hepatocytes for 
in vitro studies, methods of primary culture were devised, and these 
are discussed in the following section. 
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1.4.4 Hepatocytes in primary culture 
In the early seventies, it was reported that a high yield of viable 
hepatocytes could be isolated from adult rats by collagenase-
hyaluronidase perfusion of the liver, and that these cells could be 
readily cultured (lype, 1971; Williams and Gunn, 1974). After an 
initial burst of proliferative activity the cultures became static 
and many of the cells died. Since the reports of these early 
studies that established that hepatocytes could survive in primary 
culture, a large volume of research has ensued to enhance the 
longevity and improve the maintenance of the phenotype of 
hepatocytes in culture. 
Some of the earliest work investigated the effects of media 
composition, especially the presence or absence of hormones, on cell 
survival and biochemistry. It was reported that inclusion of 
foetal calf serum (FCS) in the medium gave maximal attachment of rat 
hepatocytes at a concentration of 10%; the presence of insulin 
(2mUml" ) in addition to the FCS increased attachment further with 
the formation of confluent cultures, although there was no 
improvement in cell survival in the presence of insulin: 75% 
survival at 24 hours, around 30% survival at 48 hours (Laishes and 
Williams, 1976a). Inclusion of DEX (IpM) maintained the morphology 
of the hepatocytes and increased longevity of the cultures: more 
than 80% of the cells survived for three days (Laishes and Williams, 
1976b). It was later reported that DEX inhibited the production of 
a neutral protease, andsit was suggested that this contributed to 
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the increased cell survival (Williams et al., 1978). Other workers 
reported that more than 80% of hepatocytes cultured in Williams' 
Medium E (WE) containing 10% FCS, insulin (lO'^M) and DEX (10"^M) 
survived for six days in culture, and that, in contrast to freshly 
isolated cells, protein synthesis could be stimulated by hormones, 
the induction of tyrosine aminotransferase (TAT) and ornithine 
decarboxylase could be demonstrated and there was an increase in 
protein secretion into the medium. It was also shown that the 
polysomes,which disaggregated in freshly isolated cells, had 
reaggregated after five days in culture (Tanaka et al., 1978). In 
the presence of glucocorticoid, insulin and glucagon, the activities 
of glucokinase, pyruvate kinase and hexokinase were maintained for 
2-3 weeks in rat hepatocyte cultures, in addition to albumin 
secretion and urea synthesis (Dich et al., 1988). 
However, an increase in foetal hepatic protein expression, with a 
concomitant decrease in adult-specific proteins has been reported in 
primary cultures. As early as 1975, Guguen et al. observed that 
after seven days in primary culture the predominant form of pyruvate 
kinase in the cells isolated from adult rats was the K-type. This 
form is present in foetal liver, placenta and hepatoma cells, but is 
a minor form in adult parenchymal cells, where the L-type 
predominates. This form was detectable for five days in culture, 
but then decreased. Gamma-glutamyl transpeptidase (GGT) and 
otl-foetoprotein (which are not normally expressed in adults) also 
increase in rat hepatocytes cultured for more than three days 
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(Sirica ft al_., 1979). GGT levels are normally very low in adult 
liver and in early hepatocyte cultures, but levels are much higher 
in foetal and neonatal liver, and in rat hepatoma cells (Edwards, 
1982). Although the presence of FCS in the medium suppressed the 
increase in GGT, DEX actually induced GGT in primary cultures, the 
effect being particularly marked at higher pH levels (i.e. 7.8; 
Edwards, 1982). It is not known why this reversion to the foetal 
phenotype occurs in culture, although the observed changes appear to 
be associated with less differentiated/ proliferative cellular 
states; however, these alterations in phenotype would seem to limit 
the use of hepatocyte primary culture to short-term studies. 
In 1977 it was reported that the drug-metabolizing capacity of rat 
cultured hepatocytes was markedly reduced, compared to the liver in 
vivo (Guzelian ft a\_., 1977), The P450 content of 
non-proliferating primary cultures was 20% of the initial fresh cell 
value at 24 hours, with 63% of the P450-reductase remaining. 
Although there was this rapid decrease in P450 levels, no increase 
in P420 was detected. The maintenance of P450-dependent enzyme 
activities after 24 hours in culture was variable: aminopyrine-N-
demethylase and aniline hydroxylase activities both decreased by 
more than 70%, and aryl hydrocarbon hydroxylase (AHH) activity fell 
by more than 50%, whereas nitroanisole demethylase was maintained at 
85% of the initial activity. Therefore, it appeared that there was 
selective loss of P450 activities (and therefore isozymes) in 
culture. The general decline in total P450 has been reported by 
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many workers and is not restricted to rat hepatocytes in culture: 
P450 declines in cultures from other rodent species (Maslansky and 
Williams, 1982), and in human cultured hepatocytes (Grant et al_., 
1985), This serious phenotypic alteration is a major obstacle in 
the use of hepatocytes for metabolism/toxicity studies. For this 
reason, many different ways of improving the maintenance of P450 in 
culture have been investigated. 
1.4.5 Maintenance of P450 in primary culture 
Media composition has received a lot of attention with respect to 
maintenance of P450 in cultured hepatocytes, Decad et al. (1977) 
reported that medium supplemented with fatty acids, delta-amino-
laevulinate (ALA), alpha-tocopherol and various hormones (including 
insulin, hydrocortisone and thyroxine) maintained P450 content of 
rat cultured hepatocytes at 100% of the initial level for 24 hours. 
A similar medium was shown to significantly improve the maintenance 
of 7-ethoxycoumarin and 7-ethoxyresorufin 0-dealkylases (ECOD, EROD) 
and biphenyl-4-hydroxylase activities (Dickins and Peterson, 1980), 
A more recent report suggests that hormone- supplementation alone 
cannot attenuate the loss of P450 in culture, although the presence 
of DEX (IpM) stabilised the total P450 content at 65% of initial 
levels for three weeks (Dich et al., 1988). 
-4 
Ascorbate (4 x 10 M) supplementation partially attenuated the early 
decline in P450 content, as well as improving the maintenance of 
cytochrome bS and P450 reductase (Bissell and Guzelian, 1979). Paine 
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et al. (1979) demonstrated that the NAD content (NAD"*" and NADH 
together) of rat hepatocytes after 24 hours in culture was 40% of 
the fresh cell value, and that nicotinamide supplementation could 
prevent the loss of NAD. In addition, unphysiological levels of 
nicotinamide i.e. 25mM could prevent the loss of P450 in culture. 
Isonicotinamide was more effective in maintaining P450 levels, but 
had no effect on NAD content. A substituted pyridine, metyrapone 
(0.5mM) was also effective in preventing the loss of total P450 in 
rat hepatocyte cultures: more than 95% of the total P450 remained 
after seven days in culture, compared to only 48% at 24 hours in 
medium lacking metyrapone (Paine et al., 1982). This medium also 
maintained ethylmorphine-N-demethylase activity for four days, 
together with a gradual increase in benzphetamine-N- demethylase to 
84% of the initial value over the same time-period. There was also 
induction of both ECOD and EROD activities over the four days in 
culture (Lake and Paine, 1982). Therefore, the maintenance of 
activities observed in culture was not always at the same level as 
in vivo. A cystine/cysteine-free medium containing ALA maintained 
total P450 at 96% for 24 hours, however, all enzyme activities were 
very low (Lake and Paine, 1982). 
Nicotinamide, at a lower concentration (5mM) than that reported by 
Paine et al_. (1979) was shown to stabilise ECOD and 
7-propoxycoumarin O-dealkylase (PCOD) activities in rat cultured 
hepatocytes (around 50-50% of fresh cell values) similar to DEX 
alone, whereas nicotinamide and DEX (IpiM) together resulted in large 
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increases in these activities. However, this effect was still 
selective for certain P450 forms in that there was no effect on the 
decline of 7-methoxycoumarin O-dealkylase (MCOD) activity in culture 
(Warren and Fry, 1988). 
Steward ft a/[. (1985) reported the differential decline of 
immunoreactive P450 isozymes in primary culture. It was also 
observed that whereas the total immunoreactive P450 fell to 76% 
after 72 hours, the total spectrally active haemoprotein was 68% of 
initial levels, and it was suggested that loss of haem was 
responsible for a loss of holocytochrome in culture. The same 
report showed that metyrapone attenuated the loss of immunoreactive 
P450 over 72 hours, and that nicotinamide had a selective effect 
with respect to maintenance of immunospecific P450s in culture. 
Inclusion of exogenous haem, ALA and selenium has also been reported 
to maintain total P450 for 72 hours in culture (Engelmann et al., 
1985) and 3mM PB has been shown to markedly enhance the long-term 
survival of hepatocytes in culture, with attenuation of the decline 
in total P450 (Miyazaki et al., 1985). 
Vind et al. (1988) reported that hormonal-supplementation of culture 
media diminished the loss of P450 over 72 hours only in hepatocytes 
from adult female rats; there was no effect on hepatocytes from 
adult males. Croci and Williams (1985) observed little difference 
in the % maintenance of P450, AHH and benzphetamine-N -demethylase 
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activities in hepatocytes cultured for 24 hours in hepatocytes from 
male and female rats, with sex differences in basal activities being 
maintained in culture. However, glutathione conjugation of 
l,2-dichloro-4-nitrobenzene declined rapidly in hepatocytes from 
male rats to around 20% of the fresh cell value; hepatocytes from 
female rats only lost 66% of this activity. 
Thus, media supplementation can profoundly affect the maintenance of 
P450 and its associated activities. Many supplements appear to 
exert selective effects on particular isozymes, which are not 
reflected in measurements of total P450, but are unmasked on 
immunochemical detection or determination of enzyme activities. 
Different effects are also observed depending on the concentration 
(and possible interactions with other supplements) used. This is 
particularly true for hormonal supplementation. Many different 
media are employed, depending greatly on personal preference and the 
aim of the study. However, no medium has yet been formulated that 
maintains in vivo P450 levels in culture, qualitatively or 
quantitatively. 
Early work involved plating of isolated hepatocytes directly onto 
plastic culture vessels (e.g. Laishes and Williams, 1976a and b), or 
onto plastic coated with a thin layer of rat tail collagen (e.g. 
Bissell and Guzelian, 1980; Dickins and Peterson, 1980) to improve 
attachment and spreading of the hepatocytes. Other workers have 
investigated the effects of extracellular matrix components on 
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hepatocyte function and maintenance of phenotype. Hepatocytes 
cultured on floating collagen gels have been reported to have a 
superior induction response of TAT to hydrocortisone (10 M) after 
eight days in culture relative to cultures on the usual 
collagen-coated plates (Michalopoulos and Pitot, 1975); P450 and 
cytochrome b5 were maintained at detectable levels after ten days of 
culture on floating collagen gels (Michalopoulos et al., 1976). In a 
comparison of different extracellular matrix components (Sawada ft^ 
al., 1987) there were no differences in attachment, longevity or 
induction of TAT; however, after two weeks in culture GGT activity 
was highest in cells cultured on collagen and lowest in cells 
cultured on fibronectin. Matrigel is a mouse tumour cell extract, 
which has been shown to be superior to collagen as a substratum for 
hepatocyte culture (Schuetz et al., 1988). More cells survived for 
eight days on Matrigel than on collagen and there was increased 
secretion of albumin, transferrin, haemopexin and glutathione 
peroxidase on Matrigel. Haem oxygenase and P450 reductase 
gradually declined over the eight day culture period. However, it is 
still not clear whether the observed changes in gene expression 
(many of the studies on substrate effects on hepatic function have 
not involved P450 activities) are sufficiently advantageous to 
routinely supplant the use of collagen-coated plates, or 
electrostatically-treated plates ('Primaria' plates, obtainable from 
Falcon Plastics) which appear to be equivalent with respect to 
maintenance of hepatocyte cultures. 
47 
Another method for maintenance of P450 in culture, which has 
received a lot of attention in recent years is co-culture of 
hepatocytes with other hepatic cells. Begue et al_. (1984) 
demonstrated that in hepatocytes co-cultured with rat liver 
epithelial cells P450 was maintained at initial levels for nine 
days, together with aminopyrine N-demethylase activity. The P450 
content and demethylase activity of conventional cultures declined 
to negligible levels after four days in culture. 
Overall, manipulation of culture media composition appears to be the 
most successful (and also the simplest) method of maintaining P450 
and its associated activities in short-term primary cultures (less 
than 72 hours) of hepatocytes, although the effects of 
supplementation are selective for particular isozymic forms. 
Although different substrata and the presence of other cell types 
can affect hepatic gene expression and biochemistry, relatively 
little is known about the effects of these culture components on the 
drug-metabolizing system of cultured hepatocytes. 
1.4.6 Induction of P450 in culture 
It was mentioned above that 3mM PB attenuated the loss of P450 in 
primary cultures of rat hepatocytes; however, P450IIB1, the major 
PB-inducible isozyme was not immunochemically detectable in these 
cells (Miyazaki et al., 1985). Other workers have also reported a 
reduced or negligible response of P450 to inducers in culture, 
especially the response to barbiturates. Forster f t a l . (1986) 
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reported that the aldrin epoxidase activity of rat hepatocytes 
declined to 55% and 8% of initial levels at 1 and 5 days in culture 
respectively, and that PB and PCN treatment resulted in 
statistically insignificant increases in this activity, in contrast 
to the situation in vivo. Benzanthracene and PB both induced EROD 
activity in culture (12- and 8-fold respectively), this induction 
being markedly reduced in the absence of DEX (present in the 
medium). It was also shown that the time-course of induction 
depended on the media used, and that P450IA1 increased over five 
days in control cultures. This anomalous increase in 
3-MC-inducible, alpha-naphthoflavone-inhibitible P450s in untreated 
cultures has also been observed by others (Fry et al., 1980; Turner 
and Pitot, 1989), although the reason is unknown. PB and BNF 
induction of ECOD activity is much reduced in culture compared to in 
vivo, even in the presence of DEX (Warren and Fry, 1988), as is the 
induction of pentoxyresorufin O-dealkylase by PB in 
chemically-defined media (Turner and Pitot, 1989). Cultured 
hepatocytes have also been used to study the metabolism of 
2-AAF(McManus et al,, 1987), In control cultures, 3-hydroxylation 
remained constant for 24 hours in culture, whereas the 1-, 5-, 7-, 
9- and N-hydroxylations declined rapidly. DEX (0.1|JM) did not 
prevent the initial decline in activity, but after 72 hours in 
culture the 5- and 3-hydroxylations activities had increased over 
initial levels and the 7-hydroxylation activity had increased to 
initial levels (after a decline at 24 hours). There was also some 
recovery of N-hydroxylation. PCN only induced 7-hydroxylation jji 
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vitro. It was noted that the induction response in vitro was much 
smaller than that seen in vivo, and also qualitatively different, 3-
and 5-hydroxylation being induced by DEX in vitro but not in vivo. 
Therefore, media composition also affects induction responses in 
vitro, although in general, P450 induction in vitro is poor, and 
qualitatively as well as quantitatively different to that seen in 
vivo. This will be discussed further in Chapter Five. 
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1.4.7 Metabolism/toxicity studies in cultured rat hepatocytes 
In 1977, Decad ft al_, demonstrated that aflatoxin Bl could be 
metabolised by cultured hepatocytes to aflatoxin Ml and various 
conjugates. It was also shown that a significant amount of 
radioactivity (after exposure to radioactive aflatoxin) was 
non-extractable i.e. remained bound to the hepatocytes. 
Rat hepatocyte cultures have also been used to demonstrate that 
substantial acetaminophen covalent binding in the cells occurs 
before any observable toxicity, and that the covalent binding is 
mostly in the microsomal fraction (37%) and in the cytosol (25%; 
Acosta et al., 1987). It has also been shown that cyclophosphamide 
can be activated to a metabolite stable enough to kill fibroblasts 
co-cultured with the hepatocytes, and that the toxicity can be 
inhibited by SKF-525A (Fry and Bridges, 1977). 
Cultured hepatocytes have also been used to discriminate between 
hepatotoxic and non-toxic substances, especially of a related group 
of compounds e.g. non-steroidal anti-inflammatory drugs (Sorensen 
and Acosta, 1985). It was demonstrated that indomethacin was the 
most toxic of the five compounds tested, followed by benoxaprofen 
and ibuprofen, and aspirin and orpanoxin were non-toxic at the 
concentrations tested, as judged by viability, lactate dehydrogenase 
leakage and urea synthesis of the cultures, A more detailed 
discussion of the parameters used to assess toxicity is given in 
Chapter Seven. 
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1.4.8 Human hepatocytes in primary culture 
Less work has been done on drug metabolism in human cultured 
hepatocytes since adult samples are difficult to obtain and it is 
much harder to get high yields of cells suitable for culture, mainly 
due to the nature of the samples. However, from the work that has 
been done, it appears that human hepatocytes in culture 
de-differentiate slower than their rodent counterparts, and also, 
that the P450 content declines more slowly: 60% of the spectrally 
determined P450 remains after four days in culture (Strom et al., 
1987). Grant ft al_. (1987) demonstrated that P450-dependent 
activities and glucuronidation were well maintained for 72 hours in 
human cultured hepatocytes; sulphation however decreased within the 
first 24 hours, and the P450 reductase had declined to 32% after 72 
hours in culture. Begue et al. (1983) investigated the metabolism 
of an anti-anaphylactio, ketotifen, in human cultured hepatocytes: 
the main metabolites produced in vitro correlated with the known 
metabolic pathways in vivo. Also, the rate of metabolism did not 
alter significantly over the first four days of conventional 
culture, or seven days for human hepatocytes co-cultured with rat 
epithelial cells. Thus, human hepatocytes would appear to have 
several advantages over rodent hepatocytes with respect to 
maintenance of drug metabolism in vitro. 
1.4.9 Use of hepatoma cell lines 
It is still not possible to obtain substantial (and reproducible) 
levels of mitotic activity in adult cultured hepatocytes. Some 
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work has been done on drug metabolism in hepatoma cell lines, both 
human and rodent in origin, since a dividing cell line would provide 
a continuous supply of hepatocytes, obviating the need to isolate 
and culture cells for every study. Wi&bel et al, (1984) examined 
the P450 activity of six differentiated rat hepatoma cell lines and 
found that the constitutive activities were very low, and some were 
undetectable. The expression of MFO sensitive to antibodies to 
PB-inducible P450s was present in widely differing amounts in the 
differentiated lines, Benzanthrancene, PB and DEX induction of 
P450 lAl and AHH activity and PB and DEX induction of P450IIB1/2 and 
aldrin epoxidase have also been observed in differentiated cell 
lines (Wiebel ft al_., 1984; Corcos and Weiss, 1988). The human 
hepatoma, HepG2 has been shown to have levels of glucuronidation and 
cytochrome reductase similar to those of freshly isolated human 
hepatocytes although levels of 0-dealkylation were reduced (Grant ft 
al., 1988), Although HepG2 cells remain differentiated in culture, 
their P450 content was 10-20% that of fresh human hepatocytes, and 
their P450 activities were 10-fold lower. However, medium 
composition altered drug metabolism activities (Doodstdar et al., 
1988). HepG2 cells also synthesize and secrete the major plasma 
proteins, and morphologically resemble hepatocytes, although they do 
possess an abnormal chromosome number (50-56) with a distinctive 
rearrangement of chromosome 1 (Knowles et al., 1980). 
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1.4.10 Species differences in metabolism 
The preceding sections referred primarily to the use of rodent in 
vitro systems, principally rat hepatocytes, in the study of drug 
metabolism and mechanisms of toxicity. Increasingly these cells 
are being used in the development of predictive toxicity tests. In 
addition to the limitations imposed by the decline of P450 and 
metabolic capacity in vitro discussed above, there are also 
problems, particularly with toxicity testing, associated with 
extrapolation both from in vitro to in vivo and from rodents to Man. 
Correlations between drug metabolism studied in vivo and in vitro 
have been discussed in the previous sections (1,3.1-5) and the same 
advantages of in vitro techniques with respect to the study of drug 
metabolism also extend to toxicity studies. Many compounds e.g. 
heavy metals, mineral fibres and arsenic usually test negative in 
short-term mammalian cell culture assays, despite the fact that they 
are known human carcinogens (Lave and Omenn, 1988). In addition, 
volatile and particulate compounds present special problems. There 
is also the problem of detection of pro-toxins i.e. the test system 
must be able to activate known non-toxic precursors to their 
reactive intermediates. The most successful in vitro toxicity 
assays to date have been those that detect genotoxins by assessing 
DNA damage e.g. unscheduled DNA synthesis (UDS) and sister chromatid 
exchange (Grisham and Smith, 1984). The sensitivity of the UDS 
assay has been improved by use of rat hepatocytes cultured from 
animals pre-treated with MFO inducers i.e. Arochlor 1254 and PB 
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(Shaddock ft al_., 1989). Hepatocytes from inducer-treated animals 
have also been used as an activation system for the mouse lymphoma 
cell mutagenicity assay (Oglesby et al., 1989). 
Even when in vitro toxicity information has been obtained, there is 
still the problem of correlation with the in vivo data, as to which 
measure of acute toxicity is the most suitable comparison (Fry ft 
al., 1988). The in vivo data exists in many forms with variations 
in routes of administration, species tested and assessment of 
toxicity. It is also difficult to make sensible extrapolations of 
toxic concentrations from static culture systems to organisms with 
dynamic elimination systems. 
There are also many known species differences in P450 metabolism, 
reviewed by Kato (1979), which have important implications for (but 
do not necessarily preclude) the use of experimental animals in the 
assessment of human metabolism and toxicity. There are species 
differences with respect to rate of metabolism e.g.hexobarbitone 
sleep time (Quinn et al., 1958) and the pattern of metabolites 
produced from a given substrate e.g. 7-hydroxycoumarin is the major 
metabolite of coumarin in Man, whereas in the rat 3-hydroxylation 
predominates, with siery little 7-hydroxycoumarin being produced 
(Cohen, 1979). Species differences in P450 composition can result 
in differences in toxicity due to differing metabolite profiles e.g. 
the guinea pig, unlike the rat, mouse and rabbit, is 
resistant to 2-AAF-induced hepatomas. The guinea pig forms very 
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little N-hydroxylated-AAF, with ring hydroxylations predominating. 
In contrast, N-hydroxylase activity in the other species correlated 
well with susceptibility to 2-AAF-induced carcinoma, with hamsters 
being the least resistant, with the highest N- and lowest 
ring-hydroxylase activities (Miller et al., 1960; Kato, 1979). Thus, 
differences in metabolite profiles could be used to predict toxicity 
in susceptible species. It has also been shown that species 
differences in susceptibility to paracetamol-induced necrosis 
correlate with the extent of tissue covalent binding and GSH 
depletion (Davies et al., 1974). There are also differences in 
induction and inhibition (Kato, 1979). Another problem is that 
experimental animals are highly inbred and kept under uniform 
conditions e.g. diet, and therefore, unlike humans, are very 
homogeneous with respect to response on exposure to xenobiotics 
(Gregory, 1988). However, the rat is still the most popular model 
for studying P450 metabolism and toxicity, not least because of the 
large accessible data base, and the ready availability of animals. 
Despite the differences in metabolism, vast improvements in 
predictive toxicology could be made by increased understanding of 
mechanisms of toxicity, and routes of metabolism in susceptible and 
resistant species (Grisham and Smith, 1984). 
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1.5 RATIONALE AND AIMS OF THIS STUDY 
The aims of this study were to develop an in vitro system for the 
investigation of hepatic cytochrome P450-mediated toxicity. Cultured 
rat hepatocytes have the potential for use as a prime in vitro model 
of hepatic drug metabolism and toxicity as has been discussed above 
(1.4.3 - 1.4.4). However, in order to investigate hepatic 
metabolism-mediated toxicity, the full range of biotransformation 
and detoxification enzymes must be present and active in the 
cultured cells. In this respect, the inability to maintain the 
P450 isozymes in cultured hepatocytes has proved to be a major 
drawback to their use in activation/toxicity studies. The large 
body of work concerned with the maintenance of P450 in culture was 
reviewed in section 1.4.5, Included in this was the effects of 
media supplementation of P450 activity in vitro. It has been shown 
that DEX in particular could maintain P450 activities in primary 
culture, and that DEX (IpM) and nicotinamide (5mM) together improved 
the maintenance of P450-dependent alkoxycoumarin O-dealkylase 
activities in vitro (Warren et al., 1985; Warren and Fry, 1988). 
However, this maintenance was selective in that the ECOD and PCOD 
activities were well maintained for 72 hours, whilst MCOD activity 
was rapidly lost in culture (Warren and Fry, 1988). In the same 
study, reduced induction by PB and BNF in vitro compared to in vivo 
was reported. 
Most of the work presented here was concerned with developing the 
culture conditions described above to support both the stable 
maintenance of a wider range of P450 activities and also induction 
of P450s in vitro. The effects of induction in vivo on P450 
activity and P450-mediated toxicity in vitro were also investigated. 
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TABLE 1.1 .ENDOGENOUS AND XENOBIOTIC SUBSTRATES OF 
CYTOCHROME P450^ 
SUBSTRATE REACTION 
steroids 
prostaglandins 
leukotrienes 
arachidonic acid 
vitamin D 
lauric acid 
phenobarbitione 
HYDROXYLATION 
(aryl or aliphatic) 
aractiidonic acid 
benzo-pyrene 
bromobenzene 
EPOXIDATION 
thyroid hormones 
halothane 
DEHALOGENATION 
uroporphyrinogen 2 
valproic acid"^ 
DESATURATiON 
benzphetamine 
codeine 
6-methyipurine 
N-,0- and 8-
DEALKYLATION 
amphetamine OXIDATIVE DEAMINATION 
2-acetylaminofluorene N-OXIDATION 
ethanol ALCOHOL OXIDATION 
azo, nitro compounds REDUCTION 
halogenated hydrocarbons 
"• information from Gibson and Skett (1986), except where indicated. 
Endogenous substrates are in italics, and xenobiotic substrates in plain print. 
2 Jacobs et al., 1988 
3 Rettie et al., 1988 
TABLE 1.2. P450 NOMENCLATURE. P450 nomenclature has now been 
standardized by Nebert ef a/.(1987,1989), and this is shown in the first 
column below. Isozyme designations from different laboratories are shown 
in subsequent columns, and are based on the summaries by Waxman (1988) 
and Ryan and Levin (1990). 
LEVIN GUENGERICH SCHENKMAN WAXMAN KAMATAKI 
IA1 
IA2 
IIAl 
IIA2 
IIB1 
IIB2 
IIC6 
IIC7 
iiC11 
IIC12 
IIC13 
IIEl 
IIIAl 
IIIA2 
c 
d 
a 
m* 
b 
e 
k 
f 
h 
i 
g 
j 
p 
BNF-B 
ISF-G 
UT-F 
PB-B 
PB-D 
PB-C 
UT-A 
UT-I 
RLM2b 
PB RLM5 
PB RLM6 
RLM5a/PBRLM4 
RLM5b 
RLM5 
fRLM4 
RLM3(g) 
RLM6 
PCN-E" 
3 
PB-4 
PB-5 
PB-1 
2c 
2d 
2a * * 
male 
female 
Arlotto and Parkinson, 1989. 
** It is not entirely clear which of the isozymes isolated in the different 
laboratories are equivalent to P450IIIAI, and which to P450IIIA2; also, 
there have been changes in nomenclature of these isozymes within 
laboratories; the multiplicity of this particular gene family has been 
discussed by Halpert (1988). 
TABLE 1,3. ENDOGENOUS AND XENOBIOTIC SUBSTRATES OF 
PHASE II METABOLISM^ 
SUBSTRATE REACTION 
steroid hormones 
bilirubin 
thyroxine 
catecholamines 
acetaminophen 
salicylic acid 
morphine 
GLUCURONIDATION 
steroids 
heparin 
acetaminophen 
2-acetylaminofluorene 
salicylamide 
SULPHATION 
histamine 
catecholamines 
thiouracil 
N-METHYLATION 
serotonin 
Isoniazid 
ACETYLATION 
bile acids 
benzoic acids 
AMINO ACID CONJUGATION 
bilirubin 
steroids 
leukotrienes 
vitamin K 
bromobenzene 
acetaminophen 
urethane 
GLUTATHIONE 
CONJUGATION 
•• information from Gibson and Skett (1986) and Ziegler(1988). 
Endogenous substrates in italics, xenobiotics In plain print. 
SH 
P450(Fe2+) P450(Fe3+)..SH 
H2O, SOH, 
b 5 ( F e 3+ ) ^ 
O2-~P450(Fe2+).SH 
b5(Fe3+) 
R 
R 
I 
O2-~P450(Fe3+)~SH 
b5(Fe2+) 
O2 
b5(Fe3+) 
P450(Fe3+)~SH 
b5(Fe3+) 
NADPHr 
R2 
NADP+ P45o(Fe3+)~SH 
b5(Fe3+) 
R-
P450(Pe3+)~SH 
b5(Fe2+) 
R-
P450(Fe2+)..SH 
b5(Fe3+) 
FIGURE 1,1. THE CYTOCHROME P450 CATALYTIC CYCLE, 
Based on information from several sources, including Jansson et al., 
(1985) and Gibson and Skett (1986). 
FIGURE 1.2. DIAGRAMMATIC REPRESENTATION OF THE 
LIVER ACINUS. Adapted from Gumucio and Chianale (1988). 
The concept of the acinus as the functional unit of the liver was 
first proposed by Rappaport ef a/.(1954). 
A terminal hepatic venule 
B bile ductule 
C hepatic arteriole 
D terminal portal venule 
E zone 1, periportal region 
F zone 2, midzonal region 
G zone 3, pericentral or perivenous region 
Arrows show the direction of blood flow. 
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CHAPTER 2 
MATERIALS AND METHODS 
MATERIALS 
2.1 ANIMALS 
The Wistar albino rats used in these studies were obtained from the 
University of Nottingham Animal Breeding Unit. Male and female rats 
(70 - 180g) were allowed free access to food and water and were 
housed at 22°C, with a 12 hour light/dark cycle (light: 08.00 -
20.00), The animals were bedded from birth on the synthetic 
bedding, Labi it (W.P. Usher, London, U.K.), to minimise enzyme 
induction from wood shavings (Vesell, 1982; Torrb'nen et al., 1989). 
2.2 CHEMICALS AND EQUIPMENT 
The suppliers of the chemicals used in these studies were as 
follows: delta-aminolaevulinate hydrochloride, 7-methoxycoumarin, 
2-methylfuran, resorufin and selenious acid were obtained from 
Aldrich Chemical Co. (Dorset, U.K.); foetal calf serum, glutamine, 
trypan blue and Williams' medium E, cellulose acetate filters (pore 
size 0.2|jm) and plate sealers were obtained from Flow Laboratories 
(Irvine, Scotland); collagen type I was obtained from B.C.L. 
(Sussex, U.K.); phenobarbitone and acetyl acetone were obtained from 
B.D.H. (Dorset, U.K.); fungizone was obtained from Squibb Surgicare 
Ltd. (Hounslow, U.K.), dexamethasone (Decadron) from Merck, Sharp 
and Dohme Ltd. (Hoddesdon, U.K.), insulin 
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(Actrapid MC) from Novo Industri A/S (Denmark); and gentamicin from 
Roussel Laboratories Ltd. (Uxbridge, U.K.). Ammonium acetate, 
benzalkonium chloride, benzphetamine, beta-glucuronidase H-I (E.C. 
3.2.1,31), beta-naphthoflavone, beta-NADP, bovine serum albumin, 
butylated hydroxytoluene, collagenase type IV (E,C, 3,4,24,3) 
Coomassie Brilliant Blue G, dicoumarol, 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), EDTA,EGTA, 
erythromycin, glucose-6-phosphate, glucose-6-phosphate 
dehydrogenase type XI (E,C. 1.1.1.49), glutathione, hemin type 1, 
HEPES, hyaluronidase type II (E.C. 3.2.1,35), 7-hydroxycoumarin, 
isoamylalcohol, isoniazid (isonicotinic acid hydrazide), 
nicotinamide (niacinamide), 4-nitrocatechol, 4-nitrophenol, 
N,N-dimethylformamide, o-phthalaldehyde, Percoll, precocenes I and 
II, Rhodamine B, semicarbazide, 6-thiopurine (6-mercaptopurine) and 
valproic acid were all obtained from Sigma Chemical Co. (Dorset, 
U.K.). 4-Ipomeanol was a gift from Dr. M.R. Boyd, National Cancer 
Institute, Bethesda, MD, U.S.A. 7-Ethoxycoumarin, 7-propoxycoumarin 
and 7-ethoxyresorufin had been synthesized by the method of Prough 
et al. (1978). "Primaria" culture dishes were obtained from Falcon 
(Becton Dickinson Ltd., Oxford, U.K.) and 24-well plastic culture 
dishes from Nunc (Denmark). All other reagents and organic 
solvents were of analytical reagent grade and obtained from local 
suppliers. 
Low-speed centrifugation was carried out using an MSE Centaur bench 
centrifuge or an MSE Mistral 6000 refrigerated centrifuge. 
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A Stuart Tube Rotator TR-2 was used for extraction procedures. Cell 
suspensions were homogenised using an MSE Soniprep. Spectrophoto-
metric analysis was carried out using a Perkin-Elmer 550S UV-Vis 
spectrophotometer or a Dynatech plate reader and fluorometric 
analysis was performed using a Baird RC200 Ratiometric fluorimeter. 
METHODS 
2.3 STERILIZATION PROCEDURES 
Standard sterilization procedures and aseptic techniques were 
practised throughout these studies, as outlined by Paul (1970) in 
addition to supplementation of culture media with antibiotics to 
reduce the risk of microbiological contamination of cell cultures. 
Water baths and the water tray inside the incubator all contained 
benzalkonium chloride (0.1%), and the water was changed frequently. 
Dry heat 
All glassware (openings covered with aluminium foil) and glass 
pipettes (bunged with cotton wool and placed in metal canisters) 
were sterilized in a Gallenkamp oven, set at 160-180°C for 2 hours. 
Moist heat 
Plastic and rubber items, wrapped in aluminium foil, and heat stable 
solutions were autoclaved in a Cabburn autoclave set at 121°C for a 
25 minute cycle. 
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F i l t ra t ion 
Non-heat stable solutions and small volumes of l i qu i d were 
s t e r i l i z ed by f i l t r a t i o n through cel lulose acetate f i l t e r s wi th a 
0.2nm pore s ize. 
Aseptic technique 
All sterile procedures were performed in a laminar flow hood 
(Intermed, Microflow, Hants., U.K.) regularly swabbed with 70% 
alcohol. Bottle and glassware openings and pipettes were all 
regularly flamed during use. 
2.4 ISOLATION OF HEPATOCYTES 
Hepatocytes were isolated either by the slice method of Paterson and 
Fry (1983) or by the lobe perfusion method of Reese and Byard (1981). 
Slice method 
The wash solution was a calcium-, magnesium-free Hanks buffer pH 7.4 
(140mM NaCl, 5mM KCl, 0.4mM KH2PO4, 0.3mM Na2HP04, 20mM HEPES, 50\iM 
phenol red, 20 ml 1" 0.5N NaOH), to which NaHCOg, glucose, 
methionine and gentamicin, at 14.8, 5.5, 2mM and 50[jgml~ (final 
concentrations), were added on the day of isolation. The wash 
solution was pre-gassed with air/COp (95%/5%), by placing in a LEEC 
incubator throughout the isolation. 
The rat was killed by cervical dislocation, the liver lobes removed 
and placed in lOml wash solution. The liver was blotted dry and 
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weighed; 3.0g was used. Subsequent manipulations were carried out 
in a flow cabinet. Individual lobes were placed on a filter paper 
on a Perspex sheet and thinly sliced using a degreased razor blade 
(Wilkinson Sword). Slices in 10ml wash solution were placed in a 
sterile 250ml conical flask sealed with a sterile rubber bung in a 
shaking water bath at 37°C, for 10 minutes at 90 
oscillations/minute. The solution was then removed and the slices 
washed twice more. The cells were then washed twice with 10ml wash 
solution containing 0.5mM EGTA. This chelating solution was 
removed and replaced with enzyme solution (10ml wash solution 
containing 1000 units (U) of collagenase Type IV, 4250 U of 
hyaluronidase and 5mM CaCl^). The flask was then shaken for 45-70 
minutes until the slices had disintegrated. The resulting 
suspension was filtered through a piece of sterile surgical gauze 
into 20ml wash solution in a sterile beaker. The suspension was 
centrifuged for 90 seconds at 50g, and the pellet washed twice with 
fresh wash solution. The final pellet was resuspended in 
incubation or culture medium (see sections 2.6 and 2.7). 
Lobe perfusion method 
The apparatus was set up as in Figure 2.1, perfusates being 
circulated using a Watson-Marlow peristaltic pump. The water bath 
was kept at 40°C to allow for the 3°C drop in temperature between 
water bath and lobe (Chenery et al., 1987). Alcohol (70% v/v, 
50ml), followed by 100ml sterile water was run through the apparatus 
prior to perfusion of the lobes. The calcium-, magnesium-free 
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Hanks buffer containing NaHCO,, glucose, methionine and gentamicin 
as described above was used to make up the perfusates, which were 
gassed continuously with Op/CO^ (95%/5%). On changing solutions, 
perfusate was run through the system for 30 seconds before being 
re-circulated, to flush the previous solution from the system. 
During perfusion the lobes were.covered with a piece of sterile 
gauze, soaked in Hanks buffer. 
The rat was killed by cervical dislocation, and the liver lobes 
removed and rinsed with Hanks buffer. Care was taken not to damage 
the lobes, which were cannulated with a 21G x U " needle through a 
vein on an exposed cut surface. The same lobes were routinely 
used. The lobes were perfused for several minutes with 
non-circulating Hanks buffer containing 0.5mM EGTA, to flush out the 
blood. When the lobes were evenly blanched, fresh buffer with EGTA 
was recirculated for 15-20 minutes. The flow rate was set at 10-15 
ml perfusate minute " cannula" . The lobes were then perfused 
with re-circulating buffer containing 100 Uml" of collagenase Type 
IV and 5mM CaCl2, for 30 minutes. The lobes were carefully 
transferred to a beaker containing a small volume of Hanks buffer 
and minced gently with a pair of scissors. After filtration 
through a piece of sterile gauze the cell suspension was centrifuged 
at 50g for 90 seconds and the pellet washed with Hanks buffer. The 
cells were then resuspended in 5ml culture medium (see 2.6) which 
was added to 5ml Percoll solution (Percoll diluted 1:10 with 
concentrated Hanks salt solution: 1.4M NaCl, 50mM KCl, 4mM KH2P0^, 
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3mM NapHPO-, 55mM glucose). Centrifugation at 50g for 10 minutes 
resulted in a separation of the viable and non-viable cells (Kreamer 
et al., 1986). The pellet of viable cells was washed with culture 
medium, followed by centrifugation at 50g for 90 seconds, and 
finally resuspended in culture medium. 
The viability of the final cell suspension obtained from both 
isolation methods was assessed using trypan blue exclusion (2,5,1). 
Suspensions of viability less than 85% were rejected. The 
concentration of the cell suspension was then adjusted (usually to 
2,0 X 10 cells ml" ) and the cells either used fresh, placed into 
culture or sonicated to give an homogenate (2,6-2.8). 
For the initial kinetic studies (2.10) hepatocytes were isolated by 
the slice method. In all subsequent experiments lobe perfusion was 
preferred, since, in combination with the use of larger rats, the 
yield of hepatocytes per animal was consistently increased whilst 
the isolation time was decreased. Table 2.1 shows the cytochrome 
P450-dependent alkoxycoumarin O-dealkylase activities measured in 
fresh hepatocytes isolated by slicing or lobe perfusion, and the 
maintenance in culture for 24 hours of these activities. The 
fresh cell activities are similar, as are the maintenance values, 
indicating that the method of isolation does not influence the P450 
activities measured in fresh or cultured hepatocytes. 
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2.5 ASSESSMENT OF CELL VIABILITY 
2.5.1 Trypan blue exclusion 
Viability of hepatocyte suspensions was determined using the trypan 
blue dye exclusion test, which has been shown to be as sensitive a 
parameter of viability as lactate dehydrogenase leakage (Jauregui ft^ 
al., 1981). It is also quicker and simpler to perform, and it 
enables a quick estimate of the number of viable cells to be made. 
Cells with an intact plasma membrane will exclude the dye: these 
cells are judged to be viable. Where membrane integrity is 
compromised the cells take up the dye and appear blue when viewed 
under a light microscope. The number of viable and non-viable 
cells were counted by mixing 0.25ml cell suspension with 0.1ml 
trypan blue (0.5% dye solution in 85% saline) and placing the 
mixture onto an improved Neubauer haemocytometer (depth 0.1mm). 
The percentage viability was then calculated. 
2.5.2 Reduction of MTT 
In experiments where compounds were screened for toxicity to 
cultured hepatocytes the number of viable cells remaining after 
treatment was determined by assessment of mitochondrial function. 
The mitochondrial enzyme, succinate dehydrogenase, can reduce the 
yellow tetrazolium salt, MTT, to a blue formazan product which 
absorbs at 560-570nm. Only cells with viable mitochondria can 
reduce the MTT and the amount of formazan produced is proportional 
to the number of viable cells (Figure 2.2). The method was modified 
from that of Denizot and Lang (1986), for use with hepatocyte 
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cultures. WEC containing 0,2mgml~ MTT was placed on the cells. 
After a 3 hour incubation at 37°C, the medium was removed and the 
formazan that precipitated in the cells solubilised in isopropanol. 
Absorbance was determined spectrophotometrically at 560nm or at 
570nm using a Dynatech plate reader. 
2.6 USE OF FRESH CELLS 
For all enzyme assays in freshly isolated hepatocytes, cells were 
resuspended at 2.0 x 10 cells ml" in culture medium or Hanks 
buffer (2.4) containing 20mM HEPES. Incubations were performed in 
25ml conical glass flasks shaken continuously in a 37°C water bath. 
Incubation times of 20-30 minutes were routinely used, the cells 
being used immediately after isolation. There was no loss of 
viability of the cells over these time periods. 
2.7 PRIMARY CULTURE OF HEPATOCYTES 
2.7.1 Culture medium 
Hepatocytes were cultured in Williams' medium E, the composition of 
which is shown in Table 2.2. To 445ml single strength Williams' E 
was added: glutamine 2mM, fungizone 2.5pgml" , gentamicin 50pgml~ , 
foetal calf serum 10% v/v, insulin lOmU ml" , nicotinamide 5mM and 
dexamethasone IpM. All concentrations are final concentrations. 
This medium is referred to as WEC, and has been shown to maintain 
certain P450-dependent activities (Warren and Fry, 1988). 
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2.7.2 Procedure 
Hepatocytes were cultured either on 60mm diameter "Primaria" petri 
dishes at 2.5 x 10 cells dish" , or on collagen-coated plastic 
5 -1 24-well plates at 2.5 x 10 cells well . Collagen was diluted 
down to 250pgml" with sterile O.IM acetic acid and spread over each 
well to give a coating of b\igcm . "Primaria" dishes are 
electrostatically treated to promote attachment and survival of 
cells. Both the "Primaria" dishes and the multiwell plates were 
pre-incubated with WEC, before hepatocytes were plated onto them. 
After allowing 1-2 hours for attachment, monolayers were rinsed with 
Hanks buffer and fresh WEC was added. Medium was replaced every 24 
hours. 
2.8 PREPARATION OF CELL HOMOGENATES 
Fresh cell suspensions were centrifuged at 50g for 90 seconds, and 
the pellet resuspended in ice-cold Tris-sucrose-EDTA buffer, pH 7,4 
(20mM - 0.25mM - 5.4mM final concentrations respectively) at 
fi - 1 
approximately 10 x 10 cells ml" . Cultured hepatocytes were 
scraped from the culture dishes, the contents of 5 "Primaria" plates 
being pooled into a final volume of 1.5ml ice-cold buffer. The 
resulting suspensions were sonicated using a Soniprep probe at an 
amplitude of 15 for two 15 second pulses. This achieved maximum 
disruption with minimum enzyme damage. Homogenates were either 
used fresh, or frozen in liquid nitrogen and stored until required 
(always less than 1 week from preparation). 
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2.9 DETERMINATION OF PROTEIN 
The protein content of fresh cell samples, cultures and homogenates 
was determined using the Bradford assay (Bradford, 1976). Samples 
were dissolved in 0,5N NaOH and diluted to approximately lOOpgml" . 
NaOH extract (lOOpl) was mixed with l.Oml dye reagent (lOOmg 
Brilliant Blue G in 50ml absolute ethanol added to lOOml 85% 
orthophosphoric acid, made up to 1 litre with water) and left to 
stand for 5 minutes. Absorbance at 595nm was determined and the 
protein content derived by interpolation from a standard curve, 
constructed with bovine serum albumin. Protein content of 
hepatocytes was shown to be linear with respect to cell number 
(Figure 2.3). 
2.10 ALKOXYCOUMARIN O-DEALKYLASE ACTIVITIES 
2.10.1 Kinetics 
The O-dealkylation of alkoxycoumarins are P450-dependent activities 
that have been shown to have biphasic kinetics in rat liver 
microsomes (Boobis et al,, 1981; Paterson et al,, 1984), preliminary 
experiments in isolated hepatocytes confirming these observations. 
The kinetics of 7-methoxy- and 7-ethoxycoumarin 0-dealkylation 
(MCOD, ECOD), determined in freshly isolated hepatocytes are shown 
in Figures 2.4 and 2.5 respectively. The kinetics were analysed 
using Hanes plots (see Appendix:A2.1). The two activities are 
clearly biphasic in the freshly isolated cells. Similar kinetic 
studies in hepatocytes cultured for 24 hours showed that whereas 
ECOD remained biphasic in culture (Figure 2.7), MCOD became 
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monophasic (Figure 2.6). 
Estimations of the kinetic parameters. Km and Vmax, are presented in 
Table 2.3. The Km of MCOD activity measured in the cultured 
hepatocytes is similar to that of the total activity in the fresh 
cells. This suggests that it is the low affinity form of the 
activity that is retained, albeit at a reduced level (reduced Vmax), 
whereas the high affinity form is lost completely. Both components 
of ECOD activity were present in cultured hepatocytes (similar Km 
values), although the activity was reduced (lower Vmax values). 
This information suggests that different populations of P450 are 
Involved in the high and low affinity components of these 
activities, a suggestion which is reinforced by the differential 
response of the substrates to P450 inducers (Matsubara et al., 1983; 
Okuno et al., 1989). Therefore, the alkoxycoumarins provide a 
series of substrates for the investigation of a range of P450s, 
since multiple isozymes appear to be involved in the O-dealkylase 
activities. In the studies reported here, O-dealkylase activities 
have been used in this way as markers for different populations of 
P450 isozymes, those responsible for the.high and low affinity 
components of each activity. For this reason, activities are 
measured at two substrate concentrations: 10 or 20pM for the high 
affinity form (MCOD activity could not be accurately and 
reproducibly determined at substrate concentrations lower than 20pM) 
and 500pM for the total activity. This two substrate concentration 
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approach has been suggested previously by Boobis et al. (1986). 
2.10.2 Determination of activity 
Alkoxycoumarin O-dealkylase activities were determined by the well 
characterised method of Fry and Bridges (1980) in which the 
7-hydroxycoumarin (7-HC) produced by O-dealkylation is assayed 
fluorometrically. Substrate (the alkyl ether) in 
N,N-dimethylformamide (DMF) at 2iilml" medium was added to freshly 
Isolated or cultured hepatocytes. Fresh hepatocytes were incubated 
with substrate for 20 minutes at 37°C in a shaking water bath; 
cultured hepatocytes were Incubated with substrate for 4 hours at 
37°C. No toxicity of the substrates to the cells was observable 
after these Incubations. The reaction was stopped by adding the 
incubate (medium + fresh cells or medium alone from the cultures) to 
4ml ice-cold water/0.2M acetate buffer (3:1 v/v). 320 U of 
beta-glucuronidase H-1 (in 1ml acetate buffer) was added to each 
sample to deconjugate the glucuronide and sulphate derivatives of 
7-HC prior to extraction and assay; Incubation with enzyme was for 2 
hours or overnight at 37°C. Under these conditions more than 97% 
of the conjugates were released with no hydrolysis of the sulphate 
(Paterson ft al^ ., 1984). The 7-HC was then extracted into 4ml 
diethylether (containing isoamylalcohol 1.5% v/v). Organic phase 
(1ml) was then extracted into 4ml 0.05M glycine-NaOH buffer, pH 
10.4, and the fluorescence determined at an excitation wavelength of 
370nm (ex 370nm) and an emission wavelength of 450nm (em 450nm). 
The 7-HC content was then derived by interpolation from a standard 
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curve. The production of 7-HC under these conditions was shown to 
be linear with respect to time and cell number. 
2.11 DETERMINATION OF CYTOCHROME P450 CONTENT 
The P450 content of hepatocyte homogenates was determined using the 
method of Estabrook et al. (1972). Homogenates were diluted in O.IM 
Tris buffer (pH 7.4), containing 20% v/v glycerol, to the equivalent 
of 1-2 X 10 cells ml" . Carbon monoxide was bubbled through the 
suspension for 1 minute, at 1-2 bubbles second" . The sample was 
split equally between 2 cuvettes and scanned between 390 and 510nra. 
Sodium dithionite was added to one cuvette, which was mixed well, 
and re-scanned. The P450 content was calculated, using the 
absorbance difference between 450 and 490nm, and the extinction 
coefficient of 91mM" cm" . 
2.12 ANALYSIS OF ENZYME ACTIVITIES IN CELL HOMOGENATES 
Enzyme activities in cell homogenates were determined using an 
Incubation mix similar to that described by Paterson and Fry (1983) 
for microsomal Incubations. Determination of enzyme activities in 
homogenates has also been described previously (Grant et al., 1985). 
The 1ml incubation mix contained 5mM magnesium sulphate, lUml" 
glucose-6-phosphate dehydrogenase, and cofactors (0.5mM NADP and 5mM 
glucose-6-phosphate, final concentrations) in 0.2M phosphate buffer, 
pH 7.4. Cell homogenates were routinely used at concentrations of 
0.5-l.Omg protein ml" incubation mix. 
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Activities were determined from standard curves of the amount of 
product. Substrate was also included in blank and standard 
samples. Reactions were determined to be linear at the chosen 
substrate concentrations over the incubation period at the required 
homogenate protein concentration, in homogenates from control and 
Inducer-treated animals. 
2.13 DETERMINATION OF 7-ETHOXYRESORUFIN 0-DEALKYUSE ACTIVITY 
7-Ethoxyresorufin is dealkylated in microsomes to a fluorescent 
product, resorufin (Pohl and Fouts, 1980). The incubation mix used 
was a slight modification of that described in 2.12, in that 
homogenate was used at 0.1 mg protein ml" and bovine serum albumin 
(Img ml" ) was included in the phosphate buffer, to prevent product 
inhibition, and maintain linearity of the reaction respectively. 
Prior to assay with substrate, dicoumarol (final concentration 10|JM) 
was added to the incubation mix, which was then incubated at 37°C 
for 10 minutes. The dicoumarol inhibits microsomal reductases that 
can reduce the unstable resorufin (Lubet et al., 1985). 
7-Ethoxyresoruf1n (final concentration 1.7|JM in DMSO) was then 
Incubated with the samples for 30 minutes. When homogenates from 
BNF-treated rats were assayed, the incubation period was reduced to 
10 minutes. The reaction was terminated by the addition of 2ml 
methanol. The fluorescence of the resorufin in the cleared 
supernatant was then determined. The product, resorufin, is 
relatively unstable, therefore Rhodamine B was used as a standard. 
The fluorescence of Rhodamine 8 at ex 550nm and em 585nm was 
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determined to be twice that of resorufin. 
2.14 DETERMINATION OF NITROPHENOL HYDROXYLASE ACTIVITY 
4-Nitrophenol hydroxylase activity was assayed by determination of 
the amount of 4-n1trocatechol produced. The method used was 
essentially that of Reinke and Moyer (1985). Nitrophenol (lOOpM 
final concentration) was Incubated in 1ml standard incubation mix 
(2.12) for 30 minutes at 37°C. TCA (15%, 0.1ml) was used to stop 
the reaction. After centrifugation to remove the precipitated 
protein, 0.1ml ION NaOH was added to the supernatant. The 
absorbance of the nitrocatechol was determined at 546nm. 
2.15 DETERMINATION OF N-DEMETHYLASE ACTIVITY 
N-Demethylase activity was measured by determining the amount of 
formaldehyde produced from benzphetamine or erythromycin (final 
concentration 50\iM). The formaldehyde was trapped with 
semicarbazide (lOmM final concentration in incubation mix). Samples 
were incubated for 30 minutes at 37°C, and then stopped with 15% 
TCA. Fresh Nash reagent (30g ammonium acetate + 0.4ml 
acetyl acetone in 100ml water, 1ml) was added to 1ml protein-free 
supernatant, and incubated at 37°C for 45-50 minutes. Samples were 
centrifuged if necessary to clear the supernatant. The 
formaldehyde was then measured spectrophotometrically at 412nm or 
fluorometrically at ex 410nm em 510nm (Nash, 1953; Belman, 
1963). 
Structures of P450-dependent enzyme substrates and products are shown 
in Figure 2.8. 
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2.16 DETERMINATION OF CELLULAR GLUTATHIONE 
Cellular glutathione was determined by a modification of the method 
of Hissin and Hilf (1976), in which o-phthalaldehyde forms a 
fluorescent derivative with reduced glutathione. Hepatocyte 
suspensions were treated with 15% TCA, and 0.1ml supernatant added 
to 3ml 0.4M K3PO4 buffer, pH 8.2. o-Phthaladehyde solution (0,1ml; 
Img ml" in methanol) was added to each sample, with thorough 
mixing. The fluorescence was then measured exactly 15 minutes 
later at ex 350nm, em 420nm. The glutathione content was 
determined from a standard curve. 
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APPENDIX 
A2.1 Kinetic analysis of enzyme activity 
The kinetics of enzyme-catalysed reactions can be described by the 
Michaelis-Menten equation: 
V = Vmax[Sl fll 
Km + LS] 
where v is the rate of reaction at substrate concentration [SI, Vmax 
is the maximum rate at saturating substrate concentrations and Km is 
the Michael is constant, commonly defined as the substrate 
concentration at which v = Vmax, The Km is thus a measure of the 
2. 
enzyme's affinity for the substrate, and the Vmax gives an 
indication of the amount of active enzyme present. Equation [11 
describes a rectangular hyperbola which can be linearly transformed 
in several ways to enable graphical estimations of Km and Vmax to be 
made (Roberts, 1977), 
The kinetics of MCOD and ECOD activities were described in 2.10 by 
use of a Hanes plot, in preference to the double-reciprocal 
Lineweaver-Burk plot. For a Hanes plot (Hanes, 1932) [Sl/v Is 
plotted against [S], re-arrangement of equation [11 giving: 
[S] = 1 .[S] + Km .... [21 
V Vmax Vmax 
A plot of [S]/v against [S] of a biphasic activity will give two 
components, each described by equation [2], from which the Km and 
Vmax can be calculated. The component with the lower Km Is the 
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high affinity form and the component with the higher Km represents 
the total activity. Subtraction of the high affinity form from the 
total will give the contribution of the low affinity component. 
With regard to estimations of the kinetic parameters Vmax and Km, 
statistical considerations indicate that of the graphical 
determinations of Vmax and Km more accurate subjective estimates can 
be obtained from Hanes plots than from the Lineweaver-Burk, assuming 
a homogeneous variance of v (Wilkinson, 1961). 
The Lineweaver-Burk plot becomes vastly inferior to the Hanes when 
applied to unweighted linear regression lines, since the smaller 
(and less accurate) determinations of v become inordinately 
important in determining the position of the line. If the error in 
V is assumed to be small, the Hanes plot gives reasonably reliable 
estimates of Km and Vmax for unweighted lines. This means that Km 
and Vmax values can be graphically estimated, especially If the aim 
is to compare values from two similar experiments where the bias of 
the unweighted data will be similar, rather than to obtain values 
for the true Vmax and Km (Dowd and Riggs, 1965). Thus, in the 
kinetic experiments presented in 2.10, Km and Vmax values were 
estimated from the unweighted linear regression lines obtained from 
Hanes plots of the data. The Km and Vmax values obtained from the 
graphs were used to compare the isozymic populations present in 
fresh and cultured hepatocytes, and should not be taken as accurate 
measures of the true values of the kinetic parameters. 
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A2.2 Statistical analyses 
Standard statistical tests were applied to the data presented in 
this thesis, which are described in detail in general statistics 
texts (Bailey, 1959). Briefly, linear regression analysis was 
applied to linear, graphical data, to obtain the line of best fit. 
Student's t-test was used to compare two group means where only one 
variable was being studied; for multiple comparisons analysis of 
variance (ANOVA) was employed. If the ANOVA detected differences 
between groups Dunnett's test (Winer, 1971) was used to compare the 
treated groups to the control group. The important point regarding 
this test is that the significance level applies to the collective 
data - the test is not Independent for each group v control test 
(i.e. groups x and y but not group z are significantly different to 
the control group at a level of p<0,05). The Mann-Whitney U-test 
(Campbell, 1967) is a distribution-free test which can be used on 
transformed data, e.g. culture maintenance data which is expressed 
as a percentage of, or relative to, a fresh cell value. It 
assesses the overlap of two population distributions, differing in 
the location of their median value by ranking the data. 
TABLES AND FIGURES 
TABLE 2,1a. ALKOXYCOUMARIN O-DEALKYLASE ACTIVITIES 
IN HEPATOCYTES ISOLATED BY THE SLICE AND LOBE 
PERFUSION METHODS, 
SUBSTRATE 
CONCENTRATION (jiM) 
ACTIVITY (pmol min-''mg-'') 
SLICE PERFUSION 
7-MC 20 18±2 17± 4 
7-MC 500 
7-EC 10 
106±10 
15±2 
91± 9 
19± 4 
7-EC 500 
VIABILITY 
293±44 
89± 1% 
309± 9 
91± 1% 
Values are the mean ± SEM activity where n = 6 (slice) and n = 4 
(perfusion). 
TABLE 2.1b.MAINTENANCE OF ACTIVITIES AFTER 24 HOURS 
IN CULTURE. 
SUBSTRATE 
CONCENTRATION (^ .M) 
MAINTENANCE 
SLICE PERFUSION 
7-MC 20 0.17 0.21 
7-MC 500 
7-EC 10 
0.27 
0.35 
0.54 
0.49 
7-EC 500 0.22 0.40 
Activities in the fresh and cultured cells were determined in separate 
experiments, therefore each value is the mean activity at 24 hours 
relative to the mean fresh cell activity, which = 1.0. Slice: n = 4; 
perfusion: n = 4. 
TABLE 2.2. COMPOSITION OF WILLIAMS' MEDIUM E"" 
Component mg L" 
INORGANIC SALTS 
CaCl2 (anhydrous) 
CuS04.5H20 
Fe(N03)3.9H20 
KCl 
MgS04 
MgS04.7H20 
MnCl2.4H20 
NaCl 
NaHCOg 
NaH2P04H20 
ZnS04.7H20 
AMINO ACIDS 
L-Alanine 
L-Arginine 
L-Asparagine.H20 
L-Aspartic acid 
L-Cysteine 
L-Cystine 
L-Glutamic acid 
Glycine 
L-Histidine 
L-lsoleucine 
L-Leucine 
L-Lysine HCl2 
L-Methionine 
L-Phenylalanine 
L-Proline 
L-Serine 
L-Threonine 
L-Tryptophan 
L-Tyrosine 
L-Valine 
200.0000 
0.0001 
0.0001 
400.0000 
400.0000 
200.0000 
0.0001 
6800.0000 
2200.0000 
140.0000 
0.0002 
90.0000 
50.0000 
20.0000 
30.0000 
40.0000 
20.0000 
50.0000 
50.0000 
15.0000 
50.0000 
75.0000 
87.5000 
15.0000 
25.0000 
30.0000 
10.0000 
40.0000 
10.0000 
35.0000 
50.0000 
(continued over) 
1 From Williams and Gunn (1974) 
2 The original formula lists lysine at 70.00 mg L'"" 
TABLE 2 .2 . ( con t inued) 
VITAMINS 
Ascorbic acid 
Biotin 
D-Ca2+pantothenate 
Choline chloride 
Ergocalciferol 
Folic acid 
i-lnositol 
Menadione sodium bisulphate 
Nicotinamide 
Pyridoxal HCI 
Riboflavin 
oGTocopherol phosphate, disodium 
Thiamine HCI 
Vitamin A acetate 
Vitamin B.|2 
OTHER COMPONENTS 
D-Glucose 
Glutathione 
Methyl linoleate 
Phenol red 
Sodium pyruvate 
2.00 
0.50 
1.00 
1.50 
0.10 
1.00 
2.00 
0.01 
1.00 
1.00 
0.10 
0.01 
1.00 
0.10 
0.20 
2000.00 
0.05 
0.03 
10.00 
25.00 
TABLE 2,3, ESTIMATED KINETIC PARAMETERS OF MCOD 
AND ECOD ACTIVITIES, 
ENZYME 
ACTIVITY 
MCOD fresh 
HIGH AFFINITY 
Km1 
33 
V 1 
*max' 
53 
TOTAL 
• ^m^  ^max2 
270 167 
24 h - - 210 42 
ECOD fresh 35 77 160 200 
24h 36 33 135 77 
Kinetic parameters were graphically determined (see Appendix 2.1). 
1 Units of Km are nM 
2 Units of Vf^ax si's pmol min"'' mg'"'. 
FIGURE 2.1. APPARATUS FOR JHE PERFUSION OF 
INDIVIDUAL HEPATIC LOBES.Method modified from 
Reese and Byard, (1981); for details, see section 2.4. 
A peristaltic pump 
B 21GX1.5" needle inserted into an exposed vein 
C lobe of liver 
D wire mesh, to support lobe 
E 95% ©2 : 5% CO2 
F water bath maintained at 40°C 
G re-circulated perfusate 
r=0.99 
2 3 
miilion cells/ml 
FIGURE 2.2, RELATIONSHIP OF FORMAZAN ABSORBANCE 
TO HEPATOCYTE NUMBER, The absorbance of the reduced MTT at 
560nm was determined in hepatocyte suspensions (n=4; SE<0.01), 
as described in section 2.5.2. 
mg protein/ml 
r=0.99 
2 3 4 
million ceils/ml 
FIGURE 2.3. RELATIONSHIP OF CELL PROTEIN TO CELL 
NUMBER. Protein content of hepatocyte suspensions was 
determined as described in section 2.9. (5.-'SE/v\,n=5). 
FIGURES 2,4-2,7, These figures show the data obtained for ECOD and 
MCOD activities measured in freshly isolated and cultured hepatocytes as 
Hanes plots.The details of this kinetic analysis are given in Appendix A2.1. 
For all figures, [S]/v was determined using the mean activity at each 
substrate concentration of 7 separate preparations, each from a different 
animal. 
5-1 
[SJ/v 
MM.min.nna 4 -
• high r=0.95 
° total r=1.00 
100 200 300 400 500 600 
[S] 
FIGURE 2.4. HANES PLOT OF MCOD ACTIVITY MEASURED 
IN FRESHLY ISOLATED HEPATOCYTES. 
See Appendix 2.1 for details of kinetic analysis. 
high r=0.95 
total r=1.00 
100 200 300 
[S]pM 
FIGURE 2.5, HANES PLOT OF ECOD ACTIVITY MEASURED 
IN FRESHLY ISOLATED HEPATOCYTES, 
See Appendix 2.1 for details of kinetic analysis. 
V\V\. min. m j 
r=0.98 
FIGURE 2,6, HANES PLOT OF MCOD ACTIVITY MEASURED 
IN HEPATOCYTES CULTURED FOR 24 HOURS, 
See Appendix 2.1 for details of kinetic analysis. 
10-1 
IS]/v 
MM.min.w^ 8 -
6 -
4 -
2 -
• high r=0.97 
a total r= 1.00 
100 200 300 400 500 600 
[S]vM If' 
FIGURE 2.7, HANES PLOT OF ECOD ACTIVITY MEASURED 
IN HEPATOCYTES CULTURED FOR 24 HOURS. 
See Appendix 2.1 for details of kinetic analysis. 
A. 0-DEALKYLATION OF ALKOXYCOUMARINS. Method: 2.10. 
ALKOXYCOUMARIN 7-HYDROXYCOUMARlN 
RO.^.^:^^s/0\.0 ^ O 
R= methyl, ethyl or propyl group 
B, O-DEETHYLATiON OF 7-ETHOXYRESORUFIN.Method: 2.13 
7-ETHOXYRESORUFlN RESORUFIN 
CHYDROXYLATION OF P-NITROPHENOL,Method: 2.14 
P-NITROPHENOL P-NITROCATECHOL 
NOb ^ 
FIGURE 2.8. SUBSTRATES AND METABOLIC PRODUCTS 
OF THE P450-DEPENDENT ASSAYS USED IN THIS 
INVESTIGATION, For details of the relevant methods see 
pages 70-75. 
D, N-DEMETHYLATION OF BENZPHETAMINE AND ERYTHROMYCIN, 
Method: 2,15. 
BENZPHETAMINE 
^ ^CH2CH2(CH3)NCH2 L j j " ^ ^ ^ ^CW^C^C\^^^CW. 
CH3 ^ ^ H 
-^  formaldehyde 
ERYTHROMYCIN 
OH N 1/ 
P ^ reaction as above; arrow 
C l ^ C H z— ( H O O ^ ^ C H ^ X C ^ denotes site o f action. 
HO N(a%)2 
H O H , C 
FIGURE 2.8. CONTINUED. SUBSTRATES AND METABOLIC 
PRODUCTS OF P450-DEPENDENT ACTIVITIES. 
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CHAPTER 3 
3.1 INTRODUCTION 
A variety of methods have been employed in attempts to attenuate the 
loss of cytochrome P450 that occurs in hepatocyte cultures, 
including manipulation of culture medium composition (reviewed in 
Chapter One). In 1985 Engelmann et al. reported that addition of 
exogenous haem to culture medium maintained the P450 content of rat 
cultured hepatocytes at more than 80% of the level in freshly 
isolated cells for 72 hours; there was no effect on the haem content 
of the hepatocytes. The rationale of this supplementation centres 
on haem as the prosthetic group of mammalian haemoproteins. 
Haem (or iron (Il)-protoporphyrln IX) is synthesized in the 
hepatocyte for incorporation into mitochondrial cytochromes, 
catalase and tryptophan pyrrolase as well as the microsomal 
cytochromes; however, on induction up to 70% of newly synthesized 
haem can be incorporated into cytochrome P450s (Muller-Eberhard and 
Vincent, 1985). It is known that deficiencies in haem biosynthesis 
can result in selective deficiencies in drug metabolism (Anderson et_ 
al., 1976). Also, Steward et al. (1985) showed that although total 
P450 declined in culture over 72 hours, there was a selective 
maintenance of certain apoproteins. They concluded that loss of the 
haem moiety was responsible for the overall loss of holoenzyme in 
culture. This, coupled with the shorter turnover of haem relative 
to apoprotein (Sadano and Omura, 1983), suggests that some 
deficiency, block or inhibition of haem biosynthesis is responsible 
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for the loss of P450 in culture. 
It is thought that haem is extracted from an Intracellular haem pool 
(or pools), fed both exogenously and endogenously, for synthesis of 
microsomal haemoproteins (Muller-Eberhard and Vincent, 1985), 
although the mechanism of regulation of this pool is uncertain. 
Haem itself exerts feedback repression on the mitochondrial enzyme 
delta-aminolaevulinate synthase (ALAS), which is the rate limiting 
enzyme in haem biosynthesis (Granick, 1966), outlined in Figure 3.1. 
Haem also Induces haem oxygenase which degrades free haem from P450s 
to biliverdin (Kutty et al_., 1988). The administration of 
delta-aminolaevulinate (ALA) in vivo can also induce haem oxygenase 
in the rat, presumably by stimulating haem synthesis, resulting in 
an expansion of the haem pool (Anderson et al., 1981). However, 
Paine and Legg (1978) could find no correlation between induction of 
haem oxygenase activity and loss of P450 in hepatocyte cultures, 
making increased degradation of haem unlikely as a cause of P450 
loss. Evarts et al. (1984) reported that although the P450 content 
fell rapidly within the first 24 hours, hepatic ALAS remained 
elevated throughout four days of culture; therefore the biosynthetic 
pathway does not appear to be repressed although the sustained 
Increase in ALAS suggests a demand for haem in the cultured 
hepatocyte. 
Addition of exogenous haem, both in vivo and in vitro, has been 
shown to have a sparing effect on allylisopropylacetamide-induced 
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destruction of P450, presumably by promoting incorporation of haem 
into newly synthesized apoproteins (Liem et al., 1983). This 
protection against degradation following allylisopropylacetamide 
administration appears to be specific for certain isozymes, 
favouring those predominating at the time of treatment (De Matteis 
et al., 1983; Bornheim et al., 1984), Exogenous haem also seems to 
act directly, as a positive modulator of P450 gene transcription, 
via the nuclear haem pool (Bhat and Padmanaban, 1988). 
Selenium is an essential trace element that is an inducer of both 
ALAS and haem oxygenase (Maines and Kappas, 1976). It is not 
porphyrinogenic, thus the Induction of both enzymes appears to 
maintain a steady state. At concentrations greater than 0.5|JM the 
element is an Inhibitor of ALAS, 
In this experiment, the effect of culture medium supplemented with 
haem, ALA and selenium on the maintenance of P450-dependent 
dealkylase activities was investigated, these conditions being 
similar to those described by Engelmann et al. (1985). 
3.2 METHODS 
Hepatocytes were isolated from 150g male rats by lobe perfusion. 
MCOD and ECOD (both total and high affinity components) were 
measured in hepatocytes cultured for 24 hours and in freshly 
Isolated cells from the same animals; hepatocytes were cultured on 
"Primaria" dishes in either WEC or in WEC supplemented further with 
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haem (IIJM), ALA (200|JM) and selenious acid (Se; 0.1[JM). Haem was 
dissolved in a bovine serum albumin solution (Imgml" O.IN NaOH) to 
enable dilution into culture medium as described by Engelmann et al. 
(1985). This medium is designated WEC+H. Protein content of fresh 
cells and cultures was determined and all activities expressed as 
pmol 7-HC produced min" mg protein' . Maintenance of activities in 
culture is expressed as a percentage of the fresh cell activity, and 
calculated for each animal. 
3.3 RESULTS 
3.3.1 Maintenance of activities in culture 
Figure 3.2 shows the activities measured in fresh cells, and in 
hepatocytes cultured for 24 hours in WEC or WEC+H. It is clear 
that the activities in the cultured hepatocytes are similar 
regardless of the medium. The WEC+H conferred no advantage over 
the unsupplemented WEC. However, the WEC (and also WEC+H) 
appeared to be adequate for maintenance of three of the activities 
measured. However, total MCOD was not maintained, falling to 46% 
of the fresh cell activity. 
Table 3.1 presents the maintenance data for all four activities as 
percentages of the fresh cell data, for both media. The mean 
values and ranges were very similar for the two media, and although 
only three animals were used, the maintenance of total and high 
affinity ECOD and high affinity MCOD is Indisputable. This 
maintenance of activity, however, is in contrast to that of the 
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kinetics experiments (Chapter 2.10, Table 2.4) where none of the 
four activities were maintained, using the same WEC medium. The 
maintenance data from the two experiments are presented together in 
Table 3.2 for comparison, and it Is necessary to consider the 
possible reasons for the inconsistency of these results. The most 
obvious causes of discrepancies in maintenance data are differences 
in the viabilities and/or fresh cell activities of the initial fresh 
cell suspensions. 
3.3.2 Comparison of dealkylase activities and viabilities 
The activities and initial viabilities of the cell preparations used 
in this and the former experiments (taken from Table 2.1a) are 
presented in Table 3.3. The viabilities were 1dentical(91 + 
1%), and the ECOD activities were very similar. However, the MCOD 
activities were very different. Total MCOD activity in this 
experiment was twice that measured previously whereas the high 
affinity form had around half the activity of the former deter-
mination. These differences in MCOD activity, whilst requiring an 
explanation, do not account for the observed differences in 
maintenance between the two experiments. 
Thus supplementation of WEC with haem, ALA and Se did not improve 
maintenance of dealkylase activities over those obtained with WEC 
alone, but this maintenance in WEC of three of the four activities 
over the 24 hour culture period was completely unexpected given the 
previous maintenance data for the same activities in similar culture 
conditions. 
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3.4 DISCUSSION 
The use of WEC supplemented with haem did not improve maintenance of 
P450-dependent enzyme activities in hepatocyte cultures, but then 
again there was good maintenance over twenty four hours in the 
unsupplemented medium. There was a selective loss of MCOD activity 
in this experiment, and supplementation of WEC with haem, ALA and Se 
did not prevent this loss. Engelmann et al. (1985) reported an 
overall maintenance of P450 content in contrast to a 25% loss at 24 
hours in medium minus haem. They used adult female rats, for which 
haem supplementation of media may have been more effective, since 
hepatocytes from female rats appear to be more susceptible to haem 
loss (Evarts et al., 1984). 
Total MCOD activity of hepatocytes fell by 50% during 24 hours In 
culture and whereas this is consistent with data from the 
preliminary kinetic experiments, the maintenance of the other three 
activities, at more than 90% of the fresh cell value in WEC, is not. 
Also, the MCOD activities in the fresh cells were different to those 
measured previously. Those experiments had ascertained that cell 
preparations isolated by slice or perfusion were equivalent with 
respect to dealkylase activity and maintenance. A major difference 
between the experiments, however, is the size, and therefore age, 
of the hepatocyte donor animal. For the initial kinetics and 
perfusion experiments 70g male rats were used, but in this study 
larger ISOg rats were used. This made cannulation of the lobes 
easier, as well as increasing the yield of hepatocytes per rat. 
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The male Wistar rats used as donors are sexually mature at 150g (6 -
8 weeks old) unlike the 70g rats (4 weeks old). 
It is known that changes in some P450-dependent activities occur 
during post-natal development in the rat, especially at the onset of 
puberty (Gram et al., 1969). It is possible that MCOD activity 
is dependent on a developmentally regulated P450(s) which accounts 
for the observed differences in MCOD activity. It is also possible 
that the age of the animal Influences the maintenance of P450 
activities in culture. 
It has been reported that the haem moiety of P450 undergoes biphasic 
turnover (Levin et al., 1975), with both a fast and a slow 
component. The ratio of fast : slow turnover forms decreased with 
increasing age in the male rat (ratio of 4.4 in immature males and 
1.9 in adult males). Parkinson et al_. (1983) investigated 
turnover of both the haem and apoprotein moieties for specific P450 
Isozymes and reported biphasic turnover for the total apoprotein. 
However, only one purified isozyme showed biphasic turnover of haem 
(and of apoprotein). This was P450IIA, now known to exist as at 
least two very similar isozymes IIAl and IIA2 which are 
differentially regulated. P450IIA2 is adult male-specific; 
P450IIA1 Is expressed only in females and pre-pubertal males 
(Matsunaga et al_., 1988). It is possible that the rats of 
Parkinson et al.. used at 4-6 weeks of age, contained both forms of 
P450IIA, and that one is a fast and one a slow turnover form. 
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Other workers have only found monophasic turnover kinetics for a 
number of purified P450s (Shiraki and Guengerich, 1984) but it is 
possible that changes in rate of turnover are associated with the 
developmentally regulated P450s like P450IIA1, which is a steroid 
hydroxylase, under hormonal control (Arlotto and Parkinson, 1989). 
Also, adult females, like immature males, appear to have 
predominantly fast turnover P450s (Levin et al., 1975). Thus, an 
Increase in slow turnover forms of P450 at puberty in the male rat 
could explain the improved maintenance of P450-dependent activ-
ities in this experiment relative to the kinetics experiment, due to 
the differences in age of the animals used for the hepatocyte 
isolations. It could also explain why haem supplementation of 
medium had no effect on maintenance, in contrast to the results of 
Engelmann et a]_. (1985), who used hepatocytes from female rats, in 
which fast turnover P450 forms predominate (Levin et al., 1975). 
In summary, these results are not consistent with hepatocyte haem 
deficiency being responsible for the loss of P450 activities in 
culture. They do Indicate that hepatocytes isolated from adult 
males may show better maintenance of selected activities in our 
chosen medium than those from immature males. The effects of age 
and sex of donor animal on P450-dependent activities is examined in 
more detail in the following chapter. 
TABLES AND FIGURES 
TABLE 3.1. MAINTENANCE OF ALKOXYCOUMARIN O-DEALKYLASE 
ACTIVITIES IN CULTURE FOR 24 HOURS: EFFECT OF MEDIUM 
SUPPLEMENTED WITH HAEM. 
SUBSTRATE MAINTENANCE (% fresh cell value) 
CONCENTRATION (^ M) WEC WEC+H 
7-MC 10 96 (57-150) 93 (91-113) 
7-MC 500 46 (36-50) 51 (48-53) 
7-EC 10 101 (63-126) 84 (66-111) 
7-EC 500 91 (85-104) 69 (59-79) 
Values are means with ranges in brackets, for 3 animals. 
TABLE 3.2. MAINTENANCE OF ALKOXYCOUMARIN O-DEALKYLASE 
ACTIVITIES IN CULTURE FOR 24 HOURS: COMPARISON OF DATA 
FROM TWO DIFFERENT EXPERIMENTS. 
SUBSTRATE MAINTENANCE IN WEC (% fresh cell value) 
CONCENTRATION (nM) I II 
7-MC 20 96 21 
7-MC 500 46 54 
7-EC 10 101 49 
7-EC 500 91 40 
I data from Table 3.1. 
II data from Table 2.1b. 
TABLE 3.3. ALKOXYCOUMARIN O-DEALKYLASE ACTIVITIES IN 
FRESHLY ISOLATED HEPATOCYTES FROM TWO DIFFERENT 
EXPERIMENTS. 
SUBSTRATE ACTIVITY (pmol min-''mg protein"'') 
CONCENTRATION (^ iM) 1 II 
7- MC 20 10±1 17±4 
7-MC 500 195±43 91±9 
7-EC 10 19±1 19±9 
7-EC 500 277±45 309±92 
Viability of 
preparation 
91 ±1% 91 ± 1 % 
Values are means ± SEM for 3(1) or 4(11) animals. 
I data from Figure 3.1. 
II data from Table 2.1a. 
FIGURE 3.1. HAEM BIOSYNTHESIS 
(adapted from Maines and Kappas, 1977) 
MITOCHONDRION CYTOSOL 
glycine + succinyl coenzyme A 
9-aminolaevulinate 
protoporphyrinogen IX -*•  
protoporphyrin IX 
HAEM 
(Fe (II) protoporphyrin IX) 
-^ 2x,3-aminolaevulinate 
porphobilinogen 
uroporphyrinogen 111 
coproporphyrinogen III 
1 3-Aminolaevulinate synthase 
2 Iron (ll)-ferrochelatase 
30 
ACTIVITY 
(pmol/min/mg) 
20 -
10 -
• FRESH 
Q WEC24h 
M WEC+H 24h 
X. 
7-MC 20^M 
SUBSTRATE 
7-EC 10nM 
ACTIVITY 
(pmol/min/mg) 
350 -1 
• FRESH 
n WEC24h 
WEC+H 24h 
7-MC SOOuM 7-EC 500nM 
SUBSTRATE 
FIGURE 3.2. MCOD AND ECOD ACTIVITIES IN FRESHLY 
ISOLATED HEPATOCYTES AND IN CELLS CULTURED 
FOR 24 HOURS IN THE PRESENCE OR ABSENCE OF 
EXOGENOUS HAEM. Hepatocytes were cultured for 24 hours 
in either WEC medium (see 2.7.1.) or in WEC+H (see 3.2.). 
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CHAPTER 4 
INFLUENCE OF DONOR AGE AND SEX ON THE ACTIVITY, AND MAINTENANCE IN 
CULTURE OF CYTOCHROME P450-DEPENDENT ENZYME ACTIVITIES 
4.1 INTRODUCTION 
To date, at least fourteen different Isozymes of cytochrome P450 are 
known to exist in rat liver (Nebert and Gonzalez, 1987). The 
isozyme profile changes with age in both male and female rats, 
although the total P450 content remains relatively constant. These 
changes in Isozyme profile are reflected in changes in enzyme 
activity (Gram et al., 1969; Waxman et al., 1985). Major 
alterations occur during post-natal development and sexual 
maturation, and again at the onset of old age, the changes being 
particularly marked in male rats. This is due to the development 
of a distinct sex difference in P450 activities at puberty (Waxman 
et al., 1985), which disappears in older rats (Kamataki et al., 
1985), This is probably caused by changes in the levels of the 
sex-specific P450 forms (Kamataki et al., 1982; Maeda et al., 
1984). These age and sex differences in P450 forms are related to 
changes in constitutive steroid hydroxylase activities (Waxman ejt 
a]_., 1985). 
A summary of the various sex-specific P450 forms and their 
associated activities is presented in Table 4.1. 
It is now known that these hepatic sex differences are initiated and 
maintained by androgens and pituitary growth hormone (extensively 
reviewed by Skett, 1987; 1988). The pattern of secretion of growth 
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hormone is different in male and female rats, although the mean 
level is similar. In males there is a pulsatile secretion with 
high peak values every 3 - 4 hours and a very low basal secretion 
during the intervening periods, whilst in females there is a more 
continuous secretion, but at a higher baseline level (Eden, 1979). 
Hypophysectomy or continuous growth hormone (GH) infusion in male 
rats essentially feminises hepatic P450 metabolism, whereas 
intermittent infusion of GH in hypophysectomised animals restores 
the male pattern of metabolism (Waxman, 1988), Neonatal exposure 
to androgens imprints or programmes the pattern of adult male P450 
steroid metabolism by imprinting the pulsatile pattern of growth 
hormone secretion (Jansson et al., 1985; Waxman et al_., 1985; 
Waxman, 1988). This imprinting appears to function via the oestrogen 
receptor (Reyes and Virgo, 1988). Androgens are also required in 
adult life to maintain a male pattern of activity (Skett, 1988; 
Waxman, 1988); interruption of the hypothalamic-pituitary axis by 
cisplatin in adult male rats reduces the amount of circulating 
androgen, resulting in a feminisation of P450 metabolism (LeBlanc 
and Waxman, 1988). 
The male-specific IICll (Nebert et al., 1989; named as P450-2c by 
Waxman et al., 1985) is dependent on pulsatile secretion of GH for 
its expression, whilst the female-specific IIC12 form (named as 2d 
by Waxman et al., 1985) requires a more constant secretory pattern 
(Waxman, 1988). The male-specific 2a form does not depend on 
pulsatile GH secretion, as it is constitutively expressed In male 
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rats, and in immature females (Waxman et al., 1985). However, 
P450-2a appears to be repressed by high levels of GH (Waxman et^ 
al., 1988), and this accounts for the suppression of this form in 
adult females, when GH is secreted at a higher, although still 
continuous, baseline level than in the immature male and female 
animals. It is possible that synthesis of P450-2a in the adult 
male is continually suppressed and de-repressed as the GH 
concentration fluctuates (Waxman et al., 1988). 
In addition to sex differences in metabolism due to direct hormonal 
influences on P450 levels, it has been reported that hypophysectomy 
and/or continuous GH supplementation lower the amount of hepatic 
P450 reductase, (which is lower in female than male rats), but that 
this (and steroid hydroxylase activities) can be raised again by 
addition of thyroxine (Waxman et al., 1989). 
Results presented in the previous chapter suggested that hepatocytes 
cultured from adult male rats may maintain P450-dependent enzyme 
activities better than hepatocytes from younger immature males, and 
that differences in P450 turnover may be the reason. Adult females 
also have a greater proportion of rapid turnover P450s, like 
Immature males (Levin et al., 1975), and therefore if turnover is^ 
affecting maintenance, hepatocytes from female rats should maintain 
activities at a similar level to the younger male rats. However, 
Vind et al^ , (1988) reported that P450 and demethylase activities 
were maintained better in hepatocyte cultures from female rats. It 
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is likely that the in vivo hormonal regulation of P450 expression, 
which changes with age and sex in the rat, is disrupted or lost in 
vitro, and it is this that affects the differential maintenance of 
P450 in hepatocytes from male and female rats of different ages. 
The maintenance of alkoxycoumarin O-dealkylase activities was 
therefore investigated in hepatocytes from immature and adult males, 
and adult females to assess the relative stabilities of 
P450-dependent activities in hepatocyte cultures. 
4.2 METHODS 
The rats used in this study were immature males (IM) and young adult 
male (AM) and female rats (AF). The adult animals were 8 weeks old 
and the immature males were 4 weeks old. Puberty occurs 4-6 weeks 
after birth in the male rat (Gram et al., 1969; Levin et al., 1975). 
Dealkylase activities were determined in fresh cells and hepatocytes 
cultured for 24 and 72 hours from each animal. Hepatocytes were 
cultured on "Primaria" dishes in WEC. In addition to MCOD and ECOD, 
7-propoxycoumarin O-depropylase (PCOD), which Is known to be a 
male-specific activity (Kamataki et al., 1983; 1985), was also 
measured at two substrate concentrations in the same manner as ECOD 
and MCOD (Chapter 2.10). Protein content of fresh cells and 
cultures was also determined and all activities expressed as pmol 
7-HC produced min" mg protein" . Statistical analysis on mean 
fresh cell activities was by unpaired t-tests. Maintenance at 24 and 
72 hours was calculated as a percentage of the fresh cell value for 
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each animal and expressed as mean + range; statistical analysis was 
by the Mann-Whitney U-test. 
4.3 RESULTS 
Viabilities of initial cell preparations were very similar: AM 
93 + 1%, AF 93 + 1%, IM 96 + 1%. 
4.3.1 Dealkylase activities in hepatocytes from male rats 
Dealkylase activities measured in freshly isolated cells from AM and 
IM rats are presented in Table 4.2. Previous studies confirmed 
the biphasic nature of MCOD and ECOD in IM cells (2.10), the high 
affinity component representing less than 25% of the total activity. 
The data in Table 4.2 is consistent with these activities, as well 
as PCOD, being biphasic in cells from AM rats. 
ECOD activities of IM and AM cells were very similar. Total PCOD 
activity was significantly less in AM cells together with a 
numerical but non-significant decrease in the activity of the high 
affinity component relative to IM cells. Total MCOD was 
significantly greater and the high affinity activity significantly 
less In AM cells compared to IM cells (as observed in the previous 
chapter). Therefore, total PCOD and both components of MCOD 
activity appear to change with age in the male rat, implying some 
developmental regulation. 
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4.3.2 Dealkylase activities in hepatocytes from male and female rats 
The dealkylase activities in fresh cells from female rats, together 
with those from AM rats are presented in Table 4.3. The high 
affinity components of both MCOD and ECOD represented less than 25% 
of the total activity, indicating that these activities are probably 
also biphasic in hepatocytes from AF rats. However, PCOD activity 
measured at lOpM accounted for 60% of the total activity in AF 
cells; from this, and the known involvement of a male-specific form 
of P450 in PCOD activity (Kamataki et al., 1985), it is suggested 
that PCOD is a monophasic activity in AF cells, existing only as a 
high affinity form. Consequently, data on the maintenance of PCOD 
in cultures from AF rats are reported only for the high affinity 
form. 
Total MCOD activity was significantly less in AF cells relative to 
AM cells and was very similar to that measured in IM cells (AF 71 + 
-1 -1 -1 -1 
5 pmol min mg ; IM 88 + 17 pmol min mg ). High affinity 
MCOD in AF cells was not significantly different to that in AM 
cells. Total ECOD was markedly and significantly less in AF cells, 
whereas high affinity ECOD was slightly increased. The high 
affinity PCOD activity in AF cells was not significantly different 
to that of AM cells and, like total MCOD, was very similar to the 
activity in IM cells (AF 2 4 + 5 pmol min" mg" ; IM 25 + 6 pmol 
min" mg" ). Therefore, there appear to be sex differences as 
well as age differences in several of these activities. 
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4.3.3 Maintenance of a c t i v i t i e s in cu l ture 
(a) MCOD 
Maintenance of MCOD activities in culture is shown in Figure 4.1. 
Both components of MCOD activity in IM cells declined to 50 - 60% of 
the fresh cell value at 24 hours. Kinetic studies (2.10) 
demonstrated that MCOD becomes monophasic in IM cultures with loss 
of the high affinity component; this explains the similarity in the 
magnitudes of the loss of activity at the two substrate 
concentrations. There was a similar decline in cultures from AF 
rats, suggesting the loss of the high affinity form. The MCOD 
activity declined further by 72 hours in IM and AF cells. In 
contrast, MCOD remained biphasic in AM cultures, the high affinity 
form being maintained (83% fresh activity) alongside a decline in 
the total activity (44% of fresh activity). These results for the 
AM rats are similar to those reported in the previous chapter. Both 
components fell to less than 20% of the fresh activity after 72 
hours in culture. 
(b) ECOD 
Figure 4.2 shows the maintenance of ECOD activity in hepatocyte 
cultures. ECOD appeared to remain biphasic over the 72 hour 
culture period in all three donor cell types. High affinity ECOD 
activity was maintained for 72 hours in hepatocytes from IM and AM 
rats, whilst the activity fell to around 50% of fresh in cultures 
from AF rats. 
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Total ECOD was significantly reduced at 24 hours in cultures from IM 
rats but was retained in AM cells. By 72 hours the activity had 
declined to the same level as in cells from IM rats. In cultures 
from AF rats the activity fell to around 80% at 24 hours and fell 
slightly further by 72 hours. 
(c) PCOD 
Maintenance of PCOD activity in culture is shown in Figure 4,3, High 
affinity PCOD was maintained at high levels over 72 hours in 
cultures from IM and AM rats; the equivalent activity fell to around 
50% in AF cells, PCOD also remained biphasic in cultures from male 
rats, although, in contrast to the high affinity form, total PCOD 
fell rapidly within 24 hours in culture, and declined further by 72 
hours. 
Overall, these dealkylase activities were maintained at higher 
levels in cells from AM rats than in cells from either IM or AF 
animals. This maintenance was significantly greater for four out of 
the six activities, with a further activity being maintained in both 
AM and IM cells. All three enzymes remained biphasic in cultures 
from AM rats. Although total MCOD and total PCOD fell to less than 
70% of the fresh activity after 24 hours in culture the other four 
activities were maintained at high levels, with the high affinity 
forms of ECOD and PCOD being maintained for 72 hours. 
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4.4 DISCUSSION 
The results of this study have demonstrated that the maintenance in 
culture of rat hepatic P450-dependent alkoxycoumarin O-dealkylase 
activities is dependent upon the choice of coumarin used as 
substrate, its concentration and the age and sex of the hepatocyte 
donor animal. It is highly likely that selective maintenance of 
particular P450 enzymes accounts for these variabilities, but the 
exact nature of these forms remains to be established. The general 
conclusion is one of better maintenance of activity over 24 hours in 
culture in hepatocytes Isolated from AM rats, but that such 
selectivity for AM cells is lost by 72 hours in culture. This is 
consistent with the idea that maintenance is linked to differential 
turnover of P450, as discussed in the previous chapter. To 
recapitulate briefly: AM rats have a lower fast:slow turnover ratio 
for haemoproteins than IM or AF rats, which implies a more stable 
population of P450 forms in the AM rat, and also improved 
maintenance in culture. The lack of selectivity for AM cells after 
72 hours in culture is also consistent with this, given the reported 
half-life of 41-44 hours for the slow turnover component (Levin et_ 
£l., 1975). If changes In turnover do influence P450 maintenance 
In culture, this would suggest that total MCOD and total PCOD 
activities are fast turnover forms, since they are the least well 
maintained (at 40-60% of fresh activity at 24 hours), even in AM 
cells. 
- 101 -
Total MCOD activity is 50% greater in AM cells than in IM or AF 
cells, indicating a possible adult male-specific component in this 
activity. PCOD activity has already been described as male-specific 
(Kamataki et al., 1983; 1985), and the results from this study imply 
that it is the low affinity form(s) that is male-specific, and that 
this is absent in AF cells. This agrees with the work of Kamataki 
et al., who also measured PCOD activity at a 500[JM substrate 
concentration. However, the P450-male isozyme reported to be 
responsible for PCOD activity (Kamataki et al_., 1983), and 
equivalent to Waxman's P450-2c (1985), is sharply Induced (20-fold) 
at puberty In the male rat, and the PCOD activities presented here 
do not fit with this pattern of expression. The total PCOD activity 
measured in this study does agree with the expression of P450-PB-2a 
(also known as 2a, Waxman et al., 1985; 1988), which is similar in 
both AM and IM rats but suppressed in AF rats. This Isozyme has 
also been shown to catalyse more than 85% of microsomal testosterone 
6 A -hydroxylase activity in the male (Waxman ^t al^ ., 1985), and 
recently Yamazoe et al. (1988) demonstrated that male-specific 
PCOD activity correlated with ^-hydroxylase activity in microsomes. 
They also showed that whereas antibodies to P450-male (P450-2c) 
inhibited PCOD activity in a reconstituted system, they did not 
inhibit PCOD activity at all in microsomal preparations. With 
regard to the maintenance of this P450, the content of P450-2a 
(measured immunochemlcally) was not reduced during culture of AM rat 
hepatocytes for 72 hours in medium containing glucocorticoid and 
nicotinamide (Steward e t a l . , 1985), whereas the low affinity 
- 102 -
(total) PCOD activity measured here, is markedly reduced by this 
time in culture. These workers also proposed that loss of haem 
rather than apoprotein accounted for much of the loss of active P450 
in culture. Supplementation of media with haem, reported in the 
previous chapter, had no effect on maintenance of activities; 
nevertheless, it seems that the apparent anomaly in maintenance of 
PCOD activity and the putative isozymes involved can be rationalized 
in terms of selective maintenance of apoprotein, but not holoenzyme. 
It appears then that the male-specific PCOD activity is mediated by 
the P450 involved in constitutive 6^-stero1d hydroxylation. This 
Isozyme/activity is regulated by growth hormone (GH, Waxman et al., 
1988; Yamazoe et al., 1988), continuous high level secretion of GH 
suppressing its synthesis. It was also suggested (Waxman et al., 
1988) that the Isozyme may be suppressed in pre-pubertal males, as 
well as in adult females, the same or a very similar Isozyme being 
subsequently re-introduced at puberty. This situation would be 
analogous to that reported for P450IIA1 and IIA2, where P450IIA1 is 
expressed in IM rats and IIA2 (a very closely related Isozyme) in 
adult males (Matsunaga et al., 1988). This would also explain the 
significantly lower total PCOD activity in the AM cells in this 
study. 
It could also be argued from this Investigation that the develop-
mentally regulated P450s are the most susceptible to decline in 
culture, being dependent for expression on GH and androgen levels 
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(Skett, 1988). The addition of GH to hormone-free culture medium 
causes a feminisation of the P450 phenotype, similar to that seen in 
hypophysectomised male rats (Guzelian et al., 1988), and recent 
reports have implicated the thyroid hormones, thyroxine and 
tri-iodothyronine, in addition to the effects of GH, in suppression 
of liver-specific P450IIA2, the male-specific 6/3-hydroxylase and 
the female-specific 7o(-hydroxylase (Arlotto and Parkinson, 1989; 
Yamazoe et al., 1989). Both GH and thyroxine are present at 
significant levels in calf serum (Honn et al,, 1975), and it is 
possible that these serum constituents suppress liver-specific 
functions in vitro (Enat et al,, 1984; Silver and Krauter, 1988), 
The WEC used also contains insulin, which can mimic the effects of 
GH on the hepatocyte, but is also essential for culture of 
hepatocytes undermost conditions (Guzelian et al., 1988). 
Pulsatile secretion of GH, with peaks every 3-4 hours that suppress 
selective P450 synthesis, could be envisaged to maintain relatively 
constant levels of rapid turnover P450s (ti 6-7h, Levin et al., 
1975), whereas slow turnover P450s (regulated by GH) would tend to 
accumulate. It is plausible (if speculative) that GH/thyroid 
hormones regulate rapid turnover P450s to maintain constant levels 
of constitutive P450s, In the adult at least. 
It has been demonstrated in this study that donor age and sex 
Influence both the activity and maintenance In culture of hepatic 
P450-dependent alkoxycoumarin O-dealkylase activities. The best 
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maintenance of a range of activities was achieved in hepatocytes 
from AM rats, cultured for 24 hours in WEC, 
TABLES AND FIGURES 
TABLE 4.1. SEX-SPECIFIC CYTOCHROME P450 ISOZYMES AND 
THEIR ASSOCIATED STEROID HYDROXYLASE ACTIVITIES. 
P450 FORM ••  
P450IIA1 
P450IIA2 
P4501IC11 
P450IIC12 
P450IIC13 
P450IIIA2 
ACTIVITY 
testosterone 7 c<-hydroxylase2 
testosterone 15o<.-hydroxylase'3 
testosterone 16 ©(-hydroxylase"* 
steroid ISB-hydroxylase^ 
progesterone 16ot-,68-
hydroxyiase^ 
testosterone 66-hydroxylase' 
SPECIFICITY 
female, 
immature male 
adult male 
adult male 
female, 
immature male 
adult male 
adult male, 
immature male, 
female 
1 Nebert et al.,(1989) 
2 Arlotto and Parkinson, (1989) 
3 Matsunaga et al., (1988) 
4 Waxman et al., (1985) 
5 Waxman et al., (1985) 
6 Swinney et al.,(1988) 
7 Waxman et al,, (1985); Yamazoe et al.,(1988). 
TABLE 4.2. ALKOXYCOUMARIN O-DEALKYLASE ACTIVIES IN 
HEPATOCYTES ISOLATED FROM IMMATURE (IM) AND ADULT 
(AM) MALE RATS. 
SUBSTRATE 
NCENTRATION 
7-MC 500 
7-MC 20 
7-EC 500 
7-EC 10 
(^ M) 
ACTIVITY 
IM 
88±17 
19±2 
(21.6) 
247±34 
19±4 
(P mol min"'m 
AM 
157±16* * 
11± 2* 
(7.0) 
228±17 
13± 1 
(7.7) (5.7) 
7-PC 500 
7-PC 10 
297±32 
25±6 
215± 8* 
15± 1 
(8.4) (7.0) 
Values are mean± SEM (n=4). 
Figures in brackets are the mean activities at 10 or 20|iM (the 
high affinity form) expressed as a percentage of the mean activity 
at 500jiM (the total activity). 
AM values significantly different to IM values at *p < 0.05 or 
" p < 0.01. 
TABLE 4.3. ALKOXYCOUMARIN 0-DELAKYLASE ACTIVITIES 
IN HEPATOCYTES ISOLATED FROM ADULT MALE (AM) AND 
ADULT FEMALE (AF) RATS. 
SUBSTRATE 
CONCENTRATION 
(RM) 
ACTIVITY 
(pmol min"^ mg'^) 
AM AF 
7-MC 500 157±16 71± 5 
7-MC 20 
7-EC 500 
7-EC 10 
7-PC 500 
7-PC 10 
11±2 
(7.0) 
228±17 
13±1 
(5.7) 
215±8 
15±1 
16± 2 
(22.5) 
67±12* * * 
16± 1 * 
(23.9) 
40± 6 * * * 
24± 6 
(7.0) (60.0) 
Values are mean ± SEM (n+4). 
Figures in brackets are the mean activities at 10 or 20 )xM (the high 
affinity form) expressed as a percentage of the mean activity at 500 nM 
(the total activity). 
AF values significantly different to AM values at *p < 0.05; * *p < 0.01; 
* ** p < 0.001. 
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FIGURE 4.1. MAINTENANCE OF MCOD ACTIVITY IN 
HEPATOCYTES CULTURED FOR 24 AND 72 HOURS 
FROM IM, AM AND AF RATS. Values shown are the mean 
maintenance values (n=4) with the ranges. 
* AM significantly different to to IM, and AF significantly 
different to AM values, p<0.05 (Mann-Whitney U-test). 
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FIGURE 4,2, MAINTENANCE OF ECOD ACTIVITY IN 
HEPATOCYTES CULTURED FOR 24 AND 72 HOURS 
FROM IM, AM AND AF RATS, Values shown are the mean 
maintenance values (n=4) with the ranges. 
* AM significantly different to to IM, and AF significantly 
different to AM values, p<0.05 (Mann-Whitney U-test). 
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FIGURE 4.3. MAINTENANCE OF PCOD ACTIVITY IN 
HEPATOCYTES CULTURED FOR 24 AND 72 HOURS 
FROM IM, AM AND AF RATS, Values shown are the mean 
maintenance values (n=4) with the ranges. 
* AM significantly different to to IM, and AF significantly 
different to AM values, p<0.05 (Mann-Whitney U-test). 
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CHAPTER 5 
INDUCTION OF ALKOXYCOUMARIN O-DEALKYLASE ACTIVITIES IN VIVO AND IN 
VITRO ~~ 
5.1 INTRODUCTION 
Many xenobiotics that are metabolised by cytochrome P450 Induce 
their own biotransformation and/or the metabolism of other 
compounds, endogenous and exogenous. This induction of P450 
activity can have a profound effect on the metabolism and toxicity 
of xenobiotics, since increased activation as well as increased 
detoxification can occur. The different classes of inducer have 
already been discussed in Chapter One. 
Induction of hepatic P450s can be studied in microsomes and 
hepatocytes isolated from animals that have been treated with 
inducers. The changes in P450 and its associated activities can be 
easily measured in these systems. The alkoxycoumarin 0-dealkylases 
have been used to Investigate Induction in vivo since the enzymes 
have different induction profiles. Microsomal MCOD activity 
(measured at 500pM) is Induced by PB, and ECOD (at 500pM) by PB and 
BNF (Matsubara et al., 1983; Paterson et al.. 1984). This pattern 
of induction has also been reported for total MCOD and ECOD 
activities measured in hepatocytes Isolated from animals Induced in 
vivo with PB and BNF (Warren and Fry, 1988). Boobis et al. (1986) 
showed that the total and high affinity components of microsomal 
ECOD activity were differentially Induced by 3-MC, total ECOD 
activity being induced 9-fold more than the high affinity form. PB 
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induced the total and high affinity forms 5- and 2-fold 
respectively. The differential Induction of the components of this 
biphasic activity is further evidence for the Involvement of 
multiple P450 forms, making the alkoxycoumarins good substrate 
markers for a range of hepatic P450 isozymes. 
More recently, researchers have tried to Induce P450 activities In 
cultured hepatocytes, with little success in reproducing the 
observed in vivo induction in the in vitro situation. The 
induction in vitro of total ECOD activity by 3-MC (and 3-MC-like 
compounds) has been demonstrated to be similar to that seen in 
vivo (Fry ^t al_., 1980; Edwards et al., 1984), and the Induction 
and expression of P450IA1 and IA2 mRNAs in response to 3-MC in 
cultured hepatocytes has also been reported (Silver and Krauter, 
1988). However, the anomalous expression of P450IA1 in untreated 
and in PB-treated cultures has been noted by several workers (Fry et 
_al_., 1980; Steward et al., 1985; Turner and Pitot, 1989). In 
contrast to the situation in vivo, total MCOD activity is not 
induced by PB in hepatocyte cultures (Warren and Fry, 1988), and the 
poor (and altered) response of P450 in culture to PB is now a well 
recognised phenomenon (Edwards et al., 1984; Forster et al., 1986). 
Interestingly, It is known that selenium deficiency leads to a 
reduced induction response to barbiturates (Burk and Masters, 1975), 
although the reason for this is not known; it has also been reported 
that selenium Is necessary for PB induction of P450 in cultured 
hepatocytes (Engelmann et al., 1985). 
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Although the two components of microsomal ECOD activity were shown 
to be differentially induced by 3-MC and PB (Boobis et al., 1986), 
only the induction of total MCOD activity has been reported, 
(Matsubara et al., 1983; Warren and Fry, 1988). Also, the previous 
Induction in vitro study on MCOD and ECOD was performed with 
substrate concentrations of 500pM, representative only of the total 
activity (Warren and Fry, 1988). Therefore, in this study, the in 
vitro induction of both components of MCOD and ECOD activities by PB 
and BNF was determined, and compared to that measured in fresh 
hepatocytes isolated from animals Induced in vivo. The effect of 
Se on PB induction of MCOD activity in vitro was also investigated. 
5.2 METHODS 
5.2.1 Induction in vivo 
Adult male Wistar rats (150g) were injected i.p. with PB (80 mgkg" , 
saline), BNF (80 mgkg" , oil of arachis), saline or oil of arachis, 
once a day for 3 days. Hepatocytes were then isolated by lobe 
perfusion, and alkoxycoumarin O-dealkylase activities determined in 
the freshly Isolated cells, as described in 2.10, except that 
incubation with substrate was for 5 minutes only (over which period 
the production of 7-HC was linear in cells from inducer-treated 
animals). 
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5.2.2 Induction in vitro 
Hepatocytes from untreated adult male rats (150g) were cultured for 
72 hours, in WEC, in the presence or absence of inducer, which was 
added after the 2 hour attachment period. Fresh medium containing 
inducer was placed on the cells after 24 and 48 hours in culture. 
After 72 hours, O-dealkylase activities were determined as described 
in 2.10 except that incubation of Inducer-treated cultures with 
500pM 7-EC was for 1 hour only. MCOD activity (at 500|JM SU bstrate 
concentration) was also determined in PB-treated hepatocytes 
cultured in WEC and WEC containing haem (IpM), ALA (200mM) and Se 
(O.lpM) as described in 3.2, PB was used at 3.0mM (dissolved in 
saline) and BNF at 50^ jM (dissolved in DMF). These concentrations 
were ascertained, from initial experiments, to give maximal 
Induction in the absence of any observable toxicity (before and 
after incubation of the induced cells with substrate). Cultured 
hepatocytes were exposed to inducer for 3 days to compare directly 
the induction in vitro with that in vivo. 
5.2.3 Expression of Results 
0-Dealkylase activities are expressed as pmol 7-HC min" mg 
protein" , and induction of activity is expressed relative to the 
control activity (which Is given the value 1.0). Statistical 
analysis was by use of t-tests and ANOVA, as appropriate. 
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5.3 RESULTS 
5.3.1 Induction in vivo 
The viabilities and yields of the cell preparations from the groups 
of treated rats were compared. These values from a group of 
untreated rats were also included in the comparison. The results 
are presented in Table 5.1. There were no significant differences 
in yield (as judged by ANOVA), although the yield from BNF-treated 
rats was lower than in the other groups. There were also no 
differences in viability. The O-dealkylase activities of the two 
control groups, saline and oil of arachis treated, were compared 
with those obtained from untreated animals (data from Table 4.3). 
Again, there were no significant differences between the three 
groups. Thus, treatment of animals with Injection vehicle does not 
affect these activities, the cells from vehicle-treated animals 
being equivalent to untreated control animals (Table 5.2). 
Induction of activities 
The activities determined in fresh cells isolated from the control 
and inducer-treated groups are shown in Table 5.3. PB 
significantly induced all four O-dealkylase activities. Both 
components of MCOD activity were Induced to the same extent in vivo 
(6.8-and 6.0-fold relative to the saline controls). High affinity 
and total ECOD activities were induced 12.9- and 5.3-fold 
respectively relative to saline controls. BNF-treatment 
resulted In a non-significant Increase in MCOD activity (3.4- and 
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1.8-fold Increases relative to oil-treated controls). However, 
there was a significant induction of both components of ECOD 
activity: 8.4- and 8.7-fold increases over control. It should be 
noted that some of the standard errors in these activities are quite 
large, especially amongst the PB and BNF-treated groups. This degree 
of variability probably reflects differences In the success of 
administration of the i.p. injections in addition to 
Inter-individual variation in response to the Inducers. 
5.3.2 Induction in vitro 
The activities determined in hepatocytes cultured for 72 hours In 
the presence or absence of inducer are shown in Table 5.4, After 
72 hours in culture, all the activities in the control cultures are 
low, as expected from the data presented in Chapter Four, In the 
PB-treated cultures there is a slight increase in MCOD activity but 
this is only 1,5- to 2,5-fold relative to the control cultures. 
There was a significant induction of ECOD activity in culture, the 
Induction of total ECOD activity relative to control being 6.7, and 
of the high affinity form 3.6. In BNF treated cultures there was a 
slight Increase In MCOD activity (1.5- to 2.6-fold relative to 
control) and a significant induction of ECOD. Induction of the high 
affinity and total activity form was 7.2- and 20-fold respectively 
relative to control. The in vitro Induction data Is summarised in 
Table 5.5. As was observed with the in vivo induction, there Is a 
wide range of response to the Inducers. Since the culture 
conditions were uniform, this must reflect either inter-individual 
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variation in response which is retained in vitro, or differences in 
the cell populations obtained from the isolation process. 
5.3.3 Comparison of induction in vivo and in vitro 
The induction of activity relative to control in vivo and in vitro 
by PB and BNF is shown in Figures 5.1 and 5.2. It can be seen from 
Figure 5.1 that PB Induction is blunted 1n vitro, with MCOD activity 
being almost totally refractory to the Inducer, in contrast to the 
situation In vivo. Only total ECOD activity is induced in vitro to 
the same extent as in vivo. BNF did not Induce MCOD in vivo or in 
vitro (Figure 5.2). Induction of high affinity ECOD in vitro was 
similar to that seen in vivo whilst the induction of total ECOD in 
vitro was much greater than that seen in vivo. Therefore, there 
are not only differences between induction in culture and in vivo 
with respect to the magnitude of the effect, but the pattern of 
Increase of the four chosen activities is also altered. 
5.3.4 Effect of selenium on PB induction in vitro 
Table 5.6 shows the effects of haem, ALA and Se supplementation of 
WEC (i.e. WEC+H) on PB Induction of total MCOD activity. WEC+H was 
used as the sole control medium since MCOD activity in WEC and WEC+H 
has already been demonstrated to be equivalent (3.3.1). Total MCOD 
was chosen since it is the least well maintained, and most 
refractory to PB induction in culture. There was a numerical, but 
non-significant, induction (3.0-fold relative to control) of MCOD 
activity in PB treated cultures. The magnitude of induction was 
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greater than in the previous experiment (5.3.2), but whereas the 
induction in 5.3.2 represents the mean of 5 animals, in this 
experiment all the cultures used were derived from the same animal. 
This result confirms the observations on heterogeneity of response 
to Inducer in vitro. Nevertheless, the increase is only 50% of 
that seen in vivo, PB induction of MCOD activity in WEC+H was not 
significantly different to that in WEC (3,0- and 3,5-fold 
respectively). Therefore, the presence of Se (haem and ALA) in the 
medium did not Improve PB induction of MCOD in vitro, 
5.4 DISCUSSION 
The pattern of MCOD and ECOD induction was as expected: PB Induced 
both MCOD and ECOD; BNF induced only ECOD activity. Whereas both 
components of MCOD activity were induced to the same extent in vivo, 
PB induced high affinity ECOD more than the total activity and BNF 
Induced the total more than the high affinity form. BNF also 
induced only ECOD activity in vitro. PB failed to induce MCOD in 
vitro although there was good induction of total ECOD activity, and 
a modest induction of the high affinity component. The Inclusion of 
haem, ALA and Se in the culture medium did not improve PB induction 
of MCOD activity in vitro. This contrasts with the work of Engelmann 
et al^ . (1985) in which induction of P450 content by PB was only 
observed in medium containing exogenous haem and Se. However, 
these workers used PB at a concentration of ImM, which did not 
Induce O-dealkylase activity in initial experiments performed in 
this study. The Se may possibly be potentiating an effect at this 
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lower concentration of inducer. It is also possible that the Se is 
increasing the total P450 Induced by PB, but that these P450s are 
not PB-speclfic Isozymes. This would explain the lack of effect of 
Se on PB Induction of MCOD activity, and would be consistent with 
other work on PB induction in vitro. 
PB-inducible P450s have been reported previously to be refractory to 
induction in hepatocyte culture (Forster et al., 1986; Warren and 
Fry, 1988), but it also appears that the isozymes Induced by the 
compound in vivo and in vitro are different. Edwards et al. (1984) 
determined that the proportion of PB-inducible P450s that could be 
inhibited by metyrapone after in vitro induction was different to 
that after in vivo Induction, suggesting that the populations of 
P450 Induced in the two conditions were not identical. In 1985, 
Miyazaki et al, observed that although PB effectively arrested the 
rate of decline of total P450 in hepatocyte cultures and preserved 
the cell morphology, the main Isozyme induced by PB, P450IIB1, was 
not detectable immunochemlcally in the cultures. 
Thus, the poor induction by PB in vitro is probably a function of 
altered regulation. It is known that the transcription rates of 
other PB-inducible proteins are different to that of P450IIB1 
(Hardwick et al., 1983a), however there have been no reports on the 
induction in vitro of non-P450 PB-inducible proteins. It may be 
that changes in the regulation of PB induction reflect alterations 
in other factors necessary for PB-inducible gene expression. 
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Although no receptor for PB has been identified, it appears that 
protein synthesis is essential for Induced expression of the CYP2B1 
and CYP2B2 genes (Chianale et al., 1988), and the Involvement of 
trans-acting regulatory factors has been suggested. Alterations in 
turnover/regulation of transcription factors in vitro could result 
in reduced gene expression. 
Although PB did not induce MCOD in vitro, ECOD activity was induced, 
ECOD activity must involve a different population of isozymes, since 
the activity is also induced by BNF, The Induction of ECOD by PB 
may Involve PB Induction of BNF-inducible P450s, The anomalous 
expression of P450IA1 in untreated and PB-treated cultures has been 
reported previously and seems to be more marked in hormone-free 
culture medium (Fry et al., 1980; Turner and Pitot, 1989). Also, 
good expression of both P450IA1 and IA2 seems to require serum-free 
medium. It is therefore possible that these P450s are normally 
repressed (e.g. by a hormone) but that this repression is disrupted 
in vitro. Despite the unusual expression of P450IA1 in control and 
PB-treated cultures, the induction of BNF-inducible forms by BNF In 
vitro is similar to that seen in vivo. 
It was suggested that the van'obility in response to Inducer was a 
result of inter-individual variation and/or variation in 
administration of inducer, these variations being retained on 
placing hepatocytes into culture. However, it is also known that 
hepatocyte heterogeneity exists with respect to distribution of P450 
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isozymes, as well as carbohydrate metabolism (Gumucio, 1989). The 
perivenous hepatocytes (in the distal part of the liver acinus) 
contain more PB-and 3-MC-induc1ble isozymes in the unlnduced state, 
and whereas PB Induction predominates in perivenous hepatocytes 
(Baron et al_., 1981), 3-MC Induction seems to predominate in the 
periportal regions (Tazawa et al., 1988). It has been shown that the 
direction of liver perfusion during hepatocyte Isolation influences 
the relative proportions of proximal and distal acinar hepatocytes 
obtained in the final preparation (Gumucio et al., 1986). It is 
possible then, that selective isolation and/or selective survival in 
culture of hepatocytes with different P450 isozyme profiles and 
different metabolic activities may also be a factor in altered 
inducibility of P450s in vitro. 
In summary, the induction of alkoxycoumarin O-dealkylase activities 
in vitro by PB and BNF was not representative of the induction 
observed in vivo. It is likely that P450 induction in vivo will 
only be successfully reproduced in culture when the mechanisms of 
induction are fully understood. However, in the meantime, an 
alternative approach for studying induced P450s in hepatocyte 
cultures would be to induce the isozymes in vivo, and then culture 
hepatocytes from the treated animals. The feasibility of this is 
investigated in the following chapter. 
TABLES AND FIGURES 
TABLE 5.1. YIELD AND VIABILITY OF CELL PREPARATIONS FROM 
UNTREATED AND INDUCER-TREATED ADULT MALE RATS. 
GROUP YIELD PERCENTAGE 
(million cells) VIABILITY 
UNTREATED 44± 3 92± 1 
SALINE 40± 1 91 ± 1 
PB 46± 4 91± 2 
OIL OF ARACHIS 45±16 91 ±1 
BNF 18±2 92± 2 
Values are mean ± SEM (n=4). 
ANOVA : no significant differences between the five groups. 
TABLE 5.2. ALKOXYCOUMARIN O-DEALKYLASE ACTIVITIES 
IN FRESHLY ISOLATED HEPATOCYTES FROM CONTROL GROUPS 
OF ADULT MALE RATS. 
SUBSTRATE ACTIVITY ( pmol min-''mg-'') 
CONCENTRATION UNTREATED SALINE OIL OF ARACHIS 
(HM) 
7- MC 20 11±2 8±2 13± 1 
7-MC 500 157±16 138±16 125± 6 
7-EC 10 13±1 9±2 17± 1 
7-EC 500 228±17 294±37 314±19 
Values are mean ± SEM (n=4). 
ANOVA : no significant differences between the three groups. 
Untreated group: data taken from Table 4.3. 
TABLE 5.3. ALKOXYCOUMARIN O-DEALKYLASE ACTIVITIES IN 
HEPATOCYTES ISOLATED FROM CONTROL AND INDUCER-
TREATED ADULT MALE RATS: INDUCTION IN VIVO. 
SUBSTRATE ACTIVITY (pmol min"'' m g" • ") 
CONCENTRATION SALINE PB OIL OF BNF 
([iM) ARACHIS 
7-MC 20 8±3 54±11* 13± 1 44± 7 
7-MC 500 138±16 834±169* 125± 6 219± 34 
7-EC 10 9±2 116± 26* 17± 1 143± 2 1 * * 
7-EC500 294±37 1554±296* 314119 27401208** 
Values are mean + SEM (n=4). 
* PB significantly different to saline control p < 0.05; 
* * BNF significantly different to oil of arachis control p < 0.05; 
unpaired t-tests. 
TABLE 5.4. ALKOXYCOUMARIN O-DEALKYLASE ACTIVITIES 
IN HEPATOCYTES CULTURED IN THE PRESENCE OF INDUCER: 
INDUCTION IN VITRO. 
SUBSTRATE ACTIVITY (pmol min-''mg-'') 
CONCENTRATION PB CONTROL BNF 
(liM) 
7-MC 20 1.710.3 0.710.2 1.810.6 
7-MC 500 11.012.0 7.311.0 12.013.0 
7-EC 10 7.512.0 2.110.5* 14.013.0* 
7-EC 500 110138 21.0+3.0* 3641112* 
Values are mean l SEM (n=5, 7-MC; n=4, 7-EC). 
* control significantly different to PB and BNF significantly different 
to control p< 0.05; paired t-test. 
TABLE 5.5. ACTIVITY AFTER INDUCTION IN VITRO RELATIVE 
TO CONTROL. 
SUBSTRATE RELATIVE INDUCTION 
CONCENTRATION PB BNF 
(jiM) 
7-MC 20 2.5(1.9-3.3) 2.6 (1.0-5.2) 
7-MC 500 1.5(1.1-1.9) 1.5 (0.8-2.3) 
7-EC 10 3.6(2.8-5.2) 7.2 (3.9-11.0) 
7-EC 500 6.7(1.8-13.0) 20.0 (5.6-37.0) 
Induced activity relative to control was determined for each animal and 
the values above are the mean induced activities relative to control, 
with ranges (n=4 or 5). 
TABLE 5.6, EFFECT OF MEDIUM SUPPLEMENTATION ON PB 
INDUCTION OF TOTAL MCOD ACTIVITY, 
pmol min"^mg"^ 
relative induction 
WEC+H 
1211 
1.0 
MEDIUM 
WEC PB 
3617 
3.0 
WEC+H PB 
421 3 
3.5 
Values are mean + SEM (n=4 plates). 
WEC PB not significantly different to WEC+H; WEC+H PB not significantly 
different to WEC PB; paired t-test. 
20-1 
RELATIVE INDUCTION IN VIVO 
D IN VITRO 
20nM SGDuM 
7-MC SUBSTRATE 
lO^M SOOuM 
7-EC 
FIGURE 5.1. INDUCTION OF MCOD AND ECOD ACTIVITIES BY PB 
IN VIVO AND IN W7/?0.Activities were determined in freshly isolated 
cells from inducer-treated animals, or in hepatocytes cultured for 72 
hours in the presence of inducer. Activities are expressed relative to the 
control activity,i.e. from the untreated cells or animals. 
RELATIVE INDUCTION 
30 
25 H 
20 
15 
10 
5 -\ 
0 
^ IN VIVO 
0 IN VITRO 
WZAjmszzi 
20)iM 500nM 
7-MC 
SUBSTRATE 
lO^M 500|iM 
7-EC 
FIGURE 5.2. INDUCTION OF MCOD AND ECOD ACTIVITIES BY 
BNF /N VIVO AND \N VITRO. Activities were determined in freshly 
isolated cells from inducer-treated animals, or in hepatocytes cultured 
for 72 hours in the presence of inducer. Activities are expressed relative 
to the control activity,i.e. from the untreated cells or animals. 
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CHAPTER 6 
INDUCTION OF P450 AND ENZYME ACTIVITIES IN VIVO AND MAINTENANCE IN 
RAT HEPATOCYTE CULTURES 
6.1 INTRODUCTION 
Exposure to Inducers of P450 can profoundly alter the metabolism and 
toxicity of xenobiotics by altering the isozyme population. 
Different Isozymes have different substrate specificies, which is 
reflected by the differential induction of an activity on exposure 
to a range of Inducers (Okuno et al_., 1989). It should be 
possible, therefore, to measure enzyme activities selective for 
different isozymes, resulting in an activity/1sozyme profile for 
each inducer. This has been attempted using stereospecific 
hydroxylation products of testosterone (Darby et al., 1986), and the 
dealkylation of a series of alkoxyresorufins (Burke et al., 1985), 
measured in microsomes from animals treated with P450 inducers. 
It was therefore decided to measure several enzyme activities which 
it was hoped would prove to be selective for different Induced P450 
Isozymes. This was done in hepatocytes Isolated from animals 
treated In vivo with prototypic inducers of the main P450 gene 
families. The inducers chosen were /S-naphthoflavone (BNF), 
phenobarbitone (PB), isoniazid (ISO) and dexamethasone (DEX) which 
induce P450s in the lA, IIB, IIE and IIIA families respectively. 
Prospective selective substrates for the different induced isozymes 
were chosen. Microsomal 7-ethoxyresorufin 0-deethylation (EROD) is 
selectively induced by 3-MC and BNF (Burke et al., 1985); 
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benzphetamine demethylation (BZDM) has been reported to be catalysed 
by P450IIB1 (Ryan et al., 1979); p-nitrophenol hydroxylase (PNPH) is 
induced in microsomes from ethanol-fed rats (Reinke and Moyer, 
1985), ethanol and isoniazid both inducing the same isozyme 
(P450IIE1) in the rat (Ryan et al., 1986), DEX and PCN both induce 
the same microsomal P450 (Heuman et al., 1982), DEX being a better 
Inducer. The macrolide antibiotics also induce this family of 
isozymes, inducing their own metabolism at the same time (Danan et_ 
al., 1981; Watkins et al.. 1986), and therefore erythromycin 
N-demethylation (EMDM) was chosen as the fourth enzyme activity. 
The enzyme/activity profile for each inducer was then examined and 
the maintenance of the activity profile in culture determined. 
6.2 METHODS 
6.2.1 Animals 
Adult male rats (6-8 weeks old) were treated i.p. with dexamethasone 
sodium phosphate (100 mgkg" in saline) for 4 days or BNF (80 mgkg' 
in arachis oil) for 3 days. PB and ISO (0.1%) were administered in 
drinking water for 5 and 10 days respectively. 
6.2.2 Procedures 
Hepatocytes were isolated by lobe perfusion, and half of the final 
cell suspension was sonicated to give an homogenate of fresh cells 
as described In Chapter 2.8. The other half of the suspension was 
plated out on "Primaria" dishes in WEC. After 24 hours in culture 
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the monolayers were washed with saline and homogenates prepared. 
P450, protein content and enzyme activities were determined in 
the cell homogenates as described in Chapter 2.11 - 2.13. 
6.2.3 Presentation of results 
Enzyme activities were calculated as nmol or pmol product min" mg 
protein" (the "activity") and as nmol or pmol product min"-^ nmol 
P450" (the "specific activity"). Induction of activity relative 
to control indicated the actual change in activity, whereas changes 
in specific activity relative to control indicated the involvement 
of induced P450 Isozymes in the activity. Statistical analysis was 
by ANOVA and Dunnett's tests for the induction of fresh activity 
relative to control, and by use of paired t-tests for the 
maintenance data. 
6.3 RESULTS 
6.3.1 Induction of enzyme activities 
Table 6.1 shows the P450 content and enzyme activities measured in 
homogenates from hepatocytes isolated from untreated and treated 
adult male rats. P450 content and BZDM activity were both 
significantly Induced by PB, DEX and BNF but not by ISO. EMDM was 
Increased by PB and DEX; PNPH was induced by PB, DEX and ISO. EROD 
was significantly Induced only by BNF. The 5,6-fold induction by 
PB was not significant; this was probably because the 320-fold 
induction of EROD by BNF, being so much greater than that by PB (and 
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the other Inducers), weighted the Dunnett's test (by yielding a 
very high estimate of the residual mean square value in the ANOVA). 
Table 5.2 shows the specific enzyme activities. PB did not 
significantly increase any of the specific activities, whereas DEX 
significantly induced EMDM, ISO significantly induced PNPH and BNF 
significantly Induced EROD. 
6.3.2 Induction relative to control 
Figures 6.1 - 6.4 show the changes in P450 content, activity and 
specific activity relative to those measured in untreated rats 
(controls = 1.0). 
PB (Figure 6.1a) induced BZDM, EMDM and EROD activities to the same 
extent as the P450 content (7.4-, 5.9-, 5.6- and 6.6-fold 
respectively), and accordingly the relative specific activities 
(RSA; Figure 6.1b) of these enzymes approximated to 1.0 (1.3, 0.8 
and 0.8), In contrast, PNPH activity was Induced 2.4-fold byPB 
although the RSA was only 0.3. The demethylase results agree with 
microsomal data for the PB-inducible aminopyrine demethylase, in 
that the activity was Induced to the same extent as the P450 content 
(Fry, 1981). Also, the induction of PNPH and EROD determined here 
from whole cell homogenates were similar to the Inductions of the 
same activities determined In microsomes (1.7-fold induction of 
PNPH, Reinke and Moyer, 1985; 6-fold induction of EROD, Burke et 
al., 1985). 
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DEX (Figure 6.2) induced P450 and BZDM activity 5.6-fold, the RSA of 
BZDM being 1.1, as seen with PB Induction. EMDM activity was 
induced 11.8-fold, whereas the RSA was 2.0. Thus, only half of the 
observed induction of activity could be attributed to the increase 
in total P450. However, this was the only activity measured that 
was selectively induced by DEX; the RSA of PNPH and EROD were less 
than 0.6. 
Only PNPH activity was increased by ISO as seen in Figure 6.3 
(7.4-fold increase, similar to the 6.1-fold increase observed in 
microsomes from ethanol-fed rats, Reinke and Moyer, 1985). The RSA 
was 3.9, indicating selective induction of this activity, although 
the total P450 content did not increase significantly after ISO 
treatment. 
EROD was selectively Induced by BNF (Figure 6.4; RA 320, RSA 32), 
and again, this was much greater than the observed induction of P450 
(9-fold). The RSAs of the other enzymes were less than 0.6. 
It would appear that BNF selectively Induced EROD, ISO selectively 
induced PNPH and DEX selectively induced EMDM, whereas PB induced 
all three demethylase activities to more or less the same level. 
6.3.3 Maintenance of activities in culture 
The maintenance of the activities after 24 hours in culture, in 
hepatocytes from untreated and treated animals is shown in Figures 
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6.5-6.9. Activity at 24 hours relative to that of the fresh 
cells (RA24) and relative specific activity at 24 hours (RSA24) are 
both shown. An RA24 of 1.0 and an RSA24 greater than or equal to 
1.0 for a particular enzyme indicates maintenance of that particular 
activity and loss of total P450; an RA24 and an RSA24 less than 1.0 
indicates a specific loss of activity whilst the bulk of the P450 is 
maintained. 
In cultures from untreated rats (Figure 6.5) P450 content fell by 
31%; there was a selective loss of BZDM (RSA24 0.46) and a loss of 
EROD activity. The loss of EROD in culture has been reported 
previously (Grant et al_., 1985), as has the loss of P450 and of 
certain PB-inducible activities (Warren et al., 1985). 
In cultures from PB-induced rats (Figure 6.6) there was a 
significant loss of P450; there was a selective loss of EMDM and 
maintenance of BZDM, in contrast to the control cultures. 
In cultures from DEX-induced rats (Figure 6.7) the P450 content fell 
by 43% and unlike the control cultures BZDM was maintained, with 
total loss of PNPH and some loss of EMDM activity, although the RSA 
was maintained. 
In cultures from ISO-treated animals (Figure 6.8) both P450 and EROD 
were maintained, as well as EMDM and PNPH activities; there was a 
loss of BZDM, similar to that seen in control cultures. 
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In cultures from BNF-treated animals (Figure 6.9) the P450 content 
fell by 47% and EROD activity was selectively lost. (However, EROD 
activity in these cultures was still 7-fold greater than that 
measured in control cultures). The other activities were 
maintained. 
In general, P450 declined by 30-50% in hepatocytes after 24 hours in 
culture and EROD activity was the least stable. The activities 
selectively induced (as determined In the fresh cell homogenates) 
were maintained in culture over 24 hours, although some of the other 
forms were lost. 
6.4 DISCUSSION 
The selective induction of enzyme activities was demonstrated in 
this study, using four of the prototypic P450 inducers. ISO only 
Induced PNPH activity and specific activity; BNF selectively induced 
EROD (i.e. increase in RA and RSA) and DEX selectively induced 
EMDM. The latter two inducers also increased at least one other 
enzyme activity, but not the relevant specific activity. PB, In 
contrast, induced all the activities but was completely 
non-selective (for the activities measured in this study). 
The fold-induction of specific activities by BNF, ISO and DEX was 
greater than the fold-induction of total P450 in each case, and 
there are several explanations for these apparent discrepancies. 
Firstly, a small increase in an isozyme with a high affinity for the 
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substrate would increase the observed activity (especially at low 
substrate concentrations), but if the total P450 was induced or 
remained unchanged a very low RSA value would be obtained. This 
could explain PB induction of PNPH, where the RA was 2,4 and the RSA 
only 0,3, Secondly, a constitutive isozyme present at low levels 
could be dramatically Increased on induction, but still account for 
a small proportion of the total P450: this could result in an RSA 
value much higher than the increase in total P450, This probably 
accounts for the induction of PNPH by ISO, The RA and RSA of this 
Induced activity were 7,4 and 3,9 respectively, but, in contrast to 
the other Inducers, there was no increase in the total P450 content. 
Other workers have reported 6-fold inductions of P450IIE1 and PNPH 
in the absence of any increase in the total microsomal P450 (Ryan et 
£]_., 1985). 
With respect to substrate specificity/affinity there were problems 
associated with choice of substrate in this study. There was a 
problem of specificity: PB did not significantly induce any RSA 
value. However, this may reflect the limited number of enzyme 
activities studied and/or the choice of activities e.g. the 
induction of pentoxyresorufin O-dealkylase (PROD), as opposed to 
BZDM, may be more specifically induced by PB (Burke et al., 1985). 
In addition to the choice of substrate, it has been shown recently 
that DEX but not PCN (pregnenolone-16(X- carbonitrile) induces the 
main PB-inducible forms in addition to the P450in proteins (Namkung 
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et al_., 1988), and also that PB can Induce the CYP3A1 gene (Nebert 
and Gonzalez, 1987). Also, PCN does not induce the PB-inducible 
PROD activity (Burke et al_., 1985). This probably explains the 
similar inductions of EMDM and BZDM by PB and DEX. In this study DEX 
was chosen over PCN because of its greater magnitude of induction. 
However, in the light of the work by Namkung et al_. (1988) PCN 
would appear to be a more selective Inducer of the P450III family. 
It is also difficult to find selective substrates for this gene 
family that are relatively easy to assay. The macrolide 
antibiotics such as triacetyl oleandomycin and erythromycin can 
present problems, since they are capable of binding to the 
cytochrome forming an Inactive complex (Danan et al., 1981). For 
this reason Namkung et al. (1988) attempted to find alternative 
substrates; separation of different testosterone metabolites by HPLC 
was the most successful assay that they tried, with respect to 
selectivity. 
In general, the selectively Induced enzyme activities were 
maintained for 24 hours in hepatocytes cultured from the treated 
rats, although the total P450 content declined by 30-50% over this 
time period. This again demonstrated selective stability of 
isozymic forms, in addition to selective induction. 
In hepatocytes cultured from ISO-treated animals, there was a 
general maintenance of both P450 and enzyme activities, although 
there was selective loss of BZDM (RA24 and RSA24 of less than 0.5), 
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similar to that seen in cultures from untreated rats. In these 
control cultures BZDM activity declined by more than 70%, whereas 
the total P450 fell by only 31%. The other activities were 
maintained In control cultures although there was some loss of EROD 
activity. This activity declined to some extent in all the 
cultures studied (except those from ISO-treated animals), however, 
constitutive BZDM appeared to be particularly labile in hepatocyte 
culture, unlike the induced activity. 
It therefore appears that the induced form, of BZDM, and also induced 
EMDM, are not identical to the constitutive forms present in control 
cultures. The induced EMDM was lost more rapidly than the 
constitutive form. This is consistent with the rapid degradation of 
P450s Induced by DEX (Watkins et al,, 1986), In contrast, the BZDM 
Induced by PB and DEX was maintained in culture for 24 hours, 
whereas the constitutive activity was lost. It has been reported 
that the main PB-inducible P450 in the liver, P450IIB1 has a high 
specificity for BZDM and the 16oc-hydroxylation of testosterone (Ryan 
et al_., 1979). This latter activity is catalysed by P450IIC11 in 
untreated rat liver (Waxman et al., 1985). It is also possible 
that the poor maintenance of constitutive BZDM reflects the poor 
maintenance of liver-specific Isozymes, especially in medium 
containing serum (Enat, 1984). This has been discussed in detail in 
previous chapters. It would appear then, that induced P450IIB1/2 
Isozymes can be maintained in culture for 24 hours, and this also 
suggests that the inability to detect PB-induction of P450IIB1/2 j_n 
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vitro is an induction- mechanism defect, not a maintenance problem. 
This study has shown that it is possible to use selective marker 
activities to monitor changes in Isozyme profile on induction. 
Induced activities can be maintained in cultured hepatocytes for 24 
hours. It should be possible to extend this approach to other 
Inducing agents, and also to compare profiles from compounds that 
induce the same P450 Isozymes. These diagnostic profiles could 
then be used to investigate new compounds for their ability to 
induce P450s. 
SUMMARY 
In the previous four chapters an hepatocyte culture system has been 
defined and characterised with respect to maintenance of P450 and 
its associated enzyme activities and the induction of these 
activities. The conditions resulting in the best maintenance of a 
range of activities seem to Involve hepatocytes from young adult 
male rats, cultured for 24 hours in WEC medium. At this time 
point, the P450 content is 50-70% that of the freshly isolated 
cells, with a range of enzyme activities being maintained at 70% or 
more of the fresh activity. The liver specific forms appear to be 
less well maintained, so there are further modifications that could 
be made to this system, including re-appraisal of the use of 
serum-containing medium. It is also possible to induce activities 
in vivo and maintain them for 24 hours in the cultured hepatocytes; 
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this approach was more successful than Induction in vitro. The next 
chapter reports on investigations into P450-mediated toxicity using 
this culture system. 
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FIGURE 6.1. INDUCTION IN VIVO OF P450 AND ENZYME ACTIVITIES 
BY PB. Each value is the mean activity (A), or mean specific activity (B) 
measured in freshly isolated hepatocytes from treated animals relative 
to that of the untreated animals. 
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FIGURE 6.2. INDUCTION IN VIVO OF P450 AND ENZYME ACTIVITIES 
BY DEX. Each value is the mean activity (A), or mean specific activity (B) 
measured in freshly isolated hepatocytes from treated animals relative 
to that of the untreated animals. 
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FIGURE 6.3. INDUCTION IN VIVO OF P450 AND ENZYME ACTIVITIES 
BY ISO. Each value is the meanactivity (A), or mean specific activity (B) 
measured in freshly isolated hepatocytes from treated animals relative 
to that of the untreated animals. 
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FIGURE 6.4. I NDUCT IONS VIVO OF P450 AND ENZYME ACTIVITIES 
BY BNF. Each value is the mean activity (A), or mean specific activity (B) 
measured in freshly isolated hepatocytes from treated animals relative to 
that of the untreated animals. 
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FIGURE 6.5. MAINTENANCE OF P450 AND ENZYME ACTIVITIES 
AT 24 HOURS IN HEPATOCYTES CULTURED FROM UNTREATED 
RATS. Each value is the mean activity (A), or mean specific activity (B), 
with range, relative to the fresh cell value. * p<0.05, {paired t-test). 
A; P450 content B: BZDM 0: EMDM D:PNPH E:EROD 
(A) 
4 -I 
RA24 
3 -
2 -
1 -
l''.'.'.'\'.-'/'7} 
(B) 
4 n 
RSA 24 
2 -
1 -
B C D 
ENZYME ACTIVITY 
J: 
B C D 
ENZYME ACTIVITY 
FIGURE 6.6. MAINTENANCE OF P450 AND ENZYME ACTIVITIES 
AT 24 HOURS IN HEPATOCYTES CULTURED FROM PB-TREATED 
RATS. Each value is the mean activity (A), or mean specific activity (B), 
with range, relative to the fresh cell value. * p<0.05, (paired t-test). 
A: P450 content B: BZDM C: EMDM D:PNPH E;EROD 
(A) 
4 -1 
RA24 
3 -
^ 
(B) 
4 -1 
RSA 24 
2 -
1 -
B C D 
ENZYME ACTIVITY 
B C D 
ENZYME ACTIVITY 
FIGURE 6.7. MAINTENANCE OF P450 AND ENZYME ACTIVITIES 
AT 24 HOURS IN HEPATOCYTES CULTURED FROM DEX-TREATED 
RATS. Each value is the mean activity (A), or mean specific activity (B), 
with range, relative to the fresh cell value. * p<0.05, (paired t-test). 
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(A) 
4 -1 
RA24 ; 
3 -
2 -
B C D 
ENZYME ACTIVITY 
(B) 
RSA 24 
3 -
2 -
1 -
B C D 
ENZYME ACTIVITY 
FIGURE 6.8. MAINTENANCE OF P450 AND ENZYME ACTIVITIES 
AT 24 HOURS IN HEPATOCYTES CULTURED FROM ISO-TREATED 
RATS. Each value is the mean activity (A), or mean specific activity (B), 
with range, relative to the fresh cell value. * p<0.05, (paired t-test). 
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FIGURE 6.9. MAINTENANCE OF P450 AND ENZYME ACTIVITIES 
AT 24 HOURS IN HEPATOCYTES CULTURED FROM BNF-TREATED 
RATS. Each value is the mean activity (A), or mean specific activity (B), 
with range, relative to the fresh cell value. * p<0.05, (paired t-test). 
A: P450 content B: BZDM C: EMDM D:PNPH E:EROD 
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CHAPTER 7 
TOXICITY STUDIES IN CULTURED HEPATOCYTES 
7.1 INTRODUCTION 
The use of in vitro systems for toxicity testing has been reviewed 
in Chapter One. In recent years, increasing use has been made of 
hepatocyte cultures in the investigation of mechanisms of toxicity. 
As outlined in Chapter One, cultured hepatocytes offer several 
advantages over other cellular and subcellular preparations for this 
kind of study: they are intact cells containing both Phase I and II 
biotransformation enzymes that can be maintained in a defined 
environment free from hormonal and other physiological influences; 
they survive longer than hepatocyte suspensions and comprise a 
metabolically stable cell population, also unlike suspensions. There 
is evidence that freshly isolated cells and hepatocytes that are 
Initially placed into culture are in a state of metabolic flux, with 
increased catabolism, but that by 24 hours in culture the cells have 
recovered from alterations in metabolism sustained during isolation 
and have reached a more stable state (Tanaka et al., 1978; Lopez et^ 
al., 1988). It has also been reported that the toxicity observed 
when hepatocytes are exposed to a toxic compound during the first 18 
hours of culture is greater than when exposure is after 24 hours in 
culture; there is also greater variability in the observed toxic 
response (Tolman et al., 1989). This is probably a reflection of a 
heterogeneous cell population with respect to metabolic stability in 
addition to changing P450 levels. Therefore, although the P450 
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content has declined to 50-70% of the fresh level at 24 hours 
(Chapter Six), in the studies described in this chapter the 
hepatocytes were cultured for 24 hours prior to exposure to the 
xenobiotic. 
Cultured hepatocytes have been used in several different 
toxicological investigations. They have been used to assess the 
role of metabolic activation in the toxicity of xenobiotics (e.g. 
Acosta et al., 1987); to elucidate the temporal relationships of 
biochemical alterations (e.g. Long and Moore, 1988; Berger et al., 
1989); to compare the pattern of metabolites produced in vivo and in 
vitro (e.g. McManus et al., 1987), and to investigate carcinogen 
activation (e.g. Butterworth et al., 1989). 
There are also a number of methods available for assessing the toxic 
effects of xenobiotics. Determination of plasma membrane 
permeability is often used as an indicator of cell viability, since 
damaged membranes will allow access/egress of bulky, charged 
particles. These assays Include trypan blue exclusion, fluorescein 
diacetate inclusion, ion leakage and enzyme leakage (Tyson and 
Green, 1987; Cook and Mitchell, 1989). However, membrane damage is 
not always the Initial lesion and early toxicity can thus be 
underestimated. Also, loss of membrane integrity is disastrous for 
the cell and therefore not particularly sensitive. Enzyme leakage 
assays are particularly vulnerable in this respect due to problems 
of compartmentalisation, high leakage in control samples and 
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inactivation of the enzyme by the toxin (Tyson and Green, 1987). 
Also, leakage does not account for cells that detach from the 
monolayer (Chao et al., 1988), unless there is some assessment of 
latency. 
Other indicators of toxicity are based on determination of cellular 
function e.g. DNA or protein synthesis; urea synthesis; ATP content 
or mitochondrial function (Tyson and Green, 1987; Cook and Mitchell, 
1989). However, not all of these are suitable for routine use with 
large numbers of samples, and although the assay may involve 
measurement of an intrinsic cellular activity, there may still be 
wide inter-individual variations in activity. In addition, there 
are cell proliferation assays that assess colony formation and 
plating efficiency (Cook and Mitchell, 1989) but these cannot be 
used in static monolayer cultures. 
There are also non-specific Indicators of cell injury which can 
demonstrate a potential for toxicity. These include cellular 
glutathione content and covalent binding (Tyson and Green, 1987). 
The depletion of reduced glutathione is not cytotoxic in itself and 
is usually reversible. However, a sustained depletion suggests 
that normal cellular regeneration/synthesis mechanisms have been 
inhibited/overwhelmed. Cell proteins can bind activated molecules, 
and this covalent binding is used as a measure of toxicity although 
the exact relationship of cell death to covalent binding remains to 
be established. It may be that the reactive metabolites bind to 
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critical cell proteins i.e. enzymes, inhibiting their function. 
The above are all used as indicators or measures of cytotoxicity, 
but do not distinguish per se between directly-acting toxins and 
those that require metabolic activation by P450. The latter can be 
demonstrated using P450 inducers and inhibitors (Mitchell et al., 
1973) and by showing a dependence on the presence of cofactors in 
microsomal incubations (Garle and Fry, 1989). 
In this study, the effect of seven hepatotoxins (thought to be 
activated to toxic species by cytochrome P450) on hepatocyte 
viability was determined, using mitochondrial function (MTT 
reduction) as the parameter of viability (2.5.2). The effect of 
induction of P450-mediated activity on the toxicity of the compounds 
was also determined, by culturing hepatocytes from inducer-treated 
animals, as for the study reported in the previous chapter. A 
report on acetaminophen toxicity in cultured hepatocytes (Kyle £t 
al., 1989) utilised a similar induction approach. The seven 
compounds used, with summaries of the available information on their 
hepatotoxicity are presented in Table 7.1. In Chapter Five it was 
shown that treatment of hepatocyte cultures with P450 inducers 
resulted in reduced and altered Induction of enzyme activities, 
relative to in vivo treatment with inducers. This suggested that 
in vitro induction would alter the observed toxicity of xenobiotics 
to cultured hepatocytes, and so toxlcity/viability assessments were 
made after induction in vitro and compared to the results obtained 
after induction in vivo. 
- 138 -
7.2 METHODS 
7.2.1 In vivo Induction, and toxicity 
Hepatocytes were isolated from untreated, and PB or BNF-treated 
young adult male rats and placed into culture. Hepatocytes were 
cultured on 24-well plates coated with collagen (as described in 
Chapter 2.7.2) for 24 hours. Cultures were then exposed to WEC 
containing the test chemical, at various concentrations, for a 
further 24 hours. The number of viable cells remaining was then 
determined using the MTT assay (2.5.2). In some experiments an 
inhibitor of P450-med1ated activity, SKF525-A, was added at the same 
time as the test chemical. 
7.2.2 In vitro induction, and toxicity 
Hepatocytes were isolated from untreated male rats and cultured on 
collagen-coated 24-well plates for 72 hours in the presence or 
absence of inducer (3mM PB or 50pM BNF, as described in Chapter 
5.2.2). Exposure to the test chemical was for a further 24 hours 
followed by assay of viability by MTT. 
7.2.3 Addition of compounds and inhibitors 
Test chemicals were diluted into WEC from IM stock solutions In 
methanol (DMSO for 6-thiopur1ne and SKF525-A). Solvent 
concentration did not exceed 0.1%. Initial dose response 
experiments were performed with 0.1-lOmM concentrations. However, 
with the exception of 4-ipomeanol (4-IP) and 2-methylfuran (2-MF), 
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ImM was found to be the maximum working concentration due to 
increased acidity of the medium (VPA, 5-TP) or precipitation out of 
the medium (precocenes, BHT). Plate sealers were used with 2-MF to 
prevent possible loss due to volatility. However, similar results 
were obtained with plates incubated with or without the plate 
sealers, so volatility was probably not an important consideration. 
In some experiments SKF525-A was added to the cultures; the maximum, 
non-toxic concentration was found to be 10[JM. 
7.2.4 Cellular glutathione and toxicity 
Cellular glutathione (GSH) was determined (as described in 2.16) in 
hepatocytes cultured on "Primaria" dishes. GSH content at 
different time-points after exposure of 24 hour hepatocytes to 
precocene II (PII) was determined, together with the viability, 
measured by MTT reduction. 
7.2.5 Analysis of results 
Dose-response curves for each compound were derived from the 
viability data. The percentage survival at each dose (or time 
point) was plotted, and the concentration at which 50% of the cells 
survived, the ID50, was determined from the curve. The ID50 was 
determined for each compound in cultures from at least four animals, 
and the mean + range quoted in the results. The range of ID50 
values gives an indication of inter-individual variability in 
response, which is an important consideration in assessing toxicity 
of xenobiotics. 
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7.3 RESULTS 
Figures 7.1-7.7 show representative dose-response curves for each 
compound, as determined in cultured hepatocytes from control, PB-
and BNF-treated rats. Table 7.2 presents the mean ID50 value with 
the range for each compound, in each condition. 
7.3.1 Toxicity to hepatocytes from control rats 
VPA, BHT, PII and PI were all moderately toxic to hepatocytes from 
untreated rats (Figures 7.1-7.4 respectively) with mean ID50 values 
between 516-643pM. The ID50 range determined for BHT was very 
narrow (less than lOOpiM), with respect to the other three compounds 
(ID50 ranges around 300piM). Also, it can be seen from the dose 
response curves that there was a sharp decrease in viability from 80 
to 20%, a difference of around 450|JM with BHT, whereas with VPA and 
the precocenes the same loss occurred over a difference of 600-800piM. 
6-TP and 2-MF were less toxic to control hepatocytes (Figures 7.5 
and 7.6), the viability at ImM being around 40%, the mean ID50 
values being 720 and 800[JM. 4-IP was toxic to control hepatocytes 
only at high concentrations (ID50 3.4mM). 
7.3.2 Toxicity to cultures from inducer-treated rats 
The seven compounds fall into three groups with respect to the 
effects of induction on toxicity. 
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BHT and VPA 
PB treatment enhanced the toxicity of VPA and BHT to cultured 
hepatocytes (Figures 7.1 and 7.2), the mean ID50 values being 232 
and 106IJM respectively, with similar ID50 ranges of around 200pM 
(Table 7.2). However, the loss of viability from 80 to 20% is much 
steeper with BHT, a difference of only 150pM, as opposed to around 
9m\in with VPA. BNF did not significantly alter the toxicity of 
either compound (as judged by ID50) relative to the control 
cultures, the dose-response curves being very similar in the 
hepatocytes from control and BNF-treated rats. 
Precocenes I and II 
Both PB and BNF treatment induced the toxicity of the precocenes to 
cultured hepatocytes, PB having the most marked effect (Figures 7.3 
and 7.4, Table 7.2). BNF produced a five-fold and PB a 14-fold 
increase in toxicity of precocene II and a 29-fold Increase of 
precocene I toxicity, with similar ID50 ranges. 
6-TP, 2-MF and 4-IP 
These three compounds, that had minimal toxicity in control 
cultures, were all toxic to cultures from PB- and BNF-treated 
animals. 6-TP and 2-MF were the most toxic to cultures from 
PB-treated rats (Figures 7.5 and 7.6) with 10- and 25-fold Increases 
in response respectively. BNF and PB had similar effects on 4-IP 
toxicity: 13 to 14-fold Increases with ID50 values around 250pM. 
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Table 7.3 summarises these results. Induction of P450 had the 
least effect on VPA toxicity; BHT toxicity was potentiated by PB, 
which markedly increased the toxicities of the precocenes, 2-MF, 
4-IP and 6-TP. BNF had the greatest effect on 4-IP toxicity with 
moderate effects on 2-MF, 6-TP and the precocenes. 
7.3.3 Variability in observed toxicity 
In addition to the wide range of ID50 values obtained for VPA, 6-TP 
and 2-MF, there was also variability in response of the cells to 
these compounds, in that concentrations up to ImM did not always 
elicit a sufficient loss of viability for an ID50 to be determined. 
In the control cultures this may be simply because the compounds are 
only moderately toxic, the upper range of the ID50 being around ImM. 
However, this variability (i.e. toxic or not toxic) was also 
observed in hepatocytes from inducer-treated animals. The 
practical considerations that could be responsible include 
instability of the compound/stock solution, volatility of 2-MF and 
intrinsic inter-animal differences. Use of fresh dilutions of 
fresh stock solutions had no effect on the observed variability, and 
the plate sealers used with 2-MF were judged to function adequately 
since the gradation of any effect was uniform across the plate. In 
any case, volatility was probably not crucial here, since incubation 
without plate sealers gave similar results to sealed plates. It 
has already been observed that there are inter-individual 
differences in response to Inducers (Chapter Five), and this can 
affect the extent of any toxicity that is due to metabolism. For 
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this reason it is Important to use hepatocytes from different 
animals, and not replicate dishes from single animals, in assessing 
the extent of a compound's effects. However, VPA, 6-TP and 2-MF are 
all more markedly toxic to Induced animals, and a complete lack of 
effect in some cultures is somewhat unexpected, and is unlikely to 
be due to poor induction, in which case a reduced effect would be 
more probable. Therefore the possible roles of other intrinsic 
factors have to be considered. 
7.3.4 Induction in vitro and toxicity 
Table 7.4 compares ID50 data from the in vivo induction experiments 
with those observed after induction in vitro, for PII and 4-IP. 
These compounds were chosen since there were marked (and easily 
reproducible) changes in toxicity on induction in vivo. However, 
after treatment of hepatocytes in vitro with PB and BNF there was no 
toxicity of 4-IP following PB, and only a slight increase due to 
BNF. PB and BNF in vitro had similar effects on PII toxicity (mean 
ID50 values of 463 and 459pM respectively), but this response was 
much reduced compared to that obtained with induction in vivo. 
Also, no toxicity of PII to control hepatocytes was observed. This 
is probably due to the decline in P450 over the 72 hour culture 
period, and suggests that the toxicity to 24 hour hepatocytes is (in 
part) P-450 mediated. This failure to Induce toxicity in vitro is at 
least consistent with the failure to Induce P450 enzyme activities 
in vitro (Chapter Five) and the observed decline in some P450 
activities in 72 hour cultures (Chapter Four). 
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7.3.5 Further studies with the precocenes 
Figures 7.8 and 7.9 show the effects of SKF 525-A in vitro upon 
precocene-induced toxicity in hepatocytes from control and 
PB-treated rats. SKF 525-A did not inhibit precocene II toxicity 
in control cultures, although there was a slight shift in the 
precocene I ID50 range: Table 7.5. However, in hepatocytes from 
PB-treated rats there was a marked inhibition of PII toxicity (a 
4-fold Increase in ID50 - Table 7.5), but not of PI toxicity. This 
was rather unusual, in that the reported effects of these two 
compounds are very similar. A further preliminary experiment 
showed that exposure of hepatocytes cultured from PB-treated animals 
to PII resulted in a depletion of cellular glutathione that was 
sustained over 24 hours, and which preceded the loss of cellular 
viability, as judged by MTT reduction (Figure 7.10). 
7.4 DISCUSSION 
The results presented in this chapter demonstrate that induction of 
P450 in vivo can potentiate the toxicity of compounds in cultured 
hepatocytes. A certain amount of Information on the extent and 
degree of toxicity can be determined from the data. 
BHT was moderately toxic to hepatocytes from control and BNF-treated 
rats and PB significantly increased the toxicity. In all cases, 
the dose-response curves fell steeply between 80 ands 20% viability. 
This suggests that BHT may have one or a few very specific sites of 
toxic assault within the cell, and that once a critical 
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concentration is achieved cell death occurs rapidly. It has been 
reported that the cytotoxicity of BHT in control hepatocytes at 
concentrations up to 750pM is not P450-mediated, but a direct effect 
upon the mitochondria. There is a rapid loss of ATP, followed by 
dissipation of the membrane potential (Thompson and Moldeus, 1988). 
This would account for the narrow ID50 range in controls and the 
steep dose-response curve (since mitochondrial function is vital for 
cell survival). It would also Indicate that BHT toxicity has a 
direct effect in hepatocytes on induction with BNF. PB increased 
BHT toxicity in hepatocytes. This agrees with reported data on BHT: 
that PB, but not 3-MC, increased the formation of a microsomal 
BHT-GSH conjugate (Tajima et al., 1985) and that PB increased serum 
transaminase levels in vivo, in BHT-fed rats (Nakagawa, 1987). 
VPA, like BHT, was also toxic to hepatocytes from PB-treated rats, 
the toxicity in hepatocytes from control and BNF-treated rats being 
very similar. However, in contrast to BHT, the VPA dose-response 
curves were much flatter, the toxic effects being manifest over a 
much wider range of concentrations. This probably reflects more 
variability in inter-cellular response, and/or more than one site of 
action of VPA. It is thought that there are two major, competing 
pathways of VPA metabolism in the hepatocyte. VPA is metabolised 
by P450 to an unsaturated metabolite,A -VPA, and this reaction 1s 
Increased by PB in vitro (Rettie et al., 1988). A -VPA can exist 
as 2 enantiomers: the (R) form is metabolised further by P450 to 
4,5-dlhydroxy-VPA- % -lactone, and the (S) form is metabolised by 
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mitochondrial /3-oxidation to a 3-oxo derivative which can then 
inhibit i3-ox1dation, production of the (R) enantiomer being 
favoured (Porubek et al., 1989a). The Inhibition of ^-oxidation 
would eventually be toxic to the hepatocyte, and would explain the 
observed steatosis in VPA-treated rats (Kesterson et al., 1984). VPA 
and A -VPA have both been reported to be hepatotoxic, but the data 
are confusing. PB-treatment increases the overall rate of 
metabolism but not the ratio of enantiomer production (Porubek et^  
al., 1989a); PB does not Increase VPA or A -VPA covalent binding in 
hepatocytes, although clofibrate, an Inducer of fatty acid 
oxidation, does (Porubek et al., 1989b); the reported toxicity of 
4 
VPA and A -VPA to hepatocyte cultures is unconvincing on critical 
evaluation of the presented data (Kingsley et al., 1983). Thus, it 
appears that the P450 system is not solely responsible for VPA 
toxicity (and may also be Involved in detoxification reactions) and 
overall, it is probably the balance of the effects of VPA 
metabolites produced by /3-oxidation and P450 that determine the 
toxicity, and that this dual effect accounts for the broad 
concentration range of the toxic effects and the resistance of some 
animals/cell cultures to VPA. In any case, the mixed in vitro data 
obtained with VPA mirrors the in vitro situation with respect to 
incidence of VPA toxicity and severity of effect, which would also 
be consistent with the idea that some individuals may be 
physiologically more prone to VPA toxicity, especially in 
conjunction with other drugs. 
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6-TP also gave some conflicting results. Both PB and BNF increased 
6-TP toxicity, although toxicity was not always observed. PB (but 
not 3-MC) has been reported to Increase the covalent binding of 6-TP 
to microsomal protein, although PB treatment decreases 6-TP covalent 
binding in vivo (Hyslop and Jardine, 1981a; 1981b). The authors 
suggest that this discrepancy is due to PB induction of conjugation 
enzymes, which results in Increased detoxification in vivo, which 
are absent in microsomal preparations. If this Is correct, then it 
implies that the Phase II reactions are inhibited/less active in 
hepatocyte cultures. It has been reported that UDP-glucuronyl 
transferases and some of the glutathione transferases are reasonably 
stable over 24-72 hours of hepatocyte culture, although there was a 
rapid depletion of UDP-glucuronic acid (UDPGA) during isolation 
(Croci and Williams, 1985; Grant and Hawksworth, 1986). This may 
account for the in vivo/in vitro discrepancy in PB Induction of 6-TP 
hepatotoxicity with regard to the variability in the 6-TP results. 
It is also possible that P450 is not the only enzyme system Involved 
in 6-TP metabolism. A major route of 6-TP transformation is via 
xanthine oxidase to thiouric acid; however, a xanthine oxidase 
inhibitor, allopurinol, did not inhibit the covalent binding of 6-TP 
(Hyslop and Jardine, 1981a). Also, 6-TP contains several nitrogen 
atoms and a sulphur group, which would make it a good substrate for 
the flavin monoxygenase system (FMO), which predominantly forms N,S 
and P-oxides (Gibson and Skett, 1986). The FMO appears to be 
fairly stable in hepatocyte cultures (Sherratt and Damani, 1989), 
but compared to the MMO, little work has been performed on the role 
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of the FMO in drug metabolism and this makes it difficult to assess 
the relative contributions of the two systems. 
4-IP and 2-MF both contain a furan group, which has been implicated 
in 4-IP toxicity (Boyd et al., 1983). Both PB and BNF Increased 
the toxicity of these furans to cultured hepatocytes. 4-IP is 
analogous to 6-TP in that PB increases the covalent binding of 4-IP 
in microsomes, but in vivo it is reduced (Boyd and Burka, 1978; Boyd 
et al_., 1978). Statham and Boyd (1982) reported the increased 
urinary excretion of a 4-IP-glucuronide on PB induction in vivo, and 
therefore, as suggested above, it may be a depletion of UDPGA in 
cultured hepatocytes that accounts for the discrepancies in the in 
vivo and in vitro data. The increased toxicity in vitro of 4-IP on 
induction with BNF is consistent with the in vivo data. PB has 
been shown to increase the covalent binding of 2-MF in microsomes, 
whereas 3-MC did not (Ravindranath et al., 1985). This does not 
agree with the results presented here although 2-MF has been shown 
to deplete GSH in microsomes from BNF-treated rats (Garle and Fry, 
1989). 
Both of the precocenes were toxic in control hepatocytes, induction 
markedly increasing their toxicity. The bigger increase in 
toxicity was with PB. Precocene I has been shown to deplete GSH 
in vivo and lead to an increase in serum transaminase levels (Halpin 
et al_., 1984; Ravindranath et al., 1987). Both precocenes can 
deplete GSH, 80-90% of the dose being rapidly conjugated with GSH 
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(Foureman et al., 1989). PB has been shown to Increase, and 
SKF525-A to decrease, covalent binding of PII (Hsia et al., 1981). 
This agrees with the data presented here, that SKF525-A can inhibit 
PII toxicity, and that a sustained depletion of GSH precedes loss of 
cellular viability. That GSH depletion and loss of viability do 
not occur concurrently, suggests that GSH depletion is one of the 
first steps in the pathology of PII toxicity. Depletion of GSH is 
not in Itself toxic; the inability of the cell to 
synthesize/regenerate GSH however would be more serious. 
Maintenance of GSH levels is linked to GSSG, NADPH, NADH and ATP 
levels. It would appear that whilst a toxic dose produces a 
sustained GSH depletion, a non-toxic dose results in a transient 
depletion, which suggests that GSH depletion is an early reversible 
event, not the cause of toxicity, and that some other biochemical 
change can precipitate a sustained loss of GSH e.g. NADPH depletion, 
inhibition of glutathione reductase. 
Overall, the approach of In vivo Induction followed by hepatocyte 
culture was successful In this study in detection of hepatotoxicity, 
the results agreeing or complementing the in vivo and the microsomal 
data. P450 Induction has been shown to increase toxicity in 
culture, and inhibition of P450 was also demonstrated. This method 
of investigating the role of P450-mediated toxicity of xenobiotics 
is probably more applicable to interaction and mechanism studies 
rather than to screening of compounds of unknown toxicity, since at 
present the system needs constant evaluation with respect to the 
toxicity invivo. 
TABLES AND FIGURES 
TABLE 7.1 REPORTED TOXIC EFFECTS OF THE COMPOUNDS USED 
IN THIS S TUDy l . 
VALPROATE (VPA) anticonvulsant 
in vivo steatosis ± necrosis; inhibition of mitochondrial B-oxidation^; 
increased covalent binding"^. 
in vitro PB increases rate of metabolism; covalent binding of VPA 
and A -VPA to protein in cultured hepatocytes . 
BUTYLATED HYDROXYTOLUENE (BHT) antioxidant 
in vivo necrosis; PB increases serum transaminase levels^. 
in vitro PB increases formation of BHT-GSH conjugate;conjugate 
formation inhibited by CO.metyrapone and SKF 525-A^. 
PRECOCENE II (PII) insecticide, from Ageratum houstonianum 
in vivo centrilobular necrosis; 
in vitro PB increases covalent binding; SKF 525-A inhibits covalent binding 
PRECOCENE I (PI) insecticide, from A. houstonianum 
Q 
in VIVO necrosis; GSH depletion; increases in serum transaminase levels . 
in vitro PB increases rate of metabolism^. 
6-THIOPURINE (6-TP) antineoplastic and immunosuppressive 
in vivo PB increases the covalent binding . 
in vitro PB increases, GSH and SKF 525-A inhibit, covalent binding . 
2-METHYLFURAN {2-MF) constituent of coffee and cigarette smoke 
in vitro PB increases, piperonyl butoxide inhibits, covalent binding; 
metabolism to acetylacrolein^^. 
7 
4-IPOMEANOL (4-IP) from Ipomea batatas infected with Fusarium solanae 
in vivo PB decreases covalent binding and lethality ; 
in vitro PB increases the covalent binding' . 
1 in vivo: rat liver;/n v/f/'o.Tat hepatic microsomes, unless stated. 
2 Kesterson et a/.,1984 
3 Porubek et al., 1989a ^ Halpin ef a/.,1984 
^ Porubek et a/., 1989b 1° Hyslop and Jardine, 1981b 
5 Nakagawa,1987 '• '' Hyslop and Jardine, 1981a 
6 Tajima et al., 1985 12 Ravindranath and Boyd, 1985 
'' Hsia et a/.,1981 ^^ goyd and Burka, 1978 
8 Ravindranath et a/.,1987 '• '* Boyd et a/., 1978 
TABLE 7.2. EFFECT OF INDUCTION IN VIVO ON TOXICITY 
IN VITRO. 
mean ID5Q value with range (p.M) 
compound 
VPA 
BHT 
PII 
PI 
6-TP 
2-MF 
4-IP 
CON 
643 
447-708 
516 
468-537 
550 
437-794 
546 
447-708 
720 
501-794 
800 
668-944 
3400 
1400-6300 
PB 
232 
100 -281* 
106 
33-224* 
40 
16-60* 
19 
7.5-38* 
76 
10 -251* 
32 
10-45* 
243 
178-316* 
BNF 
704 
501-1000 
447 
422-473 
124 
56-300* 
114 
56-168* 
134 
30 - 141 * 
84 
10 -211 * 
259 
96-335* 
Values are mean ID50S, with ranges, determined from dose-response 
curves for 4-7 animals. 
* significantly different to control, Mann-Whitney U-test, p < 0.05. 
TABLE 7.3. SUMMARY TABLE OF THE EFFECTS OF INDUCTION 
IN VIVO ON TOXICITY IN VITRO. 
compound CONTROL'' PB^ BNF^ 
VPA + 3 0.9 
BHT -f- 5 1.2 
PII + 14 5.0 
PI -I- 29 5.0 
6-TP - 10 5.0 
2-MF - 25 9.0 
4-IP - 13 14 
^ indicates toxic (+) or non-toxic (-) to control cells. 
2 fold-induction of toxicity over control (control value = 1.0). 
Values greater than 1.0 represent an induction of toxicity, 
which is a decrease in IDgQ. 
TABLE 7.4. THE EFFECTS OF IN VIVO AND IN VITRO 
INDUCTION ON THE TOXICITY OF PRECOCENE II AND 
4-IPOMEANOL TO CULTURED RAT HEPATOCYTES. 
condit ion 
4-IPOMEANOL 
CON 
PB 
BNF 
PRECOCENE II 
CON 
PB 
BNF 
mean ID5 g and range (|iM) 
in vivo 
3400 
1400-6300 
243 
178-316 
259 
96-335 
550 
237-794 
40 
16-60 
124 
56-300 
in vitrc 
>1000 
>1000 
848 
708-944 
>1000 
463 
355-562 
459 
300-562 
Each value is the mean ID5Q and range of 3-5 animals. 
TABLE 7.5. EFFECT OF SKF 525-A ON THE TOXICITY OF 
PRECOCENE I AND II IN HEPATOCYTES FROM CONTROL 
AND PB-TREATED RATS. 
condition mean IDgQ and range (jiM) 
-SKF 525-A +SKF 525-A 
PI OCN 
PB 
PII CON 
PB 
546 
447-708 
39 
4-71 
550 
237-794 
57 
33-75 
767 
708-841 
69 
56-89 
701 
525-708 
234 
178-300 
* range is significantly different to control, p<0.05 Mann-Whitney 
U-test.The values are the mean ID^Q values determined for 4 
animals,the toxicity in the presence and absence of inhibitor 
being determined in cells from each animal. 
FIGURES 7.1-7.7.Hepatocvtes were isolated from control and 
inducer-treated animals and maintained in culture for 24 hours 
prior to exposure to the test compound. In the following figures 
the data presented are from individual, but representative rats. 
The mean ID50 values are shown in Table 7.2. 
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FIGURE 7.1. REPRESENTATIVE DOSE-RESPONSE 
CURVES FOR VALPROIC ACID. 
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FIGURE 7.2. REPRESENTATIVE DOSE-RESPONSE 
CURVES FOR BUTYLATED HYDROXYTOLUENE. 
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FIGURE 7.3. REPRESENTATIVE DOSE-RESPONSE 
CURVES FOR PRECOCENE II. 
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FIGURE 7.4. REPRESENTATIVE DOSE-RESPONSE 
CURVES FOR PRECOCENE I. 
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FIGURE 7.5. REPRESENTATIVE DOSE-RESPONSE 
CURVES FOR 6-THIOPURINE. 
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FIGURE 7.6. REPRESENTATIVE DOSE-RESPONSE 
CURVES FOR 2-METHYLFURAN. 
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FIGURE 7.7. REPRESENTATIVE DOSE-RESPONSE 
CURVES FOR 4-IPOMEANOL. 
FIGURES 7.8 AND 7.9. Hepatocytes were cultured from control 
and PB-treated rats. After 24 hours the cells were exposed to PII 
± SKF-525A (10 i^^ vl). The curves shown are from individual, but 
representative rats. Mean ID50 values are presented in 
Table 7.5. 
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FIGURE 7.8. EFFECT OF SKF-525A ON THE TOXICITY 
OF PRECOCENE II TO CULTURED HEPATOCYTES. 
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log[Pl],pM 
FIGURE 7.9. EFFECT OF SKF-525A ON THE TOXICITY 
OF PRECOCENE I TO CULTURED HEPATOCYTES. 
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FIGURE 7.10. TIME COURSE OF GLUTATHIONE 
DEPLETION AND LOSS OF VIABILITY ON EXPOSURE 
TO PRECOCENE II. Hepatocytes were cultured from 
PB-treated rats and exposed to 100p.M precocene II. 
Values are mean ±range of 4 animals. 
150 
CHAPTER 8 
DISCUSSION 
- 151 -
CHAPTER 8 
CONTENTS PAGE 
GENERAL DISCUSSION 152 
8.1 AGE AND SEX OF HEPATOCYTE DONOR: 153 
P450-DEPENDENT ACTIVITIES AND MAINTENANCE 
8.2 DIFFERENTIAL MAINTENANCE OF P450 ACTIVITIES 155 
IN CULTURE 
8.3 EFFECT OF EXOGENOUS HAEM ON MAINTENANCE 156 
OF P450 
8.4 INDUCTION OF P450: METABOLISM AND TOXICITY 158 
8.5 TOXICITY STUDIES IN VITRO 162 
8.6 GENERAL CONCLUSIONS 163 
- 152 -
CHAPTER 8 
GENERAL DISCUSSION 
The alms of this Investigation were to develop and characterise a 
system for the use of rat cultured hepatocytes in 
metabolism-mediated toxicity studies. This necessitates conditions 
in which constitutive P450 levels/activities can be maintained, and 
in which the in vivo induction of P450 isozymes can be reproduced. 
Initial studies were performed on the kinetics of alkoxycoumarin 
O-dealkylase activities to confirm the biphasic nature of these 
activities and to determine their maintenance in cultured 
hepatocytes. These enzymes were chosen as indicators of P450 
activity because they are biphasic, the separate components 
representing different populations of P450 isozymes (Chapter 2.10). 
The results of these preliminary experiments indicated that although 
both MCOD and ECOD activities were biphasic in freshly isolated 
hepatocytes, MCOD activity became monophasic in hepatocytes cultured 
for 24 hours, with complete loss of the high affinity form; the 
maintenance of the other activities was poor: 55% or less of the 
fresh cell activities. The medium used was Williams' Medium E, 
developed specially for hepatocyte culture (Williams and Gunn, 
1974), supplemented further with insulin, dexamethasone and 
nicotinamide. This medium (WEC) has been shown to attenuate the 
loss of P450 activities in primary culture (Warren and Fry, 1985). 
The studies comprising this investigation were concerned initially 
with improving the maintenance of P450 activities: the effects of 
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further supplementation of culture medium and the influence of the 
age and sex of the hepatocyte donor animal were determined. 
Subsequent experiments compared induction in vitro to that seen in 
vivo, and the maintenance of induced enzyme activities was also 
ascertained. Finally, the metabolic activation of seven known 
hepatotoxins was investigated in the rat hepatocyte cultures, under 
the previously defined conditions. 
8.1 AGE AND SEX OF HEPATOCYTE DONOR: P450-DEPENDENT ACTIVITIES AND 
MAINTENANCE 
It was suggested in Chapter Three that the maintenance of three of 
the four alkoxycoumarin O-dealkylase activities at 70% or more of 
their fresh activities (in contrast to the results of the initial 
kinetic experiments, in which none of the activities were 
maintained) was due to the increased age of the donor animals. The 
results presented in Chapter Four confirmed this suggestion. 
There were differences in fresh cell activities between immature and 
adult male rats and between male and female rats, with respect to 
MCOD and PCOD activities, indicating that there are 
developmental/gender differences in the P450-isozyme complement 
and/or the regulation of these activities. The low affinity form 
of PCOD activity, which is absent in adult female rats, appears to 
correspond to the male-specific, steroid 6/3-hydroxylase activity, 
with total MCOD activity displaying an adult male-specific component 
(Chapter Four). It is thought that these age and sex differences 
in P450 metabolism are due to the effects of hormones, especially 
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growth hormone (and possibly the thyroid hormones), on the 
hepatocyte. These differential hormonal effects may also be linked 
with the lower P450-reductase levels in female rats, which 
Influences the rate of metabolism (Skett, 1988; Waxman et al., 1989). 
The differences in metabolism extend to maintenance in primary 
culture. All the activities measured were maintained at higher 
levels in hepatocytes cultured for 24 hours from adult male rats 
with all 3 alkoxycoumarin O-dealkylase activities remaining biphasic 
in culture. Overall, this selectivity for adult male rats was lost 
by 72 hours in culture; only the high affinity forms of ECOD and 
PCOD were maintained at this time point. This is consistent with 
the proposal that P450 activities are maintained in hepatocytes from 
adult males because of the reported predominance of slow turnover 
P450s, compared to females and Immature males (Levin et al., 1975). 
It was also observed that the least well maintained activities were 
those for which developmental regulation, and therefore hormonal 
regulation, was indicated, which implies that these P450s are the 
rapid turnover forms described previously (Chapter 4.4). 
Thus, although a range of P450-dependent activities were maintained 
better in hepatocytes from adult male rats, the differences in 
hepatic P450 metabolism and maintenance due to age and gender 
demonstrated here are important per se, not only in making 
inter-laboratory data comparisons but also in assessing 
inter-individual susceptibility to iatrogenic hepatic injury. It 
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is often assumed that the observed sex differences in drug 
metabolism in the laboratory rat have little relevance to Man, where 
sex differences are less marked. It is possible though that it is 
just more difficult to demonstrate any differences in Man, due to 
the Influences of many varied exogenous factors. However, it is 
well-known that neonates and young children (as well as the elderly) 
are more susceptible to drug-induced toxicity than adults (Hurwitz, 
1969; Mirkin, 1970). 
8.2 DIFFERENTIAL MAINTENANCE OF P450 ACTIVITIES IN CULTURE 
As described above, there was a selective loss of P450-dependent 
O-dealkylase activities in hepatocytes cultured for 24 hours. In 
Chapter Six it was shown that this selectivity in maintenance 
extends to other enzyme activities. In control cultures the total 
P450 fell by 31% but EMDM and PNPH activities were well maintained 
over 24 hours, and EROD activity declined slightly. However, there 
was a 54% loss of BZDM activity. In this respect BZDM is similar 
to total MCOD and PCOD activities in that it is poorly maintained in 
culture. Induced enzyme activities, however, were well maintained 
for 24 hours. 
It was suggested in the preceding section, and in Chapter Four, that 
it is the developmentally/hormonally regulated P450s that are the 
most susceptible to decline in culture, possibly because they are 
fast turnover forms of P450. It was also suggested that the loss 
of these forms in culture could be a result of suppression of 
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synthesis due to the presence of hormones in the serum that is added 
to the medium (Chapter 4.4). Foetal calf serum contains 
significant, but also variable amounts, of growth hormone and 
thyroid hormones (and also androgens and oestrogens) which are known 
to have important regulatory effects on hepatic P450, e.g. growth 
hormone and tri-iodothyronine have both been shown to suppress the 
male-specific 6/9-hydroxylase (Yamazoe et al., 1989). Other workers 
have reported the expression of liver-specific P450s in vitro, only 
in medium lacking serum e.g. P450IA2 (Silver and Krauter, 1988). 
The presence of serum could effectively 'feminise' the P450 
metabolism of the hepatocytes, in a manner similar to that seen with 
growth hormone supplementation (Guzelian et al., 1988). Serum is 
routinely Incorporated into cell culture medium since most cell 
types, including hepatocytes do not attach and/or grow well without 
it. However, it now appears that 'blanket' addition of hormones to 
culture medium, in the form of serum, may be responsible for at 
least some of the alterations in phenotype observed on placing cells 
into culture. In order to maintain constitutive expression in 
vitro it may be necessary to replace serum-containing media with 
hormonally-defined media. The development of appropriate media will 
be facilitated by further research into the hormonal regulation of 
the different P450 isozymes. 
8.3 EFFECT OF EXOGENOUS HAEM ON MAINTENANCE OF P450 
Addition of exogenous haem, ALA and Se did not affect the 
maintenance of alkoxycoumarin O-dealkylase activities in primary 
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culture (Chapter Three). Engelmann et al. (1985) reported a 
maintenance of total P450 in medium supplemented with haem, ALA and 
Se, but they did not measure any P450-dependent activities. In their 
unsupplemented cultures, the P450 content fell to 75% of the fresh 
cell value, equivalent to the P450 level reported in Chapter Six of 
this study (70% of Initial levels in control cultures at 24 hours). 
However, although the effect of haem-supplemented medium on total 
P450 levels was not determined in Chapter Three, it did not prevent 
the selective loss of MCOD activity in culture. This suggests that 
exogenous haem may boost total P450 levels, but that this masks 
alterations in the isozyme population. 
Engelmann et al. also reported that haem, ALA and particularly Se 
were essential for induction of P450 by PB in vitro. Again, they 
measured total P450 content. In an experiment reported in Chapter 
Five, no induction of total MCOD activity by PB was observed in 
vitro, in medium containing haem, ALA and Se, whereas this activity 
is induced 6-fold by PB in vivo. The Induction of total P450 by PB 
in vitro was not measured. Therefore, it seems that although haem, 
ALA and Se may increase PB induction of total P450 in vitro, this is 
not necessarily an Increase in PB-specific isozymes. This also 
Infers that determination of total P450 levels, in the absence of 
any activity and/or immunochemical data, is not particularly 
informative. The results presented in Chapters Three and Five 
suggest that a reduced haem supply does not contribute to the 
selective loss of P450 activity and Inducibility seen in primary 
culture. 
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8.4 INDUCTION OF P450: METABOLISM AND TOXICITY 
a. Induction In vivo 
In Chapters Five, Six and Seven the induction of P450 and its 
effects on metabolism and toxicity were investigated. Induction of 
the different families and subfamllies of P450 was demonstrated 
using four enzyme activities (Chapter Six). DEX, ISO and BNF each 
produced a characteristically different profile of enzyme activities 
in hepatocytes isolated from rats treated in vivo, with specific 
Induction of EMDM, PNPH and EROD respectively. PB, however, 
induced all the chosen activities to some extent. The 
non-selectivity of PB in this study was probably related to the 
choice of substrates and/or inducers, as discussed in Chapter 6.4. 
This approach should be refined and extended to other inducers (and 
in the case of PB, other enzyme activities) to obtain diagnostic 
profiles for the different classes of inducer (and possibly 
different inhibitors) which could be a useful tool in drug 
development for the prediction of possible drug interactions, as 
well as identification of novel inducers/inhibitors. 
The selective induction of P450 activities by different inducers 
indicates the involvement of specific isozymes. These Induced 
Isozymes may be responsible for changes in toxicity due to 
metabolism. The potential in vitro toxicity of seven compounds, 
reported to be hepatotoxic, after induction in vivo with PB and BNF 
was also investigated (Chapter Seven). Of the four compounds that 
were toxic to hepatocytes cultured from untreated rats, two were 
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more toxic to hepatocytes from PB-treated rats and two were .more 
toxic to hepatocytes from PB- and BNF-treated rats. Treatment with 
each inducer produced significant toxicity in vitro with the three 
remaining compounds, which were judged to be relatively non-toxic to 
cultures from untreated rats. Overall, the results of the study 
reported in Chapter Seven agreed well with available literature data 
on the seven compounds, although there were some discrepancies, 
particularly with respect to the in vivo data where involvement of 
non P450-mediated metabolism. Including Phase II metabolism, has 
been implicated as a determining factor in the toxic response. It 
was observed in Chapter Seven that for some compounds there were 
large variations in response of the cultured hepatocytes from 
individual animals (e.g. VPA), and for other compounds there was 
very little variation (e.g. BHT, in hepatocytes from control and 
BNF-treated animals). This is not necessarily a problem, since 
inter-individual variability in response to inducers and drugs is an 
important consideration in metabolism and toxicity studies. If the 
variability can be reproduced in vitro, the source of the 
variability can be elucidated, whether it be due to P450 isozyme 
content (which varies with age, sex. Induction etc.) or competing 
P450 and intermediary metabolic pathways (VPA). Induction can also 
affect Phase II metabolism, which can Influence the fate of products 
of P450 metabolism (e.g. the effect of glucuronidation on 4-IP 
toxicity). This study has shown that toxicity observed in vivo 
can be reproduced in an In vivo induction-hepatocyte culture system, 
and indicates that, despite the problems that remain to be resolved. 
- 160 -
hepatocyte cultures do have an important role in toxicological 
studies, particularly in mechanistic studies which are very 
difficult to perform in vivo. 
b. Induction in vitro 
Unfortunately, attempts to induce both P450-dependent activities and 
P450-med1ated toxicity in culture, were unsuccessful. There were 
qualitative and quantitative differences on administration of PB and 
BNF in vitro. BNF did Induce ECOD activity in vitro, but the 
induction of total ECOD activity was greater than that observed in 
vivo (Chapter Five). In contrast, with the exception of total ECOD 
activity. Induction of activities by PB in vitro was very poor. 
This suggests that whereas the high affinity component comprises PB-
and BNF-inducible forms the isozymes Involved in total ECOD activity 
may be BNF-inducible forms that can also be Induced by PB in vitro. 
This would explain why total ECOD activity was the only activity 
induced by PB in vitro. In Chapter Six it was shown that BZDM and 
EROD activities were induced by PB in vivo to the same extent 
(around 7- and 6-fold) but BNF only induced EROD activity. This is 
also consistent with the existence of PB- and BNF-specifIc isozymes, 
in addition to BNF-inducible Isozymes that also respond to PB in 
vitro. It has been reported that P450IA1, the major BNF-inducible 
Isozyme, increased In untreated hepatocyte primary cultures and that 
PB Induced this form further (Turner et al., 1988; Chapter 5.4). 
Therefore, an increase in P450IA1 basal levels coupled with P450IA1 
responsiveness to PB in culture, could account for PB Induction 
- 161 -
of total ECOD activity in vitro in the absence of MCOD induction by 
PB, and also for the increase in BNF induction of total ECOD 
activity in vitro over that seen in vivo. Also, constitutive EROD 
activity may be inducible by PB whereas P450IA1 induced in vivo 
is not. 
In addition to the anomalous induction of P450IA1 in culture, it is 
now known that, although total P450 can be induced in culture by PB, 
there is no specific induction of P450IIB1/2. Thus, the regulation 
of PB induction in vitro appears to fail. New evidence is being 
accumulated on regulation of PB induction: the hepatic levels of 
P450IIB1 and 2 can be suppressed by growth hormone and by 
tri-iodothyronine (Yamazoe let al_., 1989); phosphorylation of 
PB-inducible P450s inhibits their activity, and phosphorylation via 
cAMP Is under hormonal control (Bartlomowicz et al., 1989; Koch and 
Waxman, 1989). It may be that, like the reduced expression of 
constitutive, liver-specific P450s in serum-containing medium, the 
induction of P450s IIBl and 2 is suppressed by serum. Another 
factor could be altered regulation of transcription in vitro. The 
initial decrease of protein synthesis in vitro (Tanaka et al., 1978) 
may affect synthesis of transcription factors necessary for PB 
induction. Also, as discussed in Chapter Five, there appear to be 
intrinsic differences within the hepatocyte population with respect 
to induction, and these differences are retained in culture 
(Gumucio, 1989; Bars etal., 1989). 
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Another problem with induction in vitro is that cultures must be 
exposed to inducer for several days, over which time period the 
total P450 is declining. This leads to reduced metabolic, toxic 
and Induction responses. In Chapter Seven, Induction in vitro was 
Investigated for precocene II and 4-1pomeanol. However, in 
contrast to 24 hour control hepatocytes, PII was not toxic to the 72 
hour control cells. 
8.5 TOXICITY STUDIES IN VITRO 
Some of the problems associated with the use of cultured hepatocytes 
for metabolism studies have been discussed in the preceding 
sections. It is clear, then, that careful thought must be given to 
the development of protocols for the investigation of toxicity in 
vitro. 
The choice of time in culture prior to exposure to xenobiotic is a 
crucial decision, since the metabolic stability of the cells must be 
balanced against the decline in P450. In this study, hepatocytes 
were cultured for 24 hours prior to exposure to allow for recovery 
from the isolation procedure and the establishment of a homogeneous 
cell population. By 24 hours, all the viable cells have flattened 
onto the dish, and other workers have suggested that the cells are 
in a metabolically stable state (Tanawa et al., 1978; Lopez ^ t al_., 
1988). 
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It was also clear from the results presented in Chapters Five, Six 
and Seven that inter-individual differences in toxicity and response 
to inducers persist in primary culture. This implies that cells 
from a number of animals should be used, rather than many cultures 
from the same animal, to assess the toxic effects of xenobiotics and 
particularly the effects of Induction on toxicity. This is less 
Important, however, in more mechanistic studies. It is also more 
Informative to present the results as a range of ID50 values or 
ID30-50-70 values rather than a single numerical value. 
The toxicity results presented in Chapter Seven agree well with 
other literature data on the seven compounds used in this study, 
which suggests that an in vivo Induction-hepatocyte culture approach 
is potentially very useful for the Investigation of the role of P450 
in hepatotoxicity, particularly since many aspects of cell function 
can be assessed concurrently e.g. viability and cellular glutathione. 
8.6 GENERAL CONCLUSIONS 
This study has shown that it is possible to use cultured hepatocytes 
in metabolism and toxicity studies. It has been shown that: 
- a range of P450 activities , both constitutive and induced, 
can be maintained at high levels in hepatocytes cultured for 24 
hours . 
- differences in P450 activity and in maintenance of these 
activities with age and sex of hepatocyte donor exist. 
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- P450 activities are maintained better in hepatocytes cultured from 
adult male rats. 
- P450 activities can be used to profile the different classes of 
Inducer. 
- induction in vivo coupled with hepatocyte culture is a useful 
approach for investigating metabolism-mediated toxicity. 
- toxicity in vivo can be reproduced in an hepatocyte culture system. 
The main problems that were identified Involve the behaviour of 
hepatocytes in culture, and the alterations in phenotype that occur. 
One of the most important issues that must be addressed is the 
effect of the variable (and often unphysiological) levels of 
hormones that are added to culture medium In the form of serum. A 
more rational use of hormonally-defined media may enhance 
maintenance of developmentally regulated forms, in addition to 
improving both the overall maintenance of the constitutive P450 
population in vitro and induction of P450s in vivo. Also, P450 
metabolism in vitro cannot be investigated in isolation, 
particularly with respect to its role in toxicity. This became 
clear from the results presented in Chapter Seven, in which some of 
the discrepancies with the in vivo data may be due to alterations in 
Phase II metabolism in vitro. Less is known about the behaviour 
of non-MFO enzyme systems in hepatocyte culture e.g. Phase II 
metabolism, FMO. The balance of the activities of all these 
systems is crucial in determining whether a compound is detoxified 
or activated. 
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Overall, cultured hepatocytes would seem to have a useful role to 
play in the investigation of metabolism-mediated toxicity, in the 
evaluation of potential and actual toxicity, and, particularly, in 
elucidation of mechanisms of hepatotoxicity. Further research into 
the regulation of P450 Induction and of hepatic metabolism in 
general should greatly enhance the development of a culture system 
which mirrors the situation in vivo. Meanwhile, much information 
can be obtained by the use of carefully planned studies with due 
consideration of the present limitations governing the use of 
primary hepatocyte cultures. 
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